Studies of complementary DNAs corresponding to skeletal muscle proteins by McInnes, Colin J
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
STUDIES OF COMPLEMENTARY DNAs 
CORRESPONDING TO 
SKELETAL MUSCLE PROTEINS
Colin J. Mclnnes
Submitted for the degree of Doctor of 
Philosophy in the University of Glasgow
Department of Biochemistry 
©  Colin J, McInnes 1988
May 1988
ProQuest Number: 10948195
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10948195
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
CONTENTS
Acknowledgements (i)
Abbreviations (ii)
Summary (iii)
Chapter One : Introduction 1
1.1 General Features of Striated Muscle Tissues 2
Histology and physiology 2
General metabolism of striated muscle 3
Contractile apparatus of striated muscle 6
The excitability of striated muscle 10
The differentiation of skeletal muscle 10
1 .2 Different Isoforms of Muscle Proteins 10
Myosin 12
C-protein 14
Actin 14
Tropomyosin 15
Troponin 17
Creatine kinase 18
Enzymes of carbohydrate metabolism 19
1 .3 Organisation and Expression of Genes for Muscle Proteins 20
Chapter Two : Materials and Methods 30
A. Materials 30
30
2.1 Chemicals 30
2.2 Media and antibiotics 30
2.2.1 Antibiotics 32
2.2.2 Liquid media 32
2.2.3 Media containing agar 34
2.2.4 Buffers 34
B. Methods 34
2.3 General procedures 34
2.3*1 Bacterial strains 34
2.3*2 Storage of bacteria 35
2.3*3 Storage of bacteriophage M13 36
2.3*4 Storage of DNA and ENA 36
2.3*5 Digestion of DNA with restriction endonucleases 36
2*3*6 Gel electrophoresis of DNA/RNA 38
2.3*6.1 Agarose gel electrophoresis 40
2.3*6*2 Low melting point agarose gel electrophoresis 42
2.3*6.3 Polyacrylamide gel electrophoresis 42
2.3*7 Extraction of DNA from agarose/polycrylamide gels 43
2.3*7*1 Elution of DNA from agarose gels 43
2.3*7.2 Extraction of DNA from low melting point agarose gels 44
2.3-7.3 Elution of DNA from polyacrylamide gels 44
2.3.8 Phenol extraction and ethanol precipitation of DNA/RNA 45
2.3.8.1 Phenol extraction 45
2.3.8.2 Ethanol precipitation 45
2.4 Isolation of nucleic acids 46
2.4.1 .1 Large scale isolation of plasmid DNA 46
2.4.1 .2 Small scale isolation of plasmid DNA 49
2.4.2 Isolation of RNA and purification of Poly (A)+ RNA 51
2.4.2.1 Isolation from mouse tissue 51
2.4.2.2 Isolation from C2C12 cells, a mouse myogenic cell line 54
2.4.3 Isolation of single-stranded bacteriophage M13 DNA 55
2.4.4 Preparation of M13 replicative form DNA 57
2.5 Synthesis of single-stranded complementary DNA 58
2.6 Radioactive labelling of DNA 59
2.6.1 End-labelling of DNA fragments with the Klenow fragment
of DNA Polymerase I 59
2.6.2 Nick-translation of DNA fragments 60
2.6.3 Randomly primed labelling of DNA fragments 62
2.7 Southern and northern transfer 63
2.7.1 Southern transfer 64
2.7.2 Northern transfer 65
2.7.3 Southern and northern 'dot-blots' 66
2.7.4 Hybridisation of immobilised DNA to radioactive probes 67
2.8 Screening of a complementary DNA library 69
2.9 Subcloning of DNA into plasmid and viral vectors 73
2.9.1 Subcloning into plasmid vectors pUC18 and pUC19 76
2.9.2 Subcloning into bacteriophage M13 vectors 79
2.9.3 Preparation of competent JM109 cells 81
2.10 Sequencing of DNA 82
2.10.1 Chemical cleavage method of Maxam and Gilbert 82
2.10.2 Dideoxynucleotide method of Sanger 87
2.11 Deletion Subcloning 91
Chapter Three : Results 94
3.1 Differential screening of a mouse cDNA library 94
3.2 Characterisation and identification of clone pCM202 98
3.3 Expression of # -tropomyosin in vivo 105
Chapter Four : Discussion 108
4.1 Isolation of cDNAs specific for skeletal muscle 108
4.1 .1 tropomyosin 108
4.1 .2 Other cDNA clones specific for skeletal muscle 114
4.2 Significance of the mouse 0 -tropomyosin cDNA sequence 117
4.3 The origins of the direct and inverted repeats in the
£-tropomyosin cDNAs 122
4*4 The CpG dinucleotide distribution in ^ -tropomyosin
cDNA 125
References 130
List of Figures 
(short title)
1 .1 
2.1 
2.2
2.3
2.4
2.5 
3-1 
3-2 
3-3 
3-4 
3-5 
3-6 
3-7 
3.8 
3-9 
3.10
3-11
3.12
3.13
3-14
3-15
3.16
3-17
3.18
3*19
3-20
3-21
3.22
3-23
3*24
3-25
3.26
4.1
4.2
4-3 
4-4 
4-5 
4 *6
4.7
4.8
Sarcomeric structure 
Colony lysis 
Plasmid vector pUC18 
Bacteriophage M13 mp18
Protocol for producing deletion subclones
Generation of deletion subclones from pCM212
Synthesis of single-stranded cDNA
Initial screening of the mouse cDNA library
Rescreen of colonies selected from the mouse cDNA library
Hybridisation of selected clones with RNA from various tissues
Construction of a cDNA library in pBR 322
Digestion of clone pCM202 with Pst I.
Sequencing strategy adopted for clone pCM202 
The nucleotide sequence of clone pCM202
The result obtained from screening a nucleotide sequence database 
Comparison of the predicted amino-acid sequence of clone pCM202 
with rabbit 0 -tropomyosin 
Rescreen of the mouse cDNA library
Restriction endonuclease digestion of colonies selected from the 
cDNA library
Sequencing strategy adopted for clone pCM232
Partial sequence of clone pCM222
Sequencing strategy adopted for clone pCM222
Examination of the inverted repeat sequence in pCM222
Sequencing strategy adopted for the ^-tropomyosin sequence
contained in clone pCM212
Overall structure of clone pCM212
The nucleotide sequence of clone pCM212
Examination of specific sequence elements in clone pCM212
The nucleotide sequence and amino-acid sequence of mouse
^-tropomyosin
Northern blot of tropomyosin mRNA species in different tissues 
The expression of fi-tropomyosin in different tissues 
Morphology of skeletal muscle cells in culture 
The expression of tropomyosin mRNA species in cultured 
skeletal muscle cells
The expression of actin mRNA species in cultured skeletal 
muscle cells
Comparison of the nucleotide sequence of mouse ^-tropomyosin 
with that of human ^-tropomyosin and TM_g-tropomyosin 
Comparison of /5- tropomyosin amino-acid sequences between species
Comparison of ^-tropomyosin nucleotide sequences between species
Generation of inverted repeats in cDNA clones
Schematic diagram of clone pCM202
Theoretical secondary structure formed by clone pCM212 
The regional distribution of CpG dinucleotides in mouse 
(3-tropomyosin cDNA
Consequences of hemi-methylation of germ-line DNA
ACKNOWLEDGEMENTS
I would like to express my thanks to the following people for 
their help throughout the course of this work:
The late Professor R.M.S. Smellie for making available the facilities 
of the Department of Biochemistry. Dr D.P. Leader for his help, 
encouragement and supervision. All my friends, past and present, in 
lab C36, in particular Irene, Ying, Caroline and Beate for passing on 
their technical expertise. And everyone else in the Biochemistry 
Department for making the last three years bearable. I would also like 
to thank Patricia Rose for her skill and patience in typing this thesis 
and to medical illustration for the production of artwork.
Finally thanks must also go to my parents for their endless support 
as well as board and lodgings, but most of all my thanks must go to 
Rachel, for everything.
ABBREVIATIONS
The abbreviations used in this thesis are as set out in "Instructions 
to Authors", Biochemical Journal (1985) 2251 1-26, except for the 
following
Amp Ampicillin
bp base pairs
BSA Bovine Serum Albumin
DNAse deoxyribonuclease
dNTP deoxynucleotide-5'-triphosphate
EMBL European Molecular Biology Laboratory
kb kilobase (1000 base pairs)
PEG polythylene glycol
RNAse ribonuclease
SDS sodium dodecyl sulphate
SSC standard saline citrate
tet tetracycline
SUMMARY
The initial objective of the work described in this thesis was 
to isolate complementary DNAs (cDNAs) corresponding to mRNAs 
encoding proteins expressed solely in skeletal muscle. To this end 
a mouse skeletal muscle cDNA library was differentially screened 
with radioactively-labelled single-stranded cDNA probes derived from 
skeletal and cardiac muscle. Of 15,000 individual colonies 
subjected to the mass screening procedure of colony hybridisation, 
247 were selected on the basis that they gave a hybridisation signal 
only with the skeletal muscle probe. Southern blot analysis of 
plasmid DNA isolated from each of these revealed eight which 
continued to produce a differential hybridisation signal with the 
two single-stranded cDNA probes. However subsequent hybridisation 
of these eight radioactively-labelled cDNA clones with poly(A)+
RNA isolated from skeletal muscle, cardiac muscle, liver and brain, 
revealed only a single clone which appeared to represent an mRNA 
specific to skeletal muscle.
The nucleotide sequence of the cDNA insert of this clone, which 
was approximately 500 base pairs (bp) in length, was determined. It 
was found to contain an open reading-frame, the predicted product of 
which corresponded to part of the sequence of the j3-isoform of 
rabbit tropomyosin. This isoform has only been found in skeletal 
muscle, although other isoforms are found in cardiac muscle, smooth 
muscle, and non-muscle tissues. No previous mouse 0-tropomyosin 
cDNA clones have been described.
The skeletal muscle cDNA library was rescreened in an attempt 
to obtain a full-length 0-tropomyosin cDNA clone. Three clones were 
selected and sequenced. One of these was found to be identical to 
the original clone selected from the initial screening. The second, 
however, contained the entire 0-tropomyosin amino-acid coding region 
together with 72 nucleotides of the 5' non-coding region and 1 51 
nucleotides of the 3' non-coding region. The remaining clone lacked 
sequence from the 3' half of the mRNA, but extended the 5' non­
coding region to 95 nucleotides. From comparison with the size of 
the mRNA (l.3kb), revealed by Northern blotting, it is estimated 
that the sequence of the mouse 0-tropomyosin determined represents
approximately 90$ of the mRNA.
The expression of tropomyosin mRNAs was examined during the 
differentiation of a cultured mouse cell line from the individual 
myoblast stage to the multinucleate cell stage. Northern blot 
analysis of the mRNA isolated from the cells at different stages of 
their development revealed that upon fusion of the cells, the 
expression of several different tropomyosin mRNAs is induced. In 
particular two species, with lengths of 1.2kb and 2.6kb, which are 
not found in the RNA isolated from 11-day old mouse skeletal muscle, 
are expressed during the differentiation of skeletal muscle cells. 
The two remaining species expressed upon fusion of the cells, a 
1 .3kb species and a 2.4kb species, correspond to the species
identified in the RNA from 11-day old mice. The identities of all
four tropomyosin species are unknown, except for the 1 .3kb 0 —  
tropomyosin mRNA. However comparison with published work suggests 
that the 1 .2kb and 2.4kb species may correspond respectively to the
alternatively spliced products from the primary transcripts which 
also give rise to the ^-tropomyosin and the^_tropomyosin 
species. No previous work has reported the possible coexpression 
of alternatively spliced isoforms of tropomyosin.
Analysis of the nucleotide sequence corresponding to mouse 
£-tropomyosin mRNA revealed some unusual features. There was a 
deficit of the dinucleotide CpG in the codon position [2,3]> but not 
in the [3»l] position, throughout the amino-acid coding region of 
£-tropomyosin. One possible explanation of this is that there is 
strand-specific hemi-methylation of the corresponding germ line DNA.
Previously published comparisons of a partial human 
£-tropomyosin cDNA sequence with a human non-muscle tropomyosin 
(TM^g) cDNA sequence had indicated the likelihood that 
£ -tropomyosin and TM^^-tropomyosin are encoded by the same 
gene, with each of the isoforms arising from the alternative 
splicing of two pairs of mutually exclusive exons. Comparison of 
these sequences with the mouse ^-tropomyosin cDNA allowed the 
conclusion that none of the 5' exons not represented in the human 
£-tropomyosin cDNA clone are involved in alternative splicing.
Nucleotide comparisons with other ^-tropomyosin cDNA sequences 
reported during the completion of this work indicated that the 3' 
and 5' non-coding regions of the f-tropomyosin mRNA had been subject 
to some selective evolutionary pressure for conservation, although 
not to the extent found for certain other mRNAs encoding muscle 
proteins (e.g. actin mRNAs).
CHAPTER 1
Introduction
Skeletal muscle is the most abundant tissue in mammals, 
constituting up to 40$ of the total body mass. Historically it has 
been used as the major source of enzymes and proteins for the study 
of intermediary metabolism and protein structure. However, more 
recently, it has been used increasingly as a model system for 
investigating the molecular events occurring during terminal 
differentiation.
There are obvious physiological and histological differences 
between skeletal and cardiac muscle. However, little is known about 
these differences, in terms of the protein species expressed in the 
two tissues, other than that different isoforms of several 
ubiquitously expressed proteins are specific to the two tissues and 
are expressed at particular stages of muscle development. The 
investigation of the genes encoding such proteins is important for 
understanding the mechanisms controlling differential gene 
expression. The identification of genes encoding unique protein 
species expressed in skeletal muscle (as opposed to isotypic 
variants) will also help to elucidate these mechanisms, but, in 
addition, may help to identify major differences between skeletal 
and cardiac muscle which in turn may lead to the identification of 
the primary biochemical lesions in those skeletal muscle myopathies 
in which cardiac muscle does not appear to be affected.
This thesis will present work, the objective of which was to 
identify complementary DNAs (cDNAs) corresponding to proteins 
expressed solely in skeletal muscle. This introduction will first 
review the general biochemistry of striated muscle, emphasising 
differences that exist between skeletal and cardiac muscle. It will 
then consider in more detail those muscle proteins already shown to 
exist in multiple isoforms, and will examine the tissue-specific and 
developmentally-specific manner in which they are expressed.
1.1 General Features of Striated Muscle Tissues
The general biochemistry of muscle tissue is such a wide 
ranging topic'that no attempt has been made to provide references to 
the orignal work, which in some instances dates back over 100 years. 
Instead the reader is referred to those books by Darnell et al 
(1983), Bourne (1973) and Passmore and Robson (1968), and the 
references therein.
Histology and Physiology
Despite their common striated appearance, the general 
morphology of skeletal muscle cells is different from that of 
cardiac muscle cells.
Skeletal muscle cells are elongated and cylindrical, frequently 
measuring up to 10cm in length, with a diameter of approximately 30- 
60/ta. Each cell is multinucleate and has its own nerve sypply.
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Skeletal muscle connects the bones of the skeleton so that movement 
is made possible. Contraction is.under voluntary control, and 
therefore, skeletal muscle cells are able to remain inactive, or at 
rest, for considerable periods of time in addition to generating 
movement. In response to such stimuli as hormones, neural input and 
the changing energy requirement of the muscle, skeletal muscle 
cells can change their metabolism, composition and bulk.
Cardiac muscle cells are much shorter than skeletal muscle 
cells, never exceeding 100/xm in length. They are irregular in shape, 
branched and interconnected through intercalated discs, thus forming 
a meshwork of closely coupled cells. Cardiac muscle cells are 
mononucleate, with a high proportion of their volume (up to 40$) 
being taken up by mitochondria, reflecting their aerobic metabolism. 
The heart as a whole has a nerve supply, but because the cells are 
coupled each individual cell need not have its own nervous input. 
Contraction is under involuntary control, with each cell having its 
own inherent self-propagating rhythmic pattern of contraction. 
However again as a result of the cells being coupled, the cell with 
the fastest rhythm dictates the contraction of all the others. 
Cardiac muscle cells have the ability to change their metabolism 
composition and bulk in response to stimuli similar to those which 
effect skeletal muscle cells.
General Metabolism of Striated Muscle
The primary role of all striated muscle is the conversion of 
chemical energy, in the form of ATP, into mechanical work. However,
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even when no work is being performed, ATP is still required by the
muscle cells, not only for the normal cellular biosynthetic
processes, but also for the active transport of ions, which 
maintains the membrane potential so essential to the contraction 
process itself. In resting skeletal muscle the energy for these 
processes is provided by the 0-oxidation of fatty acids, whereas in 
the working muscle ATP is supplied by other means. Cardiac muscle, 
however, is only ever transiently at rest and therefore it is 
difficult to determine whether separate mechanisms are used for
producing ATP for each of the different processes.
During contraction the type of work performed by each muscle 
cell type largely dictates the metabolic pathways utilised for 
producing ATP. For the purpose of this review striated muscle will 
be divided into two general classifications, fast twitch cells and 
slow twitch/cardiac cells. Fast twitch skeletal muscle cells, those 
which contract and fatigue rapidly, obtain the greatest proportion 
of their energy from the anaerobic glycolysis of glycogen and 
glucose, thus producing lactic acid as the end product. The lactic 
acid cannot be metabolised by these cells during contraction, and 
although much of it is passed to the liver via the blood, the 
reduction in pH caused by its production, results in the rapid 
fatiguing of fast skeletal muscle cells. In cardiac muscle cells 
and slow twitch skeletal muscle cells it is imperative that no 
lactic acid is produced during contraction, although, paradoxically 
cardiac muscle cells are usually net consumers of the lactic acid 
produced by fast skeletal muscle cell contraction. Nevertheless, 
however, the energy in these cell types is provided by aerobic
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metabolism, a fact reflected in the large number of mitochondria 
present in both cell types. The majority of ATP is produced from 
the aerobic metabolism of fatty acids, but some energy is also 
provided by the aerobic glycolysis of glycogen and glucose, where 
the end product, pyruvic acid, is further metabolised with the 
muscle itself, via the reactions of the Tricarboxylic Acid (TCA) 
cycle.
The other major difference in ATP production is found between 
skeletal muscle and cardiac muscle cells in general. As discussed 
previously, cardiac muscle is only ever transiently at rest and as a 
consequence the reactions responsible for producing ATP are 
occurring at all times. In resting skeletal muscle the ATP 
produced by the £ -oxidation of fatty acids is not sufficient to 
allow contraction to occur, but the reactions responsible for 
producing ATP during contraction, generally do not occur or are 
occurring only at a basal level in the resting cells. Therefore at 
the onset of contraction, when the demand for ATP increases by 
several factors, skeletal muscle cells require another mechanism, 
for producing ATP, which bridges the time gap from the onset of 
contraction to the sufficient provision of ATP by the glycolytic 
pathway. This alternative mechanism involves the high energy 
compound phosphocreatine which is stored in large quantities in 
striated muscle. In a reaction catalysed by the enzyme creatine 
kinase, the phosphate group of phosphocreatine is transferred to ADP 
resulting in the synthesis of ATP. The reaction is fully 
reversible under slightly alkaline conditions and thus in the 
resting muscle cell the phosphocreatine pool is regenerated. The
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phosphocreatine pool, although limited, can produce sufficient ATP 
to allow contraction to proceed until the glycolytic reactions 
provide enough ATP for continued contraction. The creatine kinase 
reaction does occur in cardiac cells, hut to a much lesser extent 
and certainly does not have such an important role as in skeletal 
muscle cells.
In addition to the catabolic pathways already discussed, 
striated muscle cells are capable of producing ATP from the 
oxidisation of glutamate and other amino acids. However the amount 
of ATP generated by such reactions is so small that it is not 
considered important in the overall provision of energy within the 
cell. Instead it is thought that amino acid oxidation probably 
serves to replenish some of the TCA cycle intermediates.
In addition to the general biosynthetic pathways required for 
homeostasis, the principle anabolic reactions of striated muscle 
cells involve the synthesis of glycogen from glucose. The other 
major energy sources, fatty acids, can be produced in the 
mitochondria via chain elongation reactions but it is not thought 
that this is important in maintaining the fatty acid pool in muscle 
cells.
The Contractile Apparatus of Striated Muscle
The contractile apparatus constitutes up to two thirds of the 
dry weight of a striated muscle cell. The basic unit of contraction 
is the sarcomere, a highly organised array of several different
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proteins, which in the resting state is 2.5 yum in length (Figure 
1.1). The serial arrangement of these sarcomeres form what is 
called the myofibril, a cylindrical structure which can vary in 
length from approximately 100^ im in cardiac cells to as long as 50cm 
in some skeletal muscle cells. It is the parallel array of hundreds 
of these myofibrils, with sarcomeres aligned in register, which give 
the muscle its characteristic striated pattern under the light 
microscope. Table 1 .1 lists those proteins so far identified as 
being associated with the sarcomere.
-  7 -
Figure 1 .1 The structure of the sarcomere
A diagrammatic representation of the sarcomere is 
shown, indicating the major protein species associated 
with it (Novikoff and Holtzman, 1970).
Sarcomere
Z  line ( approx. in mammalian t m w l e i
M vofilam ents
mu
l u j ur r r m
Z  line
\c l in  m olecules'
M yosin
molecule
Z line
M  y«win 
m olecule
Table 1.1 Proteins of the sarcomere
I THICK FILAMENTS
Myosin heavy chain 
Myosin light chain 
C protein 
I protein 
Creatine kinase
II THIN FILAMENTS 
Actin
Tropomyosin 
Troponins C, I and T 
©c-actinin 
Amorphin
III Z-line
oi-actinin 
Amorphin 
Z-protein 
Eu-actinin
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The sliding filament theory of muscle contraction proposes that 
upon contraction the thick and thin filaments (Figure 1.1) slide 
past each other producing a subsequent shortening of the sarcomere 
to 2.25/ini* This motion requires energy, which is provided by the 
hydrolysis of ATP, a reaction catalysed by the actomyosin ATPase. 
When myosin interacts with actin in the presence of ATP, the ATP is 
hydrolysed with the concomitant production of movement. The 
movement, probably due to a conformational change in the myosin 
molecule, is very slight and consequently many molecules of ATP have 
to be hydrolysed to produce the full 10$ shortening of the 
sarcomere.
The other proteins of the sarcomere are either involved with 
the maintenance of its structural integrity, or in the regulation of 
the contraction process, with the possible exception of one or two 
proteins. These latter include creatine kinase, the importance of 
which has already been discused, and the majority of which is found 
sequestered in the M-line of the sarcomere.
The major regulatory proteins, tropomyosin, troponin-I, 
troponin-C and troponin-T all mediate their effect in the presence 
of calcium ions, without which contraction could not occur. 
Therefore, in addition, striated muscle cells contain not only an 
active transport system for calcium ions, but also a large number of 
proteins which bind calcium ions.
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The Excitability of Striated Muscle Tissue
The stimulus for contraction of striated muscle is 
depolarisation of the cell. Thus striated muscle cells contain many 
of the enzymes and proteins associated with excitable membrances. 
These include the acetylcholine receptor, acetylcholine esterase and 
the sodium and potassium channels required to maintain the membrane 
potential.
The Differentiation of Skeletal Muscle
The mature skeletal muscle cell arises from mononucleate 
precursors called myoblasts, which do not possess contractile 
activity. In vivo these myoblasts proliferate until, at a certain 
stage of development, they fuse end to end to form post-mitotic 
multinucleate myotubes, which at a later stage, further develop into 
the mature multinucleate muscle cell with its characteristic 
striated appearance and contractile activity. These three definite 
stages of development can also be followed in vitro by culturing a 
myogenic cell line. The myoblasts are grown to confluence after 
which they can be induced to fuse and thus form the multinucleate 
myotubes and subsequently the mature muscle cells.
1 .2 Different Isoforms of Muscle Proteins
The similar sarcomeric structure and metabolic pathways present 
in skeletal and cardiac muscle, might at first suggest that 
identical proteins are involved in these tissues, albeit in
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different amounts. However, structural studies, enzyme kinetics, 
immunochemistry and the isolation of specific cDNAs have, in fact, 
demonstrated that many of the proteins thought to be common to the 
two tissues, are structurally distinct. Such proteins are referred 
to as isoforms and can be defined as individual proteins which have 
very similar though not identical primary structures, but which 
serve a similar if not identical role within the cell. Many muscle 
proteins, both sarcomeric and metabolic, have been shown to exist in 
multiple isoforms, and a list of these appears in Table 1.2. In the 
following section these muscle proteins are reviewed and the 
significance of their various different isoforms is discussed.
Table 1 .2 Muscle proteins known to exist in
more than one isotypic form
I SARCOMERIC II METABOLIC
Myosin heavy chain Creatine kinase
Myosin light chain Phosphorylase
C-protein Pho spho fruet okinas e
Ac tin Aldolase
Tropomyosin Pyruvate kinase
Troponins C, I and T and many more
Creatine kinase
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Myosin
Myosin is the major protein of the thick filament (Figure 1.1). 
It is composed of two heavy chains, each having a molecular weight 
of 200000, and four light chains each having a molecular weight of 
16000-30000. In vivo myosin interacts with actin resulting in the 
hydrolysis of ATP, the rate of which is dependent on the isoform of 
the. myosin heavy chain (MHC) present (Lowey and Risby 1971; Sarkar 
et al 1971; Close 1972, Hoh et al 1978). Thus by combining 
different isoforms of MHCs a fine tuning of the rate of ATP 
hydrolysis, and therefore the speed of contraction, can be achieved 
in different muscle cells. Myosin light chains (MLCs) fall into two 
categories, the "alkali" light chains and the phosphorylatable, or 
"regulatory", light chains. Two of each type of myosin light chain 
is associated with each native myosin molecule. The MLCs were also 
thought to affect the rate of ATP hydrolysis since different MLCs are 
found associated with MHCs of different ATPase activity. Indeed 
early research workers classified muscle as either "slow twitch" or 
"fast twitch" (with slow or fast hydrolysation of ATP), according to 
the isoforms of the MLCs present within the muscle (Sarkar et al 
1971; Lowey and Risby 1971; Holt and Lowey 1977, Trayer et al 
1977)* However, more recently, evidence has been presented which 
shows that MLCs do not affect the ATPase activity of isolated myosin 
heavy chains (Wagner and Giniger 1981).. The exact role of the MLCs 
remains unclear.
The actual number of MHC isoforms is not known, but at 
least eleven have been found in the rat: one adult superfast
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skeletal, two adult fast skeletal, one adult slow skeletal, one 
perinatal, one embryonic/foetal, two adult cardiac, one smooth 
muscle and two non-muscle isoforms (Buckingham and Minty, 1983)* As 
these classifications suggest, the MHC isoforms are expressed both 
in a tissue-specific and developmentally-specific manner, although 
one of the cardiac isoforms has also been found in skeletal muscle 
(Lompre et al, 1984; Saez and Leinwand 1986). A sequential 
transition from the expression of the embryonic isoform first to the 
perinatal isoform, and then to one of the four adult skeletal 
isoforms during terminal differentiation of skeletal muscle has been 
demonstrated in vitro and in vivo in the mouse (Weydert et al 
1987).
The exact number of MLCs is also not known, but several 
developmentally regulated isoforms have been reported. These 
include two fast skeletal isoforms (Robert et al 1982), a cardiac 
ventricular isoform, which is identical to the slow skeletal isoform, 
(Barton et al 1985) and the cardiac atrial isoform which is 
identical to the embryonic ventricular and embryonic skeletal 
isoforms (Whalen et al 1982). The two fast skeletal isoforms 
reported by Robert et al (1982) were shown to be identical in part 
of their sequence, but had different amino-termini. Therefore it 
was suggested that these isoforms would be able to interact with 
myosin heavy chains in exactly the same way, but with the different 
termini providing distinct effector activities (Robert et al 
1984).
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C-Protein
C-Protein is the other major protein of the thick filament. It 
appears to be involved in maintaining the structural integrity of 
the myosin filaments. At least two distinct isoforms have been 
isolated, one from fast skeletal muscle and the other from slow 
skeletal muscle (Starr and Offer 1983), although Reinach et al 
(1983) have shown, using monoclonal antibodies, that in some chick 
fast skeletal muscle cells, two c-protein isoforms co-exist. Until 
the exact role of the c-protein has been defined more precisely it 
will not be possible to deduce the significance of there being 
separate isoforms.
Actin
Actin is the major constituent of the thin filaments. It is a 
globular protein of molecular weight 46000, but has the ability to 
form long polymers. It is the polymeric form which is found in 
vivo in the sarcomere. Amino acid sequencing studies have 
demonstrated the existence of at least six different isoforms of 
actin in mammals, each of which tends to predominate in a particular 
tissue type (Vandekerckhove and Weber 1979), although coexpression 
of some of the isoforms is also found in certain tissues (Gunning 
et al 1983, Vandekerckhove et al 1981). The six isoforms that 
have been isolated are the©c.-skeletal isoform, theoc-cardiac 
isoform, and © 6- and ^-smooth muscle isoforms and the and J*- non­
muscle isoforms. Like myosin heavy chain isoforms, the expression 
of actin isoforms is coordinately regulated throughout muscle
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development (Storti et al 1986; Schwartz and Rothblum 1981;
Caravatti et al 1982; Minty et al 1982; Bains et al 1984)* In 
particular Bains et al (1984) demonstrated in a cultured skeletal 
muscle cell line that only / S -  and £-non muscle actin could be found 
in the mononucleate myoblasts. However after fusion the amount of 
these two isoforms fell, to be replaced, firstly, by a massive 
transient increase in the 06-cardiac isoform and then by a much 
slower steady accumulation of the expected ©^skeletal isoform. In 
the mononucleate myoblasts actin is primarily associated with the 
cytoskeleton, whereas in the fused cells it forms part of the 
sarcomere, and this alone may provide a functional rationale for the 
existence of different isoforms at these two stages of development. 
However the functional significance of a switch from ©t-cardiac to c<r- 
skeletal expression remains obscure.
Tropomyosin
Tropomyosin is a dimeric filamentous protein with a subunit 
molecular weight of 33000. In striated muscle tropomyosin forms 
head to tail aggregates which are found lying in the groove of the 
actin polymer. It has fourteen binding sites for actin per molecule 
and is thought to help to stabilise the actin polymer and thus the 
thin filament (Stone and Smillie 1978). Each molecule has at least 
one binding site for tropinin-T and, along with the troponin 
complex, it regulates the activity of the actomyosin ATPase. 
Tropomyosin is also found in non-muscle cells, most probably 
associated with the cytoskeleton (Moosekar 1983)*
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Several isoforms of tropomyosin have been reported (Cummins and 
Perry 1973; Mak et al 1980; Romero-Herrera et al 1982; Heeley 
et al 1984)» In man, Talbot and McLeod (1983) and McLeod (1986) 
have described the isolation, from fibroblasts, of at least five 
polypeptides with properties expected of tropomyosin, and have 
further described cDNA clones representing the mRRAs for three of 
these non-muscle isoforms (McLeod et al 1985; McLeod et al 
1986; McLeod et al 1987)* Complementary DNA clones have also 
been described for the human oc- and £ -striated muscle isoforms, 
and a smooth muscle isoform isolated from chicken gizard (Helfman 
et al 1984; Sanders and Smillie 1985)» The amino acid sequence of 
the smooth muscle isoform was reported to be similar to one of the 
five non-muscle isoforms reported by McLeod et al (1985), but as 
yet no mammalian smooth muscle isoform has been isolated.
The non-muscle tropomyosins are 247 amino acids in length, 
compared with the 284 amino acids of the striated muscle isoforms. 
This results in them lacking one of the binding sites for actin and 
also the binding sites for troponin-T, which are not required in non­
muscle tissues which do not contain the troponin complex. Although 
theot* and(S-striated muscle isoforms differ at 39 out of 284 amino 
acids (Mak et al 1980), it is not clear how (or indeed if) they 
differ in function, and indeed, it has not yet been determined 
whether hetero-dimers ofotand£-tropomyosin can form in vivo.
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Troponin
The troponin complex of striated muscle is composed of three 
separate proteins which interact with each other, and with 
tropomyosin, actin, and calcium ions, to regulate muscle 
contraction. Troponin-T hinds to tropomyosin, troponin-c binds to 
calcium ions, and troponin-I binds to actin and troponin-c. The 
interaction between troponin I and actin has been shown to inhibit 
the ATPase activity of actomyosin.
Two separate troponin-Cs have been isolated, one from 
cardiac/slow skeletal muscle, the other from fast skeletal muscle, 
which differ in their stoichiometry of binding calcium ions (Potter 
and Johnson 1982). These forms differed only in a single amino 
acid, which would make them the most closely related isoforms yet 
described.
Different troponin-I isoforms have been isolated from rabbit 
slow skeletal, fast skeletal and cardiac muscle cells. They all 
show a high amino acid homology in the actin-binding region, but are 
heterologous in the N-terminal region where the binding site for 
tropinin-C is found (Wilkinson and Grand 1978).
Peptide mapping, amino acid sequencing and two-dimensional gel 
electrophoresis have shown the existence of several troponin-T 
isoforms. Briggs et al (1984) have isolated two rabbit fast 
skeletal isoforms, and Wilkinson et al (1984), three chicken fast 
skeletal isoforms. However Imai et al (1986) using two­
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dimensional gel electrophoresis and immunoblotting have reported the 
existence of at least forty distinct troponin-T isoforms in chicken 
leg muscle. The existence of so many isoforms was reinforced by the 
isolation of four cDNAs and the gene, encoding rat fast skeletal 
troponin-T isoforms, and will be discussed in more detail later 
(Breitbart et al 1987, Nadal-Ginard et al 1987)*
Creatine Kinase
Creatine kinase is required for the synthesis of ATP both in 
muscle and non-muscle cells. It is a dimeric enzyme with a subunit 
molecular weight of approximately 40,000, and is composed of two 
polypeptides, the M- or the B-isoforms. The three possible isozymes 
MM, BB and MB seem to have both a tissue-specific and 
developmentally specific pattern of expression. A sequential 
transition from the BB isoform to the MM isoform has been 
demonstrated in differentiating embryonic muscle tissue (Ziter 1974) 
and in myogenic cell lines (Turner et al 1974; Lebherz and Rutter 
1969)- In adult tissue the BB isoform occurs predominantly in 
smooth muscle and non-muscle tissue, whereas the MM isozyme seems 
confirmed to skeletal muscle, with the mixed dimer MB being 
predominant in mammalian heart tissue (Eppenberger et al, 1961).
The separate cytoplasmic isoform of creatine kinase may be explained 
by it having no requirement to associate with the sarcomere.
However it is not clear why two different sarcomeric isoforms are 
required, one for skeletal muscle and the other for cardiac muscle.
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Enzymes of Carbohydrate Metabolism
Many metabolic enzymes have been shown to exist in multiple 
isoforms, some of the best studied being Phosphorylase (Sato et al 
1972, Delain et al 1973), Phosphofructokinase (Layzer and Epstein 1972, 
Korata et al 1972, Delain et al 1973), Aldolase (Horecker et al 
1972, Toutsumi et al 1983) and Pyruvate Kinase (Ibsen 1977, Peters 
et al 1981, Moore and Bulfield 1981). For each of the enzymes cited 
there is a clear tissue-specific distribution of isozymes in adult 
tissues and the same developmentally regulated sequential pattern of 
expression of isozymes during the terminal differentiation of skeletal 
muscle, as was found for actin and myosin isoforms.
Each of these enzymes is multimeric in structure. The principles 
involved in the formation of isotypic variants are similar for each 
enzyme and therefore only the case of Pyruvate Kinase will be discussed.
Pryuvate Kinase, an enzyme of the glycolytic pathway, is a 
tetrameric protein. At least four different subunit types have been 
found which result in four different homo-tetrameric isozymes, although 
many hetero-tetramers may also exist (Ibsen 1977)* The four different 
homologous isozymes exhibit a very definite tissue-specific distribution, 
with one being found in muscle tissue, one in liver, one in kidney and 
one in erythrocytes. Each isozyme is distinguishable kinetically and 
therefore different isozymes may be adapted to the environment of the 
tissue in which they are found.
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Many isoforms of muscle proteins are classified by the adult tissue 
in which they are found. However, it is quite clear, from the examples 
already discussed, that isoforms, other than those classified as being 
specific to skeletal muscle, are expressed during the normal development 
of a skeletal muscle cell. Consequently it has been suggested that, 
rather than being tissue-specific many isoforms are expressed in response 
to the physiological and metabolic demands of the individual muscle cell 
at the various stages of its development. This suggestion is consistent 
with the fact that different isoforms of the same protein do possess 
different properties in many of the cases already discussed. However, 
for some proteins, eg actin, functional advantages conferred by 
particular isoforms, in specific tissues, have not yet been discovered.
1 Organisation and Expression of Genes for Muscle Proteins
Analysis of the genes encoding several muscle proteins has suggested 
that there are two ways in which the differential expression of isoforms 
may be controlled. The first involves simple transcriptional units; that 
is those in which one gene encodes one protein. Expression of these 
proteins is, therefore, most likely to be controlled through the 
transcription of their genes. The second involves what may be termed 
complex transcriptional units; those in which one gene encodes two or 
more proteins. There is no evidence that DNA rearrangements, similar to 
those occurring in immunoglobulin gene expression, occur here, but rather 
it appears that in this case expression of a particular protein species 
requires control of pre-mRNA processing. Table 1.3 lists the proteins 
discussed in the preceding sections, according to the way in which the 
expression of their isoforms is thought to be controlled.
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Table 1 .3 Muscle proteins and the method by which the expression
of their isoforms is controlled.
I Transcriptional Control
Myosin heavy chains 
Actin
Creative kinase 
Metabolic enzymes?
II Alternative processing of pre-mRNA
Troponin T 
Tropomyosin 
Myosin light chains
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Of the proteins discussed previously, only the actins and myosin 
heavy chains have been shown to have simple transcription units. The 
exact number of genes encoding MHC isoforms is not known, but has been 
estimated as being between seven and twenty-two, with the genes coding 
for the skeletal muscle isoforms being clustered on chromosome 11 in 
rats (Czosneck et al 1982, Weydert et al 1985, Gelbeiter et al 
1986) and chromosome 17 in humans (Saez et al 1987)* The cardiac 
isoforms, too, are also linked being on chromosome 14 in both species. 
Weydert et al (1985) have proposed that the clustering of skeletal 
MHC genes is essential for their sequential expression throughout 
development. However, actin isoforms are also expressed sequentially 
during differentiation of skeletal muscle cells, and although the 
chromosomal locations of the genes for all six isoforms have not yet 
been determined, the genes for o^-skeletal, ©4r-cardiac and /S-cytophasmic 
actins in the rat are situated on separate chromosomes - 3, 17 and 5 
respectively (Czosneck et al 1983, Robert et al 1985)- Therefore the 
coordinate expression of actin isoforms, at least, does not require close 
chromosomal linkage.
Studies of the control of the expression of specific genes in other 
cases have revealed the presence of regions of DNA sequence 5' to the 
structural gene (cis-acting elements) which bind protein factors (trans­
acting elements), present in the nucleus, in such a way as to stimulate 
transcription of the gene (Dynan and Tjian 1985)* Furthermore, several 
research workers have shown that certain regions of DNA 5' to the gene 
are essential for the tissue-specific expression of the e<.1 -antitrypsin 
and albumin genes in the liver (Ciliberto et al 1985, Ott et al 1984) 
the insulin gene in the pancreas (Walker et al 1983), the «4-A-crystallin
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gene in the lens (Chepelinsky et al 1985) and actin genes in muscle 
(Melloul et al 1984).
Recently Minty and Kedes (1986) and Miwa et al (1987) have 
identified two short regions of DNA upstream of the human cardiac actin 
gene which modulate its transcription when transfected into a myogenic 
cell line. These same two regions did not affect transcription when the 
gene was transfected into either a fibroblast or pheochromocytoma cell 
line and this led to the proposal that these sequences must interact with 
a tissue-specific transcriptional factor(s) present within muscle cells. 
Their results, however, also suggest that the postulated tissue-specific 
factor(s), although necessary, is not sufficient for expression. Thus, 
myoblasts of the C2 skeletal muscle cell line show an abundant expression 
of their cardiac actin gene (albeit transiently) at the onset of fusion 
(Bains et al 1984), but do not express the (endogenous) gene before 
differentiation. However if a human cardiac actin gene is transfected 
into the undifferentiated myoblasts it is transcribed (Minty et al 1986). 
Minty et al (1986) thus proposed that the tissue specific transcription 
of the cardiac actin gene must be, at least, a two stage process in which 
the gene had first to be activated in some way before the DNA regulating 
regions could respond to the controlling transcriptional factor(s).
It is not known why the cardiac actin gene should remain innactive 
until the onset of differentiation, but several theoretical possibilities 
exist. The presence of protein factors which bind to DNA in such a way 
as to prevent gene transcription, as is the case in both adenovirus gene 
transcription (Borelli et al 1984) and gene transcription in mammalian 
embryonic stem cells (Gorman et al 1985); or protein factors which
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prevent post-transcriptional processing of the mRNA, are both 
possibilities. However Minty et al (1986) demonstrated that the 
transcription of a human actin gene, containing 5kb of upstream sequence 
and 2kb of downstream sequence, transfected into a C2 myogenic cell line, 
is not repressed in any way during the time that the endogenous actin 
gene transcription is being repressed.
It has been found that regions of DNA close to several genes contain 
a large proportion of methylated cytosine residues in the dinucleotide 
CpG, but that these regions become selectively demethylated when the 
genes are being transcribed (Chiu and Blau 1985, Keshet et al 1985)« 
However when Shani et al (1984) investigated the methylation state of 
the skeletal muscle actin and myosin light chain > 2  genes, they did not 
detect any change in the methylation state during the terminal 
differentiation of a rat Lg myogenic cell line, and therefore 
concluded that methylation was not involved in the inactivation in this 
case. However, since the methylation state of DNA in vivo can only be 
apraised by using certain restriction enzymes which can discriminate 
between methylated and unmethylated DNA, but which will only act on a 
small proportion of the possible methylation sites, one cannot rule out 
some involvement for DNA methylation.
Chromatin structures within the chromosome, can innactivate genes by 
blocking access to them by the transcriptional factors. Conformational 
changes in chromatin structure are then needed to activate the gene 
(Weintraub 1985). Such a change of chromatin structure has been shown 
for the skeletal muscle actin gene in differentiating Lg cells, as 
assayed by DNase I sensitivity (Carmon etal 1982). Therefore an
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analogous situation has been proposed for the cardiac actin gene.
Whatever the gene activation or deactivation mechanism is, a primary 
stimulus is required to initiate either the conformational change in the 
chromatin structure, the selective (de)methylation of DNA, or the 
expression of a repressor protein. Candidates for such a stimulus include 
the release of a neural or hormonal factor. Evidence for a neural factor 
being involved was supplied when it was shown that the full maturation 
process of myogenic cell lines, including the sequential expression of 
MHC genes, is obtained only when the culture medium is supplemented with 
nerve extracts (Toyota and Shimada 1983; Gonoi et al 1983; Periasamy 
et' al 1984; Weydert et al 1985)- However other research groups have 
disputed this fact by demonstrating that the same sequential patterns of 
isoform expression are obtained, albeit at a slower rate, both in vivo 
and in vitro in the absence of any nervous input (Phillips and Bennet 
1984; Kano et al 1983; Weydert et al 1984), and so the involvement 
of a neural factor may still be questionable.
Thyroid hormone, on the other hand, has been shown to be involved 
in MHC gene expression (Lampre et al 1984, Izumo et al 1986). It 
was demonstrated that <x.-cardiac MHC expression increases in hyperthyroid 
rates, but decreases, with a subsequent increase in 0-cardiac MHC 
expression, in hypothyroid animals. The mechanisms by which thyroid 
hormone might initiate gene (de)activation has yet to be elucidated. 
However the identification of its receptor and the demonstration that 
this has DNA binding properties reveals a possible mechanism by which 
thyroid hormone may mediate its effect.
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Before discussing the question of the control of the alternative 
processing of gene transcripts, some specific examples of differential 
splicing will be described.
The expression of troponin-T isoforms has been shown to be subject 
to alternative splicing. Comparison of four cDNAs with each other and 
the gene encoding them (Breitbart et al 1984, Breitbart et al 1987, 
Nadal-Ginard et al 1987) demonstrated that, theoretically, as many as 
sixty-four distinct isoforms of fast skeletal troponin-T could be 
produced by the alternative splicing of exons within one gene. 
Furthermore, analysis of nuclear ENA showed that at least two, and 
possibly many more, of the isoforms arise from identical primary 
transcripts, and therefore alternative splicing mechanisms alone are 
sufficient for producing protein diversity. Imai et al (1986) had 
previously shown by 2D-gel electrophoresis and immunoblotting that at 
least forty troponin-T isoforms were coexpressed in checken leg muscle, 
but whether or not the expression of each was tightly controlled, by 
specific alternative splicing mechanisms, still has to be determined.
Alternative splicing is also used to generate two distinct isoforms 
of skeletal muscle myosin light chains (Robert et al 1982). These 
isoforms are first expressed in late embryonic development and then 
accumulate at different rates in skeletal muscles of different metabolic 
types. Comparison of the DNAs of these, with the gene encoding them, 
indicated that the majority of the coding region and all of the 3' non­
coding region was shared by the two isoforms, but that they differed in 
the first exon and the 5' non-coding region. Thus it would appear that 
two distinct transcriptional promoters had been used to produce two
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distinct primary transcripts, which differed in length by some 10 kb. 
However since the longer transcript also includes the 5' non-coding 
region and first exon of the smaller transcript, alternative splicing 
mechanisms must be used to produce a specific protein isoform (Periasamy 
et al 1984)* In addition since the isoforms accumulate in different 
muscles at different rates, then it is suggested that two distinct 
transcriptional factors (or sets of factors) would be required to produce 
the separate primary transcripts.
McLeod et al (1986) have described the isolation of two 
tropomyosin cDNAs; one encoding the striated nuscle <*.-tropomyosin and the 
other encoding TM^, a non-muscle isoform. Comparison of the 
nucleotide sequences of these two cDNAs suggests that they were both 
transcribed from a single gene, and arose via the alternative splicing of 
mutually exclusive exons. A similar proposal was made about the origin 
of the 0-tropomyosin isoform and another non-muscle isoform
(McLeod et al 1985)» However in this case only part of the 
f-tropomyosin sequence was known. There is no evidence to suggest that 
the oL.-tropomyosin and TM^q isoforms are coexpressed in either muscle 
or non-muscle tissues and therefore it would appear that in this 
particular case one gene encodes two protein isoforms in separate 
tissues. However as in the case of MLC isoforms, the different 5' 
termini of the cDNAs suggest that two separate transcriptional promoters 
may have been used to produce separate pre-mRNAs.
Little is known about any of the mechanisms mediating alternative 
splicing of exons. However the theoretical possibilities are strikingly 
similar for each of the three examples outlined above. The first model
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involves the primary transcripts forming specific secondary structures 
which juxtapose exons that have to he spliced together. Computer 
analysis of the troponin-T gene sequence has shown that the formation of 
stem and loop structures, which juxtapose specific exons, is possible, 
and, furthermore, that these structures theoretically could be stabilised 
by interaction with certain small nuclear RMs (Breitbart and Nadal- 
Ginard 1986). In the case of the MLC isoforms, however, since the primary 
transcripts differ in length by about 10 kb it is thought that each 
should have a different "folding" capability, and therefore the 
interaction with additional small nuclear RNAs may not be required to 
stabilise specific secondary structures.
It has also been suggested that the use of alternative promoters and 
hence alternative transcription initiation sites, as is the case for MLC 
transcripts, may predetermine the splicing pattern to be used. Whether 
or not sequence elements within the primary transcript, acting in-cis, 
would be sufficient to direct alternative splicing, is not yet known. 
Following on from this suggestion, however, is one in which the choice of 
a particular pair of exons for the first splicing event, is thought to 
predetermine the subsequent splicing pattern. This is because it has 
been shown that certain "donor" and "acceptor" splice junctions have a 
different affinity for each other and therefore some pairs of exons may 
be more compatible for splicing together than others. In this model 
the control would be exercised by a specific factor(s).
It is not clear why some isoforms of muscle proteins, the actins and 
the myosin heavy chains, are subject to transcriptional control alone, 
while others are also subject to alternative splicing of pre mRNA. Any
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evolutionary advantage gained by being able to produce greater protein 
diversity from a relatively small section of the genome, by using 
alternative splicing mechanisms, must surely be lost by the need for at 
least one more tier of control. Only a fuller investigation of the genes 
encoding isoforms of muscle proteins may help to solve this paradox, but 
more importantly will provide valuable evidence about the control of 
expression of eukaryotic genes throughout development.
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CHAPTER 2
Materials and Methods
A. Materials
2.1 Chemicals
All chemicals were AnalaR Grade supplied by BDH Chemicals Ltd 
or Formachem (Research International) Ltd, unless otherwise stated 
in the text. A list of all chemical and equipment suppliers is 
given in Table 2.1
2.2 Media and Antibiotics
All culture media, and other solutions used in the cloning 
work, were sterilised by autoclaving at 15 p.s.i. for 15 mins. 
Solutions containing glucose, sucrose or glycerol were autoclaved 
at 5 p.s.i. for 30 mins. Heat labile compounds such as antibiotics 
and thymine were sterilised by passage through a 0.2jum filter, 
(Flow Research), and added as< eptically to the cooled culture 
media.
2.2.1 Antibiotics
Antibiotics were supplied by Sigma and used at the following 
concentrations;
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TABLE 2.1 Chemical and Equipment Suppliers
Aldrich Chemical Company, Gillingham, Dorset, England 
Anglian Biotechnology Limited, Colchester, Essex, England 
Amersham International pic, Amersham, Bucks, England 
BDH Chemicals Ltd, Poole, Dorset, England 
Beckman Instruments Inc, Edinburgh, Scotland 
B.R.L. UK Ltd (GIBCO), Paisley, Scotland
The Boehringer Corporation (London) Ltd, Lewes, E. Sussex, England 
James Burroughs Ltd, Pine Alcohols Division, London, England 
Difco Laboratories, West Molesey, Surrey, England 
Fisons Scientific Apparatus, Loughborough, Leicestershire, England 
Flow Research Labs Ltd, Irvine, Scotland
Fluka A.G., Fluorochem Ltd (UK distr.), Glossop, Derbyshire, England 
Koch-Light Laboratories Ltd, Colnbrook, Bucks, England 
Kodak Ltd, Kirby, Liverpool, England 
LKB Instruments Ltd, South Croydon, Surey, England 
New England Biolabs, CP Labs Ltd, (UK distr.), Bishops Stortford, 
Herts, England 
Pharmacia Ltd, Milton Keynes, England
Schleicher and Schuell, Anderman <Sc Co. (UK distr.), East Molesey, 
Surrey, England 
Sigma London Chemical Co Ltd, Poole, Dorset, England 
Whatman Lab Sale Ltd, Maidstone, Kent, England 
UV Products Ltd, Winchester, Hants, England
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Ampicillin: stored at -20°C as a 5mg/ml solution in water, used 
at a concentration of 30^g/ml in culture media.
Tetracycline: stored at -20°C as a 20mg/ml solution in 50$ 
ethanol and used at a concentration of 20Jkg/ml in culture media for 
routine growth, and 13yOg/ml for transformations.
2.2.2. Liquid Media
L-Broth: 10g Bacto Tryptone (Difco 0123-01)
5g Yeast Extract (Difco 1880-17)
5g NaCl
per litre of distilled water. pH was adjusted to 7.2 with NaOH 
and the media autoclaved. Antibiotics were added as appropriate.
2xYT Broth; 16g Bacto Tryptone 
10g Yeast Extract 
5g NaCl
per litre of distilled water.
2.2.3 Medium Containing Agar
LB Agar: 15g Bacto Agar (Difco 0140-01)
per litre of L-Broth with or without antibiotics as appropriate.
2xYT Agar: 1 5g Bacto Agar
per litre of 2xYT Broth
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Hammersmith Stahs: 0«9g Nutrient Broth (Difco 0003-02)
0.75g Bacto Agar 
0.5g NaCl
per 100ml of distilled water. pH was adjusted to 7*2 and the 
solution autoclaved. Once cool 1ml Thymine (lOmg/ml stock in 
water; Sigma) was added.
Glucose/Minimal Media Agar: M9 Salts: 6g Na^HPO^
per litre of distilled water.
For minimal media each reagent was sterilised separately and 
then mixed asceptically;
3g KH2po4 
1g NH^ ci 
0.5g NaCl
1 litre M9 salts
1 ml 1M MgSO.4
1 ml 0.1 M CaCl
2
1 ml 1M Thiamine - HC1
10 ml 20$ Glucose
15 g Bacto Agar
H-Agar: 10 g Bacto Tryptone
8 g NaCl
12 g Bacto Agar
per litre of distilled water
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H-Top Agar: 10 g Bacto Tryptone
8 g NaCl
8 g Bacto Agar
per litre of distilled water. H-top agar was stored as 50-100ml 
aliquots.
2.2.4 Buffers
T.E. Buffer: 10 mM Tris-HCl pH 8.0
1 mM EDTA
B. METHODS
2 .3 General Procedures
The following section describes the maintenance of bacteria,
DNA and ENA stocks, as well as those procedures which were used 
frequently throughout the course of this work.
2.3-1 Bacterial strains
Two strains of bacteria were used and their genotypes appear in 
Table 2.2.
E.Coli DH1 was used as the host strain for the growth of the 
two plasmid DNA libraries.
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E.coli JM109 was used as the host strain for the growth of 
the pUC 18 and pUC 19 and related recombinants, as well as the 
growth of both RF (replicative form) and single-stranged DNA of 
bacteriophage M13 and M13 derived recombinants.
TABLE 2.2 The genotypes of the E.Coli strains used in this work.
Organism Strain Genotype Reference
E .coli DH1 F “,rec A1,end A1 
gyr A96,thi,hsdR17 
sub E44>relA1 ,
Law, 1968 
Meselson and 
Yuan, 1968
E.coli JM109 rec A1 ,end A1,gyr A96, Yanish- 
thi, hsi R17 ,SupE44»relA1 Perron et al 
Jt', A(lao-pro AB), [F ", 1985
tra D36,pro AB,lao IqZ AM1 5]
2.3-2 Storage of Bacteria
Stock cultures of JM109 and DH1 transformed with plasmid DNA, 
were stored at -70°C under glycerol. Sterile glycerol was 
added, to 50$, to an exponentially growing culture and vortexed to 
ensure a homogenous solution was obtained. The bacteria were then 
stored as 1ml aliquots at -70°C where they remained viable for 
the period of this work, at least.
Working stocks of DH1 were stored at room temperature for up
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to one year in the form of Hammersmith stabs.
Working stocks of JM109 were stored at 4°C on minimal agar 
plates to ensure the retention of the F episome required for the 
detection of recombinants.
2.3-3- Storage of bacteriophage M13
M13 virus particles which cannot be frozen were stored in 
sterile 2xYT medium at 4°C.
2.3 *4 Storage of DNA and RNA
Replicative form (RF) and single stranded DNA from M13» and 
plasmid DNA, was stored at -20°C in T.E. buffer, in tightly 
fitting capped tubes (Eppendorf).
Genomic DNA was stored in T.E. at 4°C to prevent shew?ing 
of the DNA caused by freezing.
RNA, both poly A+ and total RNA, was stored in sterile tubes 
at a concentration of 1 mg/ml, in sterile T.E., at -70°C.
2-3*5 Digestion of DNA with Restriction Endonucleases
Restriction endonucleases were purchased from the following 
companies; Bethesda Research Laboratories (BRL), New England 
Biolabs, The Boehringer Corporation (London) Ltd., Pharmacia, and
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Anglian Biotechnology Ltd.
Digestion of DNA using restriction endonucleases from BRL were 
performed using the "REact" system of buffers supplied by B.R.L. 
Other digestions were performed using High, Medium or Low Salt 
buffers as indicated by the manufacturer. Restriction 
endonucleases, Sma I, Bgl I, and Bgl II required more specialised 
buffers. A list of the 10X stock concentration of all buffers 
appears in Table 2.3*
One unit of enzyme activity is defined as the amount of enzyme 
required to digest 1 jjig of DNA in 1 hour. In a typical reaction 1 
Jjg of DNA was incubated with a 5-10 fold excess of enzyme to ensure 
complete digestion. Reaction volumes were kept to a minimum
(usually 20 jjJl) t but with the volume of enzyme added never exceeding
10$ of the total reaction volume. The reaction mixture was 
incubated at the appropriate temperature for at least two hours 
after which the digestion was stopped by the heat denaturation of
the enzyme or by the addition of EDTA to 10mM. Digested DNA
samples could then be analysed by gel electrophoresis.
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2.3*6 Gel electrophoresis of DNA/RNA.
DNA, DNA fragments and ENA were separated by electrophoresis 
through agarose or polyacrylamide gels as follows:
In general polyacrylamide gel electrophoresis was used for 
separating radiolabelled fragments of DNA in preparation for Maxam 
and Gilbert sequence analysis, and agarose gel electrophoresis used 
at all other times, unless greater resolving power was required.
Table 2.4 lists the electrophoresis buffers used as well as 
the sample loading buffers.
size range
0.5-5kb
0.1- 2kb
> 5 kb
% gel concentration 
0*1% agarose 
1% agarose 
2$ agarose or 
4$ polyacrylamide
\
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TABLE 2.3 Contents of the buffers used for 
restriction endonuclease digestion of DNA
Buffer Tris-HCl NaCl KC1 MgSO, DTT
4
Low Salt 10mM pH7 *4 - - 10mM 1mM
Med Salt lOmM pH7 *4 50mM - 10mM 1mM
High Salt 10mM pH7*4 100mM - 10mM
Sma I 10mM pH8.0 - 20mM 10mM 1mM
Bg11/Bg1 II 10mM pH9 *4 - - 10mM 1mM
The above concentration of ingredients are for the 1x reaction 
butter. 10x stock solutions of each buffer were prepared and stored
2.3*6.1 Agarose Gel Electrophoresis
Agarose (Type II; BRL) gels were prepared by adding the 
appropriate amount of agarose to 80ml of 1 x electrophoresis buffer 
(normally TBE) and heating the mixture to boiling point. The 
solution was allowed to cool to approximately 50°C and the gel 
cast in a 12cm x 12cm gel apparatus. Gels were then immersed in the 
same 1 x running buffer in an electrophoresis tank and the samples 
loaded using one third volume of "loading buffer". The DNA samples 
were then subjected to electrophoresis at 50mA for approximately 
one hour or until the desired resolution was obtained.
After electrophoresis DNA bands could be visualised by 
illumination under long wave u.v. light using a u.v. 
transilluminator (U.V. Products), and photographed if desired, using 
a Polaroid Cu-5 land camera and Type 665 Positive/Negative film.
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TABLE 2.4 Content of the buffers required for electropheris 
with agarose and polyacrylamide gels
Buffer Loading buffer
10 x T.B.E.: 1M Tris-HCl 
1M Boric Acid 
1 OmM EDTA 
pH is 8-3
0.02$ bromo- 
phenol blue,50$ 
glycerol in 1 x 
TBE
20 x Tris-Acetate Buffer:
800mM Tris
100mM Sodium Acetate 
2OmM EDTA
pH to 7 *4 with Acetic Acid
0.02$ bromo- 
phenol blue, 50$ 
glycerol in 1 x 
Tris-Acetate
Ethidium Bromide was added to 5ng/ml in the 1 x buffer except 
for polyacrylamide sequencing gels, when it was omitted altogether.
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2.3-6 .2 Low Melting Point Agarose Gel Electrophoresis
LMP agarose (BRL) gels were prepared as above, but were allowed 
to set at 4°C. The current was not allowed to exceed 40mA 
during electrophoresis.
2.3-6.3 Polyacrylamide Gel Electrophoresis
Polyacrylamide gel electrophoresis was performed using 16cm x 
16cm glass plates, 1.5mni spacers and the V161, BRL vertical gel 
apparatus. A typical gel contained 4$ acrylamide (19$ acrylamide,
1$ N,N-methylene bisacrylamide stock; BRL), 10$ glycerol and 0.04$ 
ammonium persulphate in a total volume of 50ml 1 x TBE (Table 2*4) • 
The gel plug was made by mixing 5ml of the above gel mixture with 
40 pi TEMED (N,N,N’N'-tetramethylethylene-diamine) and pouring.
Once the gel plug had set 30p i  TEMED was added to the remaining gel 
mixture and the main gel cast.
DNA samples were prepared by the addition of 0.3 volumes of 
loading buffer (50$ glycerol, 0.05$ Xylene Cyanol, 0.05$ 
Bromophenolblue, in 10xTBE). They were then loaded onto the gel and 
electrophoresed, in 1x TBE, at 200V for 2-3 hours depending on the 
resolution required. In a typical 4$ polyacrylamide gel the xylene 
cyanol migrated with a mobility equivalent to a DNA fragment of 
350bp in length, and the bromophenol blue, one of 70bp in length.
After electrophoresis the gel was left on one glass plate and 
stained for approximately 10 minutes in a 40pg/ml solution of
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Ethidium Bromide. The DNA was then visualised as before, under UV 
illumination, and photographed if required.
2.3*7 Extraction of DNA from Agarose/Polyacrylamide Gels
2.3*7*1 Elution of DNA from Agarose Gels
Electrophoresis of digested DNA was performed in Tris-acetate 
buffer at 60V for as long as was necessary to separate the required 
fragment(s).
The DNA band(s) was then excised from the gel with a scalpel and 
placed in 9mm dialysis tubing, (The Scientific Instrument Co.), with 
200jp. of 1 x Tris-acetate buffer, and sealed at both ends. The 
tubing was then placed in the electrophoresis tank, in known 
orientation, and electrophoresis performed at 60V for one hour, 
after which the solution was removed from the dialysis bag and 
retained. A further 200JM of 1x Tris-acetate buffer was then 
added to the dialysis bag and electrophoresis continued in the same 
orientation for a further 15 mins, after which the orientation was 
reversed and back-electrophoresis performed for 1-2 minutes. The 
solution was again removed from the bag and pooled with the earlier 
aliquot. This was then centrifuged to remove agarose. The 
supernatant was then transferred to a fresh Eppendorff tube and the 
DNA precipitated with ethanol (see Section 2.3*8).
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2.3-7*2 Extraction of DNA from Low Melting Point Agarose Gels.
Electrophoresis was performed for as long as was necessary to 
separate the required fragment(s), which was then excised from the 
gel and placed in a 1 .5ml Eppendorff tube with 100jjl TE buffer.
The gel was then melted by heating to 65°C for 15 minutes, and 
the agarose removed with phenol. The DNA was then recovered from 
the supernatant by ethanol precipitation (both Section 2.3*8).
2.3*7*3* Elution of DNA from Polyacrylamide Gels
The appropriate DNA band(s) was cut from the gel and placed in 
a siliconised 1ml Eppendorff tip heat-sealed at one end, and 
containing siliconised glass wool. The gel was ground up using a 
glass rod, and then washed to the bottom of the tip using 600jiX of 
Eluting buffer (500mM ammonium acetate, 10mM magnesium acetate 1mM 
EDTA, 0.1$ SDS). The tip was then sealed at the other end using 
parafilm and incubated at 37°C overnight.
After incubation the sealed end of the tip was cut off with 
scissors, the parafilm removed, and the buffer allowed to drain into 
a siliconised glass centrifuge tube (e.g. 15ml Corex). The tip was 
then rinsed, four times, with 200jx 1 of Elution Buffer and the DNA 
precipitated from the pooled eluate with ethanol (Section 2.3*8).
The DNA was sedimented by centrifugation at 2000g and resuspended in 
400jjCL 3M sodium acetate pH 6.0. Pieces of acrylamide were then 
removed by centrifugation in a table-top Eppendorff centrifuge, 
after which the DNA was recovered from the supernatant by ethanol
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precipitation.
2.3*8 Phenol Extraction and Ethanol Precipitation of DNA/RNA.
DNA was routinely purified free of protein by denaturation, and 
subsequent removal of the protein, by phenol, after which it was
recovered from the aqueous supernatant by ethanol precjp^ation.
/
2.3*8.1 Phenol Extraction
Typically a mixture of phenol:chloroform:isoamyl alcohol 
(25:24:1) was used. Generally the aqueous phase was extracted three 
times by vortexing it with an equal volume of the phenol mixture, 
with the phases being separated each time, by centrifugation. When 
gentle handling was required, the aqueous and phenol phases were 
mixed by hand, since vortexing would have sheared the high molecular 
weight DNA.
Any residual phenol remaining in the aqueous phase after 
extraction, was removed by extracting twice with water saturated 
diethylether, after which the nucleic acids were recovered from the 
aqueous phase by ethanol precipitation.
2.3 *8.2 Ethanol Precipitation
Nucleic acids were recovered from aqueous solutions by the 
addition of 0.1 volume 3M sodium acetate pH 6.0 and 2.5 volumes 
ethanol, and incubating overnight at -20°C or at -70°C for
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1 5  minutes.
After incubation the nucleic acids were sedimented by 
centrifugation at ca 10,000 rpm (l7,000g) and then washed with 80$ 
ethanol to remove excess salt. After recentrifutation, the nucleic 
acids were dried by lyophilisation, and finally redissolved, to the 
required concentration in T.E. buffer.
2.4 Isolation of Nucleic Acids
The following section describes the various methods used for 
isolating, plasmid DNA, mRNA and bacteriophage M13 replicative form 
(RF) and single-stranded DNA.
2.4*1 Isolation of Plasmid DNA
2.4*1 *1 Large Scale Isolation of Plasmid DNA (Birnboim & Doly 1976)
Growth and Amplification of Plasmid DNA
25ml of L-Broth containing the.appropriate antibiotic was 
inoculated with a single colony of the bacterial clone in question and 
incubated overnight at 37°C in an orbital shaker. Two 5ml aliquots 
of the overnight culture was then taken to seed two flasks, each 
containing 800ml of L-Broth (without antibiotic) and the bacteria
grown until the turbity of the broth reached an O.D.^^ = 0.8.
bOO
Bacterial growth was then halted and plasmid copy number amplified 
by the addition of chloramphenicol (Sigma) to 165^LAg/ml and further
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incubation at 37°C on the orbital shaker overnight.
Lysis of Bacteria and Extraction of Nucleic Acid
Bacteria were sedimented by centrifugation at 5000 rpm (4000 )g
for 10 minutes, in a suitable large capacity rotor, the supernatant 
discarded, and the cells resuspended in 9*5ml total of 0.05M 
Glucose, 0.01M EDTA, 0.025M Tris-HCl pH8.0. The cells were then 
lysed by the addition of lysozyme (Sigma) to 2mg/ml and incubation 
at 0°C for 30 minutes. A further incubation at 0°C for five 
minutes with 20ml 0.2M NaOH, 0.1$ w/v SDS, served to irreversably 
denature the host cell protein and chromosomal DNA, after which the 
plasmid DNA was selectively renatured by neutralising the solution 
with the addition of 15ml 3M sodium acetate pH4.8 and a final 
incubation at 0°C for 1 hour.
Cellular debris was removed by centrifugation at 30,000 rpm 
(64,000g) for 30 minutes in a Beckman Ti60 rotor, the supernatant 
collected and the nucleic acids precipitated by the addition of 0.6 
volume isopropanol.
Purification of Plasmid DNA
The nucleic acids were sedimented by centrifugation at 10000 
rpm (l7,000g) for 15 minutes in a suitable rotor, such as the 
Sorvall SS-34, and then redissolved in 30ml T.E.
28.9g CQ&sium chloride (BCL) was dissolved in this to give a
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solution of density = 1.59 to which ethidium bromide was added to a 
concentration of 0.4-mg/ml* Protein and other debris precipitated by 
the addition of caesium chloride was removed by subjecting the 
solution to a clarifying centrifugation at 1500 rpm (500g) for 30 
minutes in a Beckman TJ-6 'table top' centrifuge.
The clarified solution was then transfered to sealable Beckman 
VTi50 centrifuge tubes which were filled to capacity, if necessary, 
by the addition of ceasium chloride solution of the same density.
The tubes were sealed and the solution subjected to 
ultracentrifugation at 50,000 rpm (240,000g) and 20°C for at 
least 16 hours in order to equilibrate the DNA.
After untracentrifugation the plasmid DNA could be visualised, 
under long wave ultra violet illumination, as the lowest discrete 
band in the tube. The DNA was then collected by piercing the tube 
with a 21g hypodermic needle just below the band and allowing it to 
drain into a sterile centrifuge tube, being careful not to 
contaminate the collected band with any other band appearing above 
it in the tube. At this stage, however, the collected plasmid DNA 
was usually still contaminated by tRNA, but which was removed if 
necessary by ultracentrifugation, at 65,000 rpm (400,000g) and 20°C 
for a further 16 hours, in a Beckman VTi65 rotor. The band of 
plasmid DNA was subsequently collected as outlined previously.
Ethidium bromide was removed from the pooled solution by 
extracting it four times with 3-methyl-l-butanol (Koch-Light). The 
volume of solution was then measured and four times this volume of
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T.E. was added to it. The DNA was recovered by ethanol 
precipitation overnight.
The precipitated DNA was sedimented by centrifugation at 10000 
rpm (I7,000g) and 0°C for J>0 minutes in a suitable rotor (Sorvall 
HB-4), thereafter resuspended in a small volume (eg 100Jkl) T.E. and 
transfered to a 1.5ml Eppendorff tube where it was again 
precipitated with ethanol. The final DNA pellet obtained from this 
stage was lyophilised and then dissolved in a suitable volume of 
T.E. for storage. The yield was usually of the order of 1mg.
2.4--1 *2 Small Scale Isolation of Plasmid DNA (Holmes & Quigley 1981)
Growth of Bacteria
A single colony of the bacterial clone in question was spread 
onto the appropriate antibiotic selection plate in such a way as to 
produce a lawn of cells covering half of the plate. The bacteria 
were allowed to grow overnight.
Lysis of Bacteria and Extraction of Plasmid DNA
The bacteria were harvested by gently scraping the cells off the
agar plate, and then resuspending them in 1ml of a solution 
containing 8$ w/v Sucrose, 0.04M Tris-HCl pHS.O, 0.05M EDTA pH7*5,
5$ v/v Triton X-100, in a 1.5ml Eppendorff tube. Lysis and 
denaturation of protein and genomic DNA was achieved by the addition 
of Lysozyme (Sigma) to 200^ug/ml and subsequent boiling of the
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solution for 7 minutes.
Cellular debris was then sedimented by centrifugation in an 
Eppendorff centrifuge, and 0.6ml of the remaining supernatant taken 
for isolating the plasmid DNA.
The supernatant, at this stage, was usually contaminated with 
RNA and so boiled RNAase A (Sigma - 1mg/ml stock in H^O) was 
added to approximately 4^ug/ml and the solution incubated at 37°C 
for 15 minutes. The RNAase A was then inactivated by the addition 
of 1 jjX  diethylpyrocarbonate (Sigma) and a further incubation at 
65°C for 10 minutes.
Plasmid DNA was precipitated by the addition of 2/5 volume, 5M 
ammonium acetate (unbuffered) and 0.9 volume isopcopanol with an 
incubation on dry ice for five minutes. DNA was sedimented by 
centrifugation in an Eppendorff centrifuge for 10 minutes and then 
resuspended in 0.3M ammonium acetate/70^ isopropanol. The DNA was 
again sedimented and then washed with 80$ ethanol, after which the 
final pellet was lyophilised, dissolved in 30jjd. T.E. and stored at 
-20°C.
The DNA obtained was occasionally still contamined with tRNA 
and protein, but was usually suitable for performing restriction 
enzyme analysis. 1-2ya of this prep was sufficient for 
visualisation on an agarose gel.
- 50 -
2.4*2 Isolation of ENA and Purification of Poly A+ RNA
2.4*2.1 Isolation from mouse tissue (Kirby 1956)
All solutions and items of equipment, including dissecting 
instruments and glassware, were sterilised, by autoclaving, before 
use. Disposable gloves were worn at all times to prevent 
degradation of the RNA by contaminating ribonucleases.
Preparation of Tissue
RNA was prepared from 11 day old mice (Porton), and although 
different tissues were used (brain, liver, skeletal muscle and 
cardiac muscle) the technique for isolating the RNA was identical 
in each case.
The tissue was excised rapidly from the dead animal and placed 
immediately into liquid nitrogen. It was ground in a mortar until 
it was completely powdered and then added to 20ml Calvaria Buffer 
(0.05M NaCl, 0.005M sodium acetate pH5*0, 0.001M EDTA, \% w/v SDS).
Extraction of Protein
Protein was denatured and extracted using phenol (Section 
2.3*8). The extraction was performed, at 65°C for 3 minutes, in 
30ml glass tubes (Corex), with the phases being separated each time 
by centrifugation; the aqueous phase was drawn off with a pasteur 
pipette and stored until later. The phenol phase was reextracted
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with a further 20ml Calvaria Buffer which was then pooled with the 
first aqueous phase and reextracted with phenol as often as was 
required to produce a clear solution. Nucleic acids were then 
recovered from this aqueous phase by precipitation with ethanol 
(Section 2.3*8).
Isolation of RNA
The nucleic acids were sedimented by centrifugation and then 
redissolved in 4ml \% w/v N-lauroyl sarcosine (Sigma L5125), 0.01M 
EDTA pH 7*0. This stow process was accelerated by passing 
successively through sterile 19g and 23g hypodermic needles which 
also served to sheer the genomic DNA, which helped to reduce losses 
of RNA.
Once dissolved, 4g of caesium chloride was added and allowed to 
dissolve. The sample was then halved and each was layered over a 
ceasium chloride cushion (5g CsCl in 4ml 0.01M EDTA pH 7*0) in 
Beckman SW40 rotor centrifuge tubes. Approximately 0.5ml of the 
sarcosyl buffer was then laid over this and the tubes then filled to 
capacity with parafin oil.
RNA was separated from the DNA, by ultracentrifugation at 17000
rpm (36,000 ) and 20°C overnight. After centrifugation the 
g
supernatant was removed to below the level of the caesium chloride 
interface, the tubes drained, and cut down to prevent the RNA 
precipitate being contaminated by DNA or protein higher up the 
tube. The RNA precipitate was then dissolved in 2ml sterile water
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and the yield and purity checked by measuring the absorbance at 260nm 
and 280nm (1 ^ unit=40^Cg RNA). Essentially pure RNA should
give an A^qj A23Q ratio of two, but in practice was 
sometimes slightly less. Finally the RNA was recovered by ethanol 
precipitation and the resulting precipitate redissolved in a suitable 
volume of T.E. buffer.
Isolation of Poly (A)+ RNA (Edmonds et al 1971)
Since poly (A)+ RNA represents only 5$ of total RNA a 
minimum of 1mg of total RNA must be obtained from the previous 
stage before it is beneficial to proceed with poly(A)+ RNA isolation.
Isolation was carried out by means of oligo dT cellulose 
chromatography through a small column. 100mg of oligo dT cellulose 
(BRL) was applied to the column in water/diethylpyrocarbonate. The 
column was then washed with water/diethylpyrocarbonate followed by a 
large volume of loading buffer (0-5M NaCl, 0.01 M Tris-HCl pH 7-5,
0.001M EDTA). Total RNA, in 2ml loading buffer, was heated to 
65°C for two minutes, cooled rapidly, and then applied to the 
column. The eluate was collected and the procedure repeated twice. 
After the third passage through the column unbound RNA was eluted 
from it by washing the column with loading buffer plus 0.5$ w/v SDS.
At this stage 1ml fractions were collected and the absorbance at 
260nm monitored until it fell below 0.05* The fractions collected up 
to this point contain the poly (A)” RNA. Poly (A)+ RNA was eluted from 
the column using elution buffer, (0.01M Tris-HCl pH 7»5» 0.001M 
EDTA, 0.2$ w/v SDS), with the absorbance at 260nm being measured to
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calculate the yield.
Once the appropriate fractions were pooled the poly (A)+ RNA was 
precipitated with ethanol overnight and the resultant precipitate 
dissolved and stored in sterile water at -70°C.
2.4*2.2 Isolation of RNA from C2C12 cells, a mouse myogenic cell line
(Blau et_al 1985)
C2C12 cells are derived from the satellite cells isolated from 
crushed thigh muscle (Yaffe and Saxel 1977)* At high concentrations 
of serum they can be cultured as mononucleate myoblasts, but at low 
serum concentrations they withdraw from the cell cycle and form 
multinucleated myotubes. The C2C12 cell line was a gift from R. 
Akhurst, St Mary's Hospital, London.
p
C2C12 cells were cultured in 80cm flasks in 1 x Delbeco's 
Modification of Eagle's Medium (DMEM; - NBL) containing 0*375$ 
sodium bicarbonate (GIBCO), 0.05 mM glutamine (GIBCO), 20$ foetal 
bovine serum (Flow) and 0.5$ chicken embryo extract (Flow). The 
cells were grown at low density, with the culture medium being 
changed every 48 hours, to prevent premature withdrawal from the 
cell cycle. Differentiation was promoted by allowing the cells to 
grow to about 70$ confluence and then reducing the serum 
concentration. The fusion media used was 1 x DMEM, 0.375$ sodium 
bicarbonate, 0.05mM glutamine, 2$ horse serum (Flow).
p
Two 80cnr- flasks were used to prepare RNA. The cells were
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harvested by scraping them into the culture medium with a rubber 
policeman. They were then sedimented by centrifugation at 
approximately 1 500g and then resuspended in 0.5ml 1 x Calvaria 
buffer (Section 2-4-3-1 )• The protein was denatured and extracted 
with phenol (Section 2.3*8) and total nucleic acids recovered from 
the aqueous phase by precipitation with ethanol. The RNA was 
separated by ultracentrifugation through a ceasium chloride step 
gradient, as before (Section 2.4*3*2), but this time the preparation 
was scaled down for use with the Beckman SW56 rotor, where the tube 
capacity is only 4ml* Ultracentrifugation was at 19,000 rpm 
(36,OOOg) and 20°C, overnight.
The resulting RNA precipitate was treated as before, with the 
RNA finally being redissolved in an appropriate volume of T.E. 
buffer and stored at -70°C.
2.4*3 Isolation of Single-Stranded Bacteriophage M13 DNA
The following procedure was used to isolate single-stranded DNA 
from both wild-type M13 phage and recombinants derived from M13*
Growth and Amplification of Phage
Single plaques, obtained from the transformation of competent 
JM109 cells, with single stranded (ss) or replicative form (RF) DNA, 
were picked and inoculated into separate 2ml volumes of a 1/100 
dilution of an overnight culture of JM109 cells. The cells were 
then shaken on an orbital incubator at 37oC for 5-6 hours after
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which they were harvested by centrifugation in an Eppendorff 
centrifuge for five minutes.
At this stage the supernatant contains the phage particles and 
so should be retained for preparation of single-stranded DNA.
However the sedimented cells can also be retained for a small scale 
isolation of replicative form DNA by the procedure outlined in 
section 2.4*1 *2 .
Isolation of single-stranded DNA
The supernatant was poured into a new Eppendorff tube and the 
phage particles precipitated by the addition of 20$ w/v polyethylene 
glycol 6000, 2.5M NaCl to 20$ v/v and incubating at room temperature 
for fifteen minutes. The phage was then sedimented by centrifugation 
in an Eppendorff centrifuge for five minutes after which the 
supernatant was aspirated off. It is very important to remove all 
traces of the polyethlene glycol 6000, therefore the tubes were 
recentrifuged and any remaining supernatant was again drawn off with 
an aspirator.
The phage pellet was resuspended in 100jjl T.E. buffer to which 
100jlL phenol was added and the mixture vortexed to destroy the 
phage coat and other phage proteins. Approximately 500jXL of 
chloroform was then added and the mixture vortexed to further reduce 
the risk of contamination by polyethylene glycol 6000. The two 
phases were then separated by centrifugation and the aqueous phase 
drawn off. Single- stranded DNA was then recovered from the aqueous
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phase by precipitation with ethanol (Section 2.3-8) and the final 
D M  precipitate redissolved and stored in 25>L T.E. Buffer.
2.4-4 Preparation of M13 Replicative Form DNA
The following procedure was used to isolate replicative form (RF) 
DNA from wild type M13 mp 18 and mp 19 virus and that of recombinants 
derived from M13-
Growth of Bacteria and Amplification of ReplicatjVe, Form DNA
Competent JM 109 cells were transformed with the single­
stranded DNA template of interest and plated out on H-Agar plates.
A single plaque was picked and inoculated into 1 .5ml of a 1/100 
dilution of an overnight culture of JM109 cells and incubated on an 
orbital shaker at 37°C for 4-5 hours. The cells were then 
sedimented and the supernatant shored at +4°C overnight. 100ml of 
fresh 2 x YT medium was inoculated with 1ml of an overnight culture 
of JM109 cells, 1ml of the stored supernatant, and then incubated at 
37°C for five hours.
The cells were harvested, in a suitable large capacity 
centrifuge, and the RF DNA isolated in the same manner as for the 
large scale isolation of plasmid DNA outlined in Section 2.4-2.1
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2.5 Synthesis of single-stranded complementary D M  
(Wickens et al 1978)
Single stranded complementary DNA, (cDNA), was synthesised from 
poly (A)+ RNA isolated from both skeletal and cardiac muscle tissue.
A minimum of 1 ^ Ag of poly (A)+ RNA was required for each batch of cDNA 
synthesis.
The reaction buffer was assembled fresh on each occasion and 
contained 50mM Tris-HCl pH 8.3, 10mM MgCl2, 100 mM KC1, 50jrfk 
of non-radiolabelled dATP, 1mM of each of the other three dNTPs,
10mM dithiothreitol and 0.1 mg/ml oligo-dT (12-18; DCL). Preliminary 
experiments had been performed to determine the optimum concentration 
of the unlabelled radioactive nucleotide (dATP) which would give the 
best combination of length and specific activity of the cDNA 
synthesised.
The reaction mixture, containing 60jjl Reaction buffer, 10^g 
poly (A)+ RNA, 25 units of AMV Super Reverse Transcriptase (Anglian) and 
20jXL of e>c-32p in a total volume of 100jjl, was assembled on
ice and then incubated at 42°C for one and half hours. Poly (A) +
RNA was removed from the reaction mixture by boiling for three 
minutes, followed by rapid chilling of the solution. The cDNA was 
then recovered from the reaction mixture by size-exclusion chromotography, 
using the same method as outlined in section 2.6.2. The cDNA could 
then be checked for length by electrophoresing small sample of it on an 
agarose gel, drying the gel down and subjecting it to autoradiography.
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2.6 Radioactive Labelling of DNA
Fragments of DNA were labelled with or 35g prior to 
Maxam and Gilbert sequencing, for use as radioactive probes in 
Southern and Northern transfer, and as radioactive molecular weight 
markers for use in Southern and Northern Blots. Three methods were 
used.
2.6.1 End labelling of DNA fragments with the Klenow Fragment of
E.Coli DNA Polymerase I.
This method was used to prepare DNA for subsequent sequencing 
by the method of Maxam and Gilbert and for the preparation of 
radioactive molecular weight markers. The method relies primarily 
on the initial restriction of the DNA with a restriction enzyme 
which leaves 5' protruding ends. The DNA is then labelled by 
filling in these "sticky'* ends, with complementary radioactive bases, 
using the Klenow enzyme.
After restricting the DNA with an appropriate enzyme it was 
ethanol precipitated (Section 2.3*8) and the following added to the 
dried DNA precipitate; 3 *75/11 of the Medium Salt Restriction Buffer 
(Table 2.3), 30 jXL ^ P  dNTP (an appropriate radioactive dNTP 
complementary to one of the nucleotides in the "sticky" end), 1 jxl 
of a mixture of the other three non-radioactive dNTPs each at a 
concentration of 0.1mM, and one unit of Klenow fragment (BRL). The 
reaction volume was made up to 25/XL with sterile distilled water and 
the mixture incubated at room temperature for 30 minutes.
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The radioactively labelled DNA fragment was then removed from 
the majority of unreacted mucleotides by precipitating it with 90 <
minutes in dry ice (solid C02; Distillers). The DNA was 
sedimented by centrifugation, with the supernatant containing the 
unincorporated radioactive nucleotides being discarded. The DNA 
precipitate was then resuspended in 10Oyuil 0.3M sodium acetate pH 6.0, 
and precipitated with 300 pX ethanol and incubation in dry ice for 
15 minutes. The DNA was then sedimented, lyophilised, and stored at
The two separate precipitation steps were usually sufficient to 
remove the unreacted radioactive dNTP, however since the DNA is 
subjected to electrophoresis, at a later stage, slight contamination 
did not matter.
When labelling DNA for use as radioactive molecular weight 
markers ^ S  dNTP was substituted for the ^ P  dNTP.
2.6.2 Nick-Translation of DNA Fragments (Rigby et al 1977)
The following method was used to radioactively label DNA 
fragments for use as probes for Northern and Southern transfer.
2 .5M ammonium acetate (unbuffered) ethanol for five
-20°C.
The DNA fragment to be labelled (for optimum labelling 0.3-1^g 
were used) was dissolved in a total of 2.5^1 water. To this was added 
1 *8jjlX of 10x Medium Salt Restriction Buffer (Table 2.3) > 50jjjd of
any dNTP, 1 .5 of a mixture of the other three non-
radioactively labelled dNTPs, each at a concentration of 0.1mM, 
of a fresh 1 in 10,000 dilution of DNAase I (5 mg/ml stock in 
distilled water) and one unit of E. Coli DNA Polymerase I (BRL).
The DNAase I was used to introduce nicks into the DNA fragment which 
were subsequently repaired by DNA polymerase using the mixture of 
radioactive and non-radioactive dNTPs. The reaction mixture was 
incubated at 15°C for at least four hours.
Once the reaction was complete the unreacted radioactive 
nucleotides were separated from the labelled DNA fragment by 
size-exclusion chromotography. A 1ml plastic Eppendorff tip, or a 
pasteur pipette, was packed with siliconised glass fibre and a 
column of Biogel P60 (Biorad) was poured. The Biogel P60 is stored 
preswollen in N.E. buffer (50mM NaCl, 0.5mM EDTA pH 7*0) with 0.02$ 
w/v sodium azide as preservative.
The volume of the sample was increased to 100^1 with NE 
Buffer, and then passed through the column which had been previously 
preequillibrated with several volumes of NE buffer. The eluate was 
collected and the column washed with further 100yAl volumes of N.E. 
Each 100 fraction was collected in separate Eppendorff tubes, 
with ten fractions in total being collected.
The labelled DNA fragment eluted first, appearing as a peak of 
radioactivity centered around fraction 5 or 6 , with the unreacted 
radioactive nucleotides appearing mainly in fractions 9 and 10.
The radioactivity in each 100jk.1 fraction was measured either in a
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scintillation spectrometer using Cherenkoff counting or with a Type 
5.10E hand held Geiger counter.
The fractions containing the labelled DNA fragment were pooled 
and stored in a lead pot at -20°C.
2 .6 .3 Randomly Primed Labelling of DNA Fragments by E .Coli 
DNA Polymerase I (Feinberg and Vogelstein 1983)
The following method was used for labelling of DNA fragments 
used as probes in Northern and Southern transfer. It was found to be 
a particularly useful method of labelling DNA if the quantity of DNA 
available was limited, since as little as 30ng of DNA could be labelled 
to high specific activity. However problems of probe specificity 
may arise if the length of the DNA fragment to be labelled is less 
than 1300 b.p.
Solutions required for the Labelling Reaction
Solution A; Each of the three non-radioactively labelled dNTPs 
each at a concentration of 100mM in 1 ml 1.25 M Tris-HCl pH 8.0,
0.125 M MgCl^, \Qjjl± (S-mercaptoethanol. This solution is stored 
at -20°C.
Solution B: 2M Hepes (Sigma) pH 6 .6 , stored at +4°C.
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Solution C: Hexadesoxyribonucleotides (Pharmacia Ph No 2166)
evenly suspended in T.E. buffer at 90 A u n i t s  per ml, and stored 
at -20°C.
Stop Solution: 0.02M NaCl, 0.02M Tris HC1 pH 7*5, 0.002M, EDTA,
0.25$ w/v SDS, 1jvJl dNTP (the non-radioactive version of the 
labelled dNTP used).
Bovine Serum Albumin (BSA) as a stock solution of 10 mg/ml, -^P 
dNTP, sterile distilled water and E. Coli DNA polymerase I were 
also needed for the reaction.
The DNA was added to 10 jaJ. reaction mixture, 2 BSA, 20 jjJJC
32P dNTP, 2-3 units Pol 1 and the volume increased to 50jj<.1 with 
sterile distilled water. The solution was then incubated at room 
temperature overnight, after which 50 jjl of Stop Solution was added. 
The unreacted radioactive nucleotides were then separated from the 
labelled DNA fragments by size-exclusion chromatography as outlined 
for nick-translation (Section 4*2).
2.7 Southern and Northern Transfer
Southern and Northern transfer procedures were used to transfer 
DNA and RNA samples respectively from agarose gels on to 
nitrocellulose (Schlier & Schull) or nylon (NEN or PALL) membranes 
for subsequent hybridisation to radioactive probes. DNA and RNA 
samples were also spotted directly onto the nitrocellulose or nylon 
membranes for Mdot-blots".
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2.7*1 Southern Transfer (Southern 1975)
DNA was separated on an agarose gel (Section 2.3*6) with T.B.E. 
as the electrophoresis buffer. The gel was photographed before 
proceeding. It was then bathed in approximately 2.5 volumes 0.5M 
NaOH, 1 .5M NaCl for 30 mins in order to denature the DNA. The 
denaturing solution was poured off, the gel rinsed twice in 
distilled water and then neutralised in approximately 5 volumes of 
0.5M Tris-HCl pH 7*6 , 1 .5M NaCl for 30 minutes. It was important to 
neutralise the gel, since alkaline conditions have a deleterious 
effect on the nitrocellulose membranes.
While the gel was soaking, the blotting apparatus was 
assembled, comprising two reservoirs, each containing approximately 
300ml 20 x SSC (3M NaCl, 0.3M sodium citrate), connected by a solid 
support. A double layer of 3MM Chromatography paper (Whatman) was 
placed on the solid support with each end extending into the two 
reservoirs to act as wicks. The 3MM paper was allowed to soak 
completely before proceeding. Once neutralisation of the gel was 
complete it was placed, in known orientation, on top of the solid 
support. The nitrocellulose membrane, appropriately marked for easy 
identification of the gel tracks, and four layers of 3MM paper, were 
then placed on top of the gel, ensuring that no air bubbles were 
trapped between any of the layers, especially between the gel and 
the nitrocellulose membrane. The nitrocellulose membrane and the 
four layers of blotting paper were presoaked in 2 x SSC (0.3M NaCl, 
0.03M sodium citrate), to promote transfer of the DNA from the gel
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to the nitrocellulose "by the salt gradient. Finally approximately 
6cm of dry "tissues", weighted down by a 1kg weight, were stacked on 
top of the blotting paper to draw the buffer from the reservoirs up 
through the gel, thus carrying the DNA with it onto the 
nitrocellulose membrane where it binds.
Transfer was allowed to proceed overnight, and once complete 
the nitrocellulose membrane was carefully washed in 2 x SSC for 5 
minutes to remove any gel still adhering to it. The nitrocellulose 
was then allowed to air dry at room temperature, and the DNA 
immobilised covalently, by baking the filter in a vacuum oven at 
80°C for two hours. The filter was then ready for hybridisation 
to a radioactive probe.
2.7*2 Northern Transfer (Thomas 1980 , Ellis et al 1983)
The procedure for transferring RNA from agarose gels to 
nitrocellulose or nylon membrances was identical to that for 
Southern transfer (Section 2.7*1)* However since RNA is hydrolysed 
by strong alkali, it had to be denatured in a manner other than that 
of soaking the gel in sodium hydroxide. Therefore RNA was separated 
on a denaturing agarose gel.
A 1$ agarose acetate formaldehyde gel was prepared by 
dissolving 0.6g agarose (BRL) in 60ml 1 x RB (0.02M MOPS, 0.005M 
sodium acetate, 0.001M EDTA pH 7*0)* The solution was allowed to 
cool below 60°C after which 10ml 35-37$ formaldehyde (Koch- 
Light) was added to a final concentration of 2.2M and the gel cast.
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RNA samples were prepared by adding three volumes of a solution 
containing 66$ v/v Formamid; FLUKA, 13$ v/v 10x RB, 20$ v/v 35- 
37$ formaldehyde and heating to 60°C for 5 minutes. 0.5 
volumes of loading buffer (10$ w/v Ficol; Pharmacia, 0.1$ w/v 
Bromophenol blue; Sigma; in water) was added to the samples and 
electrophoresis performed at 60V in 1 x RB containing 2.2M 
formaldehyde for the length of time it took for the dye to migrate 
80$ of the length of the gel.
The gel was not stained with ethidium bromide since the 
formaldehyde prevents fluorescence of the RNA and DNA size markers. 
Therefore radiolabelled DNA size markers (Section 2.6.1) were 
generally used instead.
2.7*3 Southern and Northern 'Dot Blots'
This procedure involved spotting the DNA and RNA directly onto
the membrane, thus eliminating the gel eletrophoresis stage. Before 
loading the nucleic acid samples, the nitrocellulose filter was 
soaked in 20 x SSC and then allowed to air dry at room temperature.
DNA samples, usually about 2 ^  of the plasmid DNA from the 
small scale isolation outlined in Section 2.4*1 *2, were denatured by 
heating to 90-100°C for 5 minutes followed by rapid cooling on 
ice. Samples were then spotted, 1jxl at a time, directly onto the 
nitrocellulose filter. Once all the samples had been loaded the
filter was baked in a vacuum over at 80°C for two hours.
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The procedure for spotting RNA samples onto the membrane was 
identical, but for the fact that the RNA was denatured by heating to 
65°C for 15 minutes, before rapid cooling and loading.
2.7*4 Hybridisation of Immobilised DNA to Radioactive Probes
Detection of RNA or DNA immobilised on nitrocelulose or nylon 
membranes is dependent on hybrids forming between the immobilised 
nucleic acids and the radiolabelled probe. Consequently the 
conditions under which stable hybrids can form have to be 
considered.
The use of Formamid (Fluka) in the hybridisation medium lowers 
the temperature at which stable hybrids can form, thus eliminating 
the problems caused by higher temperatures needed in its absence. 
Similarly salt concentration in the hybridisation medium is kept 
relatively high to promote the formation of stable hybrids. Thus by 
manipulating temperature and salt concentration a variety of 
hybrids can be detected dependent on their relative stability.
The baked nitrocellulose filter was taken and presoaked in 5 x 
SSPE (0*9M NaCl, 0.01 M Na^PO^, 0 *05M NaOH, 0.001 M EDTA) and 
then prehybridised, at 42°C for at least two hours, in the 
hybridisation solution (50$ v/v deionised formamid, 5 x SSPE, 0*1$ 
w/v SDS, 10 x Denhardt's solution) 50 x Denhardt's solution is 1$ 
w/v Ficoll, 1$ w/v Polyvinylpyrolidine, 1$ w/v B.S.A. - all Sigma - 
filtered through Whatman No.1 filter paper. This is to block non­
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specific binding of the probe to the nitrocellulose filter.
After prehybridisation was complete the radiolabelled probe was 
denatured by heating to approximately 80°C for 10 minutes or by 
the adddition of 0.1 volume 1M NaOH, followed 10 minutes later by 
0.1 volume 1M Tris-HCl pH 7-5 and 0.1 vol 1M HC1. The denatured 
probe was added to fresh hybridisation solution (as above) and 
sealed in a polythene bag with the prehybridised filter, ensuring 
that no air bubbles were present. Hybridisation was then performed 
at 42°C for at least 16 hours.
Once hybridisation was complete the radioactive solution was 
carefully removed and the filter washed to remove non specifically 
bound probe. The conditions under which the filters were washed 
were altered to suit the stringency required for detecting the , 
sequences of interest.
The stability of the hybrids is decreased by raising the 
temperature and lowering the salt concentration of the washing 
solution. Thus conditions were obtimised for detecting non­
identical hybrids as well as identical hybrids.
Filters were washed initially in 2 x SSC, 0.1$ w/v SDS (2 x SSC 
is 0.3M NaCl, 0.03M Sodium Citrate) at room temperature for 50 
minutes with the washing solution being changed every 10 minutes. 
This was sufficient for detecting partially homologous sequences, 
however if highly homologous sequences were to be detected then the 
stringency was increased by raising the washing temperature to
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CONDITIONS OF STRINGENCY USED FOR WASHING HYBRIDISED FILTERS
Filters washed at high stringency were washed in 2 x SSC at room
temperature for 50 minutes and then for a further hour in 0.1 x SSC at a 
o
temperature of 60 C.
Filters washed at medium stringency were also washed for 50 minutes at
room temperature in 2 x SSC and then in 0.1 x SSC for 1 hour at a temperature 
o o
m  the range 42 -50 .
Filters washed at low stringency were subjected only to the 50 minute 
wash in 2 x SSC at room temperature.
45°C and above, whilst also lowering the salt concentration to 
0.1 x SSC, 0.1$, w/v SDS. The filter was then washed for a further 
60 minutes with one change of washing solution.
When washing was complete, the filers were allowed to air dry 
and were then subjected to autoradiography using X-OMAT film 
(Kodak).
2.8 Screening of a Plasmid Vector Complementary DNA Library 
(Grunstein and Hogness 1975)
The plasmid library was stored as frozen cells under glycerol 
at -70°C. When it was to be screened a small piece of the 
frozen stock was chipped off and into 1ml sterile L-Broth (Section 
2.2) containing 30$ v/v glycerol. Serial dilutions were made of 
this, and the library titred by growth of the bacteria overnight or 
L- plates containing tetracycline. The original 1ml of L-Broth with 
glycerol was stored overnight at -20°C.
Once titred the appropriate dilutions were made, and the 
plasmid library grown on L-plates plus tetracycline (20^g/ml) at a 
density of approximately 500 colonies per 9cm petri dish.
When the colonies had grown, but before they became too large 
and diffuse, a nitrocellulose filter was placed directly on top of 
the colonies, for approximately 5 minutes, and its orientation 
marked precisely both on the filter and the master plate of 
bacteria. The filter was then taken and placed ’other side up' on a
aoias
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nutrient agar plate (L-broth plus tetracycline). The colonies were 
then allowed to grow directly on the nitrocellulose filter. In this 
way several duplicate filters of bacteria could be prepared for use 
with different probes. Once grown the colonies could be lysed and 
the plasmid DNA, contained within them, baked onto the 
nitrocellulose filters.
The colonies were lysed, and the proteins and genomic DNA 
denatured, by placing the filters colony side up, successively on 
top of a small volume (1ml) of several different solutions which are 
listed in Table 2-5• Bacterial debris was then removed from the 
filters before proceeding with covalent attachment of the plasmid 
DNA and'subsequent hybridisation steps. Figure 2.1 presents a flow 
chart indicating this procedure.
- 70 -
Table 2.5 The Solutions requried for Colony Lysis
Solution A:- 25$ Sucrose, 50mM Tris-HCl pH 7 «6 , 0.5mg/ml Lysozyme,
Solution B:- 0.5M NaOH, 0.2$ v/v Triton X-100
Solution C:- 0-5M NaOH
Solution D:- 1M Tris-HCl pH 7-6
Solution E:- 1 -5M NaCl, 0.1 M Tris-HCl pH 7-6
Solution F:- 0.3M NaCl.
All solutions can be prepared in advance and stored at room 
temperature, except Solution A. Solution A is prepared in advance 
minus the lysozyme, which is added to the appropriate concentration 
immediately prior to use. None of the solutions needed to be 
sterilised.
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Figure 2.1 Flow Chart indicating the Protocol for Colony Lysis
Step 1 3 ^ 1  minute solution A
Step 2 1 x 1  minute solution B
Step 3 1 x 3  minutes solution C
Step 4 2 x 1  minute solution D
Step 5 1 x 5  minutes solution E
Step 6 Filters are allowed to air dry
Step 7 Immersion in solution F
Step 8 Filters rolled between Whatman
54 chromatography paper 
Step 9 Filters are allowed to air dry
Step 10 Filters baked in 80°C vacuum oven.
The introcellulose filters were laid successively on top of 1ml 
of solutions A to E for varying lengths of time (steps 1 to 5)» 
allowed air dry (step 6), and then immersed in solution F (step l)• 
The filters were then rolled between Whatman 54 chromatography paper 
(Ashless), using considerable weight, to remove bacterial debris 
(step 8 ), and were once again allowed to air dry (step 9) • Steps 7 
to 9 were then repeated as often as was necessary to remove all 
visible traces of bacterial debris before the plasmid DNA was 
immobilised on the filter by baking in a vacuum oven for two hours 
(step 10).
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2.9 Subcloning of DNA into Plasmid and Viral Vectors
DNA fragments were subcloned into the appropriate vectors 
either to facilitate direct sequencing of the fragments or to 
provide material for the preparation of radiolabelled probes.
The plasmid vector pUC18 (Figure 2.2) and indeed the M13 
vectors, use a simple chromogenic method for selecting recombinants 
which requires the host strain of bacteria, JM109> to be totally 
deficient in 0--galactosidase activity. When the host is transformed 
with a non-recombinant plasmid, or M13 phage particle, (&- 
galactosidase activity is restored and can be detected by the blue 
colour of colonies or plaques.
|S-galactosidase activity is restored by non recombinant pUC18 
because of what is known as oC-complementation. The host strain, 
JM109, carries the F-episome which contains a mutant £ -galactosidase 
gene (lac Z MI5) which is capable of complementation with the 
N-terminal fragment of the £-galactosidase gene carried by pUC18.
The restored galactosidase activity of the transformed cell is used 
to convert the colourless substrate x-gal (5-*bromo-4- chloro-3- 
indolyl-f-D-galactoside) into a blue chromophor which subsequently 
gives a blue colour to bacterial colonies.
The insertion of a piece of foreign DNA into the 54bp multiple 
cloning site of pUC18 prevents ©c-complement at ion and therefore 
£ -galactosidase activity is not restored by such recombinant 
plasmids. Thus when grown in the presence of X-gal, no blue colour
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is formed, and the resulting colonies have a white appearance. In 
order to distinguish these white colonies from colonies resulting 
from untransformed host, the transformation mixture is grown on LB 
plates containing Ampicillin, thus making use of the Ampicillin 
resistance gene in pUC18. Therefore, when the transformation 
mixture is gown on LB plates plus Ampicillin only colonies 
transformed with pUC18 grow, and in the presence of X-gal non­
recombinant plasmids give rise to blue colonies whereas recombinant 
colonies are white.
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Figure 2.2 Plasmid Vector pUC18
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pUC18 is a small (2826 bp) E. Goli plasmid, constructed by 
Messing and coworkers, out of pBR322 and M13 mp18. It carries a 
54bp multiple cloning region which forms the basis of the subcloning 
strategy and also allows easy detection of recombinants. The above 
figure illustrates this 54bp region with the 13 unique restriction 
sites. It also shows the location of the lac gene fragment, the 
Ampicillin resistance gene and the origin of replication.
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2-9 »1 Subcloning into Plasmid Vectors pU18 and pU1 9
The multiple cloning site of pUC18 contains sites for thirteen
hexanucleotide-specific restriction enzymes and it is into this
\
region that foreign DNA is inserted.
The vector DNA, pUC18, (5-10>iKg) and the cloned foreign DNA (2 
yg) were separately digested with the appropriate enzyme(s), and 
agarose gel electrophoresis performed to check for completeness of 
digestion or isolation of particular fragments, as appropriate.
Both vector and insert DNA were purified by extraction with phenol 
and then precipitated with ethanol (Section 2.3*8) After 
lyophilisation the insert DNA was redissolved in T.E. buffer at 0.2 
mg/ml, while the vector DNA was kept as a lyophilised pellet.
Alkaline Phosphatase Treatment of Vector DNA
Transformation of JM109 with a ligation mixture in which there 
are undigested plasmid molecules would result in a high background 
of blue colonies. Similarly if digested vector DNA is ligated, even 
in the presence of insert DNA, without first of all treating with 
alkaline phosphatase, then the greater efficiency of intramolecular 
ligation will lead to a large number of religated native pUC18 
molecules, thus also giving a high background of blue colonies upon 
transformation. Therefore it is important to check for completion 
of digestion and also to treat the vector DNA with alkaline 
phosphatase to prevent self religation, by removing the 5' phosphate 
groups at the ends of the DNA molecule. However, the need for
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alkaline phosphatase treatment was reduced when the vector DNA was 
cut with two different enzymes and was not he performed at all when 
subsequent blunt end (into the Sma I site) ligation was attempted.
The lyophilised vector DNA was redissolved in 20 ^ CL 50mM Tris- 
HCl pH9*5> 0»1mM EDTA, 1mM spermidine, to which 1 unit of Calf 
Intestinal Alkaline Phosphatase (Boehringer grade 1) was added. The 
mixture was incubated at 37°C for 30 minutes after which the 
volume was increased to 1 0 0 with TE and the DNA purified by 
phenol extraction and ethanol precipitation. The vector DNA was 
finally redissolved in TE at a concentration of 0.2mg/ml.
Ligation of Insert and Vector DNA
The ratio of insert DNA to vector DNA was carefully assembled 
so as to avoid either too little or too much insert DNA being 
incorporated thus leading respectively to low efficiency of 
incorporation or to the formation of insert polymers. Consequently 
ratios of 1:1 and 3:1> vector:insert, were generally prepared. The 
ratio is dependent on the number of restriction sites present in the 
foreign DNA for the particular enzyme(s) used.
The ligation mixture was assembled on ice by combining the 
appropriate amount of insert DNA, vector DNA (usually 0.5jULg), 4JjX 
5mM ATP, 1 j j J l 100mM DTT, 3 10 x Ligase Buffer (400mM Tris-HCl pH
7*6, 100mM MgCl^), 1 unit T4 DNA Ligase (BRL) and increasing 
the volume to a total of 30JM. with sterile distilled water. 
Incubation was at 15°C overnight after which the ligation mixture
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was stored at -20°C ready for transformation.
Transformation of Competent JM109 Cells
Frozen competent JM109 cells (Section 2 .9 .3) were allowed to 
thaw on ice and then aliquoted into 100^1 volumes in Eppendorff 
tubes. 10 of the ligation mixtures were then added to separate
100 Jp. aliquots of competent cells and these mixtures incubated on 
ice for 30 minutes. During this incubation LB plates containing 
ampicillin were spread with ] 20 jjJL 2% X-gal: 2% IPTG: H^O 
(1:1:2). IPTG (isopropylthio-£-galactoside) is a gratuitous 
inducer of the lac operon and thus induces £- galactosidase 
expression by the plasmid and the F-episome. It is stored at 
+4°C. 2% X-gal in dimethyformamide is stored at -20°C. This
mixture should be allowed to absorb onto the plates before the 
transformation mixtures are spread on them.
After the 30 minute incubation the transformation mixtures were 
taken and incubated at 42°C for 2 minutes and then transferred 
back to ice until they could be spread on the Amp plates.
Once the transformation mixtures had been spread the plates were 
inverted and incubated at 37°C overnight.
Any resulting white colonies were picked and plasmid DNA 
isolated by the small scale isolation method (Section 2.4 .1-2). The 
presence of the desired insert was then checked by restriction with 
the appropriate enzyme(s) and subsequent agarose gel electrophoresis.
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2.9*2 Subcloning into Bacteriophage M13 Vectors
DNA was subcloned into M13nip18 and M13mp19 routinely to 
provide single stranded DNA for sequencing by the method of Sanger.
Subcloning of Foreign DNA into M13mp Vectors
The general features of subcloning into pUC18 are also applicable 
to subcloning into the M13mp vectors. The same 54 bp multiple 
cloning region is present and recombinants are also detected by 
growth on X-gal and IPTG. However in M13 it is "plaques" that are 
formed instead of colonies of bacteria. Recombinant "plaques" are 
clear whilst non-recombinant "plaques" are blue. In fact, however, 
since M13 is not a lysogenic bacteriophage it is not true phage 
plaques that are formed but instead areas of restricted bacterial 
growth with the appearance of plaques.
Ligation of Insert and Vector DNA
The insert and vector DNA were preparated as for pUC18 (Section 
2-9«1) with the vector DNA being treated with phosphatase as 
appropriate. The ligation protocol was also identical but for the 
fact that smaller quantities (20-100ng) of DNA were used.
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Figure 2.3 Bacteriophage M13mp18
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M13mp18 (Yanish-Perron et al 1985) is a filamentious 
bacteriophage of E. Coli. The phage particle contains a single 
stranded DNA molecule. However, upon infection, this strand of DNA 
serves as a template for the synthesis of the complementary strand 
thus creating a double-stranded replicative form of the viral DNA 
which is subsequently amplified to about 200 copies per cell. It 
is this RF DNA which is used for subcloning since it can be 
manipulated as if it were a large plasmid (7250 bp).
M13mp18 and M13mp19 contain the same 54 bp multiple cloning 
region as pUC18 and pUC19 respectively, and only differ from each 
other in the orientation of this region thus making sequencing 
possible from either direction. The above figure shows that 54 bp 
region of M13mp18, the position where the 17bp universal primer 
anneals and the direction of sequence initiation. It also shows 
the position of the lac gene fragment and the origins of plus and 
minus strand replication.
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Transformation of Competent JM109 Cells
The transformation procedure was identical to that for pUC18 
however the plating procedure was different.
H-plates (Section 2.2*3) were used and were preincubated at 
37°C for about two hours. Meanwhile H-top agar was melted, 
aliquoted into 2.5ml volumes, and kept liquified at 42°C. 10
10% X-gal, 10^1 2% IPTG and 100JU1 of a saturated suspension of fresh 
JM109 cells were added to the H-top agar immediately prior to 
plating. The fresh JM109 cells were required to produce a lawn of 
bacteria on the H-plates to enable easy identification of plaques.
After raising the temperature of the transformation mixture to 
42°C for two mintues the 100 JJOL of transformed cells were added 
to the 2.5ml H- top agar (with additions) mixed gently, and then 
poured onto an H- plate. The top agar was allowed to solidify and 
plates incubated overnight at 37°C. Clear plaques were picked 
and single-stranded DNA prepared by the method outlined in Section 
2.4*5*
2.9*3* Preparation of Competent JM109 Cells (Cohen et al 1972)
A single colony of E. Coli JM109> stored on minimal agar, 
was taken, inoculated into 25ml L-Broth, and grown to saturation at 
37° overnight on an orbital incubator. 2.5ml of this overnight 
culture was then used to inoculate 500ml of L-Broth in a 2 litre 
flask and the cells grown until they reached a turbility of O.D.
- 81 -
= 0.2* A convenient quantity of cells was produced from four such 
500ml cultures.
The cells were harvested in a suitable large capacity 
centrifuge by centrifugation at 5000 rpm (4000g) for 15 minutes 
after which the cells were carefully resuspended in 250ml cold
sterile 100mM CaCl^ (i.e. half volume of 500ml culture). After 
incubating the cells on ice for 20 minutes they were resedimented at 
5000 rpm (4000g) and 4°C for 15 minutes. All subsequent 
manipulations were performed in a cold room (temperature 4°C).
The cells were resuspended in 5ml ice cold 100mM CaCl^ and 
sterile glycerol added to 10$. They were then aliquoted into 
suitable volumes (1ml and 0 »5nil) snap frozen in liquid nitrogen, and 
then stored at -70°C until required.
2.10 Sequencing of DNA
2*10.1 Chemical Cleavage Method of Maxam and Gilbert (1977»1980)
DNA sequencing by the method of Maxam and Gilbert requires a 
double stranded fragment of DNA labelled at one end. The labelling 
reaction was performed using the Klenow fragment of E. Coli DNA 
Polymerase 1 (Section 2.6.1) which requires an initial restriction 
enzyme cut to be made leaving a linear piece of DNA with 5 ' 
protruding ends. All 5' protruding ends are labelled by the Klenow 
"filling in" reaction and therefore a second restriction enzyme cut 
must be made. The second restriction enzyme is chosen so that the 
labelled DNA is cleaved asymmetrically, preferably into two
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fragments, which can subsequently be separated by polyacrylamide gel 
electrophoresis (Section 2.3*6.3)• The appropriate band was excised 
from the gel, the DNA eluted from the polyacrylamide and temporarily 
stored as a lyophilised precipitate.
Chemical Modification and Strand Scission
Sequencing by this method is dependent on base-specific 
modification and cleavage of the DNA. Table 2.6 lists the solutions 
required.
The lyophilised precipitate of labelled DNA was dissolved in 11 
jj). water with (4mg/ml) calf thymus DNA being added as carrier.
The mixture was then aliquoted into four equal parts in siliconised 
Eppendorff tubes, in preparation for the four sequencing reactions, 
the procedure of which is outlined in Table 2*7.
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Table 2*6 The solutions required for sequencing by the 
chemical cleavage method of Maxam and Gilbert
Dimethylsulphate 
Hydrazine 
Piperidine 
Pyridine Formate
DMS Buffer
DMS Stop
HZ Stop 
NaCl
DMS (Aldrich Chemical Co)
HZ (Kodak) stored at -70°C 
(Koch-Light) stored at 4°C 
4% v/v formic acid adjusted to pH2.0 
with pyridine (BDH)
50mM sodium cacodylate; 10mM MgCl^;
0.1 mM EDTA adjusted to pH8.0 and stored 
at 4°C
1.5M sodium acetate pH7.0, 1M 
jj-mercaptoethanol (Koch-Light), 200 g/ml 
yeast tRNA. Stored at -20°C.
0.3M sodium acetate, 0«1mM EDTA 
50yUg/ml yeast tRNA. Stored at 4°C 
As solution in H^O
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TABLE 2.7 Protocol for base specific reactions for Maxam 
and Gilbert sequencing
G + A T + C
Mix on ice
Add
Incubate at 
20° C
Add
Store
Centrifuge
Add to 
Pellet
200 u1 DMS buffer 10jA Hx0
/1 //i 32^ mTA ^  32p M A
Store
Centrifuge
Rinse
Pellet
Add to 
Pellet
Heat to
Add
Add
4/d. ''"v DNA 
1/d DMS
3 mins
50/1 DMS stop 
750/d ethanol
-70°C, 10 min
10 mins
250/d 0.3M 
sodium 
acetate 
750/d ethanol
-70*C, 10 min
10 mins
10% ethanol 
lyophilise
100/d. 1M 
Piperidine
90*0, 30 min 
lyophilise
10/d. Hz0 
lyophilise
10/d H^O 
lyophilise
10/1 h 20
4 /  52 p DNA
15 /I 5M NcCl
50/4 Pyridine 30/d HZ 
Formate
5 mins 5 mins
4/1 
30/dL NZ
5 mins
p DNA
180/4 HZ stop 200/4 HZ stop 200/d HZ stop 
750/d ethanol 750/4 ethanol 750/d ethanol
-70cC, 10 min -70°C, 10 min -70*0, 10 min
10 mins 10 mins 10 mins
250/4 0.3M 250/1 0.3M 250/4 0.3M
sodium sodium sodium
acetate acetate acetate
750/d ethanol 750/1 ethanol 150/1 ethanol
-70°C, 10 min -70*0, 10 min -70°C, 10 min
10 mins 10 mins 10 mins
10% ethanol 10% ethanol 10% ethanol
lyophilise lyophilise lyophilise
100/1 1M 
Piperidine
100/1 1M 
Piperidine
100/d 1M 
Piperidine
90cC, 30 min 90*C, 30 min 90°C, 30 min 
lyophilise lyophilise lyophilise
10/1 H^O 
lyophilise
10/d Hx0 
lyophilise
10/d HJC 
lyophilise
10/d # x0 
lyophilise
10/d Hx0 
lyophilise
10/1 Hx0 
lyophilise
All reactions were stored as a lyophilised pellet until they 
were ready to be loaded on to the gel.
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DNA Sequencing Gels
Once strand scission was complete the four sequencing reactions 
were electrophoresed through a denaturing polyacrylamide gel with 
the DNA fragments being separated according to molecular weight.
A typical gel (40cm x 20cm x 0.4mni) contained 6$ acrylamide 
(from 19$ acrylamide, 1$ bis-acrylamide stock), 7M Urea and 0.01$ 
ammonium persulphate in a total volume of 100ml 1 x TBE buffer. The 
gel plates were siliconised before use with Repelcote (2$ 
Dimethyldichlorosilane in 1,1,1-trichloroethane; BDH) and assembled with 
0*4mni spacers. 40jjiL TEMED (NNN'N' - tetramethylethylenediamine) was 
added to the gel mixture immediately prior to pouring. Once poured a 
comb (14 teeth; 7mni x 0.4™0 was inserted and the gel allowed to 
set.
Although DNA samples were denatured before loading, and the gel 
itself is denaturing, the temperature of the gel was also kept high 
during electrophoresis to help prevent secondary structure forming.
To this end the gel was pre-electrophoresed at 25mA for 1 to 2 hours 
during which the four sequencing reactions were dissolved in 5p -1 of 
loading buffer (99$ deionised formamide, 0*05$ xylene cyanol).
Immediately prior to loading, the DNA samples were denatured by 
boiling for 2 minutes and then rapidly chilled on ice. 1.5 p X  of 
each of the four samples was then loaded into separate adjacent wells 
and electrophoresis performed at 25 niA until the dye front had 
travelled 20cm. A further 1,0jH of each sample was then loaded into
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the next set of wells and electrophoresis continued until the dye 
front of these samples had travelled 15cm* The remainder of each 
sample was then loaded into the final set of wells and 
electrophoresis continued for a further 13cm after which the gel 
was ready for autoradiography. The DNA samples were also denatured 
by boiling immediately prior to the 2nd and 3rd loadings.
After electrophoresis, one gel plate was carefully removed, the 
gel covered with clingfilm, and autoradiography performed at 
-70°C overnight. Autoradiography was performed using Kodak X- 
Omat H film and an intensifying screen (Cronex Lighting Plus,
Dupont).
The above procedure, with the three separate loadings, was 
sufficient for reading between 150 to 200 bases per gel.
2.10.2 Dideoxynucleotide Method of Sanger (Sanger 1981)
DNA sequencing by this method requires a single-stranded DNA 
template for synthesis of the complementary stand. To achieve this, 
DNA is cloned into the bacteriophage, M13 (Section 2*9*2), and 
single-stranded DNA prepared from recombinants (Section 2.4*5)*
The complementary strand is synthesised by the Klenow fragment of 
E. Coli DNA polymerase 1 .
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Strand-Elongation
The complementary strand of DNA is synthesised by the Klenow 
enzyme using the single-stranded recombinant DNA as template and a 
short region of double stranded DNA, 3' to the multiple cloning site 
(Figure 2-3) > as primer to direct synthesis in the 5' to 3' 
direction. Dideoxy sequence analysis is dependent upon the random 
incorportion of dideoxribonucleotides into the growing DNA strand 
thus causing chain termination. To determine the DNA sequence of a 
template, four separate elongation reactions are performed, each 
containing only one of the ddNTPs, ^5g dATP and the three 
remaining dNTPs. The ratio of dNTPiddNTP in each raction is 
controlled so that chain termination occurs randomly over the 
complete sequence. Table 2-8 outlines the dNTPiddNTP content of 
each of the four base specific reactions.
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Table 2.8 The dNTP/ddNTP content of the four base specific working 
solutions used in Sanger dideoxy sequencing.
A G C T
10 x Klenow buffer 20/fl 20 jfX 20 jH 20/JL
0.5mM dATP -
0.5mM dGTP 20/A 1^1 20j*L
0.5mM dCTP 20^1 20^1 1^1 2 0^
0.5mM dTTP 20^ 20^ iL 20^L 1 ^
0.1 mM ddATP 80/*l -
0.1mM ddOTP - - 61^
O.^mM ddGTP - 6^  jjl
0.5mM ddTTP - - - 61 j&
The working solutions were stored at -20°C.2 1 of each
working solution was used for each base specific sequencing 
reaction. The above table represents working solutions when the 
label being used was ©c-35s dATP. If another oC-35g labelled 
dNTP was to be used the working solution were altered appropriately.
- 89 -
Annealing of Primer and Sequence Reaction
Before performing the sequencing reactions, the M13 17-base 
primer (BRL), which is complementary to a region of DNA immediately 
3' to the multiple cloning site of M13> has to be annealed to 
produce the double-stranded primer region. This was achieved by 
assembling 7.5yiA.l of the single-stranded template (Section 2 .4 .5)
1.5/il 10 x reaction buffer (lOOmM Tris HC1 pH8-0, 100mM MgCl^,
300mM NaCl) and 1 .O^^l of the M13 universal 17-base primer. The 
mixture was incubated at 56°C for two hours and then allowed to 
cool to room temperature in preparation for the sequencing reaction. 
Once cooled, 1.2^ ia1 of the solution was aliquoted into each of four 
reaction tubes. 2^1 of the appropriate dNTP;ddNTP mixture was then 
added to each tube and the reaction started by centrifugation of the 
two solutions to the bottom of the reaction tube. Incubation was at 
room temperature for 20 minutes after which 2jk of chase mix (all 
four dNTPs at 0«5 was added, and incubation continued, at room 
temperature, for a further 15 minutes.
After incubation the reaction mixes were ready to be separated 
on a sequencing gel, but could also be stored at -20°C for up to 
two weeks beforehand. Also only half of the reaction mix was 
required for visualisation by autoradiography and thus the other 
half could also be stored for performing a second longer sequencing 
gel. If the separation of the samples was to be performed 
immediately, 2 jjil loading dye (0.03$ xylene cyanol; 0.03$ bromophenol 
blue; 20mM EDTA in formamide) were added to 3/A.l of each sample to 
stop the reaction. The DNA was denatured at 100°C for three
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minutes and then loaded onto the sequencing gel.
DNA Sequencing Gels
Denaturing polyacrylamide gels were prepared as outlined in 
Section 2.10.1 but using a 32 tooth (2.5mm x 0.4mm) comb to prepare 
the wells. DNA samples were denatured by boiling for three minutes 
before loading and electrophoresis performed at 25mA until the 
bromophenol blue (Sigma) was 0.5cm above the bottom of the gel 
(approximately two hours). Such electrophoresis was sufficient for 
resolving 180-200 bases, however further resolution could be gained 
by electrophoresing a second loading of the samples for five and a 
half hours.
2.11 Deletion Subcloning (Labeit et al 1986)
Sequence determination by either the method of Maxam and 
Gilbert or that of Sanger, requires that there be appropriate 
restriction sites, either for direct labelling of the DNA, or for 
subcloning into the multiple cloning region of M13« Occasionaly, 
however, some stretches of DNA are inaccessible to sequence 
determination because they lack suitable restriction enzyme sites. 
The following procedure can be used to generate a library of M13 
derived recombinants containing serially random deletions of insert 
DNA, thus enabling sequence determination of regions lacking 
suitable restriction sites.
The fragment of DNA to be sequenced was subcloned into M13 in
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the normal manner (Section 2.9*2), but RF DNA was isolated by the
procedure outlined in Section 2.4*6. Figure 2*4 outlines the
principles involved in generating the deletion library. Briefly,
the RF DNA of the recombinant M13 was subjected to limited digestion
?+by DNase I, in the presence of Mn^ ions, to ensure that only a 
small fraction of the DNA molecules were linearised. This resulted 
in breaks which were nearly random in their distribution. Subsequent 
digestion with the unique restriction enzyme A (i.e. enzyme A has 
only one restriction site in the original M13 recombinant, occuring 
in the multiple cloning region between the primer region and the 
inserted foreign DNA), introduced deletions extending from the 
priming site into the insert DNA. The resulting staggered ends were 
"filled in" using Klenow enzyme, and a blunt end ligation is 
performed to recircularise the deleted molecules.
Digestion with a second unique restriction enzyme B, the site 
for which was situated between that for enzyme A and the inserted 
foreign DNA in the original recombinant, should linearise any non­
deleted DNA molecules, since only deleted molecules will have lost 
restriction site B. Since transformation of linear DNA is 
inefficient, subsequent transformation of competent JM109 cells will 
produce plaques representing deleted molecules which can be selected 
for the preparation of single-stranded template DNA. The single­
stranded DNA is then run on an agarose gel and size selected 
recombinants chosen for subsequent sequencing.
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Figure 2.4 Generation of random deletions in M13
replicative form DNA
The 2.5kb Pst I fragment of clone pCM212 was cloned 
into M13mp19 and replicative form DNA isolated. This was 
digested for 2 minutes with DNAse I in the presence 
Mn^+ ions (Figure 2.5a) and then with the restriction 
endonuclease Eco HI. The ends of the DNA were made 
flush using the Klenow reaction outlined in section 2.6.1 
and then ligated. Undeleted molecules were then 
linearised with the restriction endonuclease Bam HI and 
the whole reaction mixture used to transform competent 
JM109 cells. Since intact circular DNA molecules 
transform at a higher efficiency than linear molecules the 
resulting plaques represent deletion subclones of the 
original M13mp19 clone containing the 2.5kb Pst I 
fragment. Single-stranded DNA was prepared from randomly 
selected plaques and screened for size (Figure 2.5b) 
before sequencing by the method of Sanger (1977).
4-circular 
undeleted 
m
olecules
DNase I Digestion
A 10^-fold dilution of a 5mg/ml DNAse I stock was prepared 
in 2mM MnCl2/80mM Tris-HCl pH 7-4- 10/ng of M15 RF DNA
was diluted in 50^ H^o and then added to 50jwl of the DNAse I 
solution which was then incubated at room temperature. 2 0 /J l aliquots 
were withdrawn at two minute time intervals and the reaction in the 
aliquots immediately halted, by the addition of 2 j j d . 0»1M EDTA.
The extent of DNAse I digestion in each of the aliquots were 
visualised by subjecting 3yyi of each to electrophoresis in a 0*1% 
agarose gel. Meanwhile the aliquots were stored frozen. A typical 
result is shown in Figure 2.5a.
The appropriate aliquot which showed digestion to approximately 
a fifth to a third of the circular form of the RF DNA (lane 2 Fig 
2.5^) was chosen and the DNAse I extracted with phenol. After 
precipitation with ethanol, the DNA was then digested with the 
appropriate enzyme, blunt ended and religated, and then redigested, 
with the second unique enzyme. Figure 2»5t> shows a typical size 
distribution of recombinants obtained from the subsequent 
transformation of JM109 with the deleted DNA molecules.
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Figure 2.5 Digestion of M13 Replicative Form DNA with
?+DNAse I in the presence of Mn*1 ions and 
the size selection of the resultant deletion 
subclones
The 2 .5kb Pst I fragment of clone pCM212 was cloned
into M13mp19 and replicative form (RF) DNA isolated, (a)
The RF DNA was digested with DNAse I in the presence of 
2+Mn ions and the reaction stopped by the addition of 
EDTA to 10mM at 2, 4> 6, 8 and 10 minutes. A sample from 
each reaction mixtures was electrophoresed through a 0.7$ 
agarose gel. Lanes 1-6 contain, from left to right, the 
samples taken after 10 minutes, 8 minutes, 6 minutes, 4 
minutes, 2 minutes and a zero time control (undigested 
DNA). The sample which was digested for 2 minutes was 
selected for performing the subsequent steps to produce 
the deletion library (Figure 2.4) • (b) The single­
stranded M13 DNA isolated from the deletion subclones was 
electrophoresed in a 0.7$ agarose gel, overnight at 12 
mA. A large difference in the sizes of molecules 
generated by the DNAse I delection method can be seen. 
Appropriate clones, spanning all sizes of molecules were 
chosen and sequenced by the method of Sanger (1977).
3 3 3 3 3 3
H- H H* H- H- H-
2 3 3 2 3 2
C C c c £
c+ c+ C+ c+- c+ c+
CD CD o CD 0 0
CO 0 OQ 0 0 0
(a)
CHAPTER 3
Results
3*1 Differential Screening of a Mouse cDNA Library
The initial aim of this work was to isolate complementary DNA 
(cDNA) clones corresponding to proteins expressed solely in skeletal 
muscle. The approach adopted was to screen a mouse skeletal muscle 
cDNA library with two radiolabelled single-stranded cDNA probes, 
one derived from skeletal muscle mRNA, the other derived from what 
may be regarded as the most closely related tissue, cardiac muscle.
First, experiments were undertaken to optimise the conditions 
for producing the labelled single-stranded cDNA probes. It was 
found that the lengths and specific radioactivity of the probes 
were dependent on the chemical concentration of the radioactively- 
labelled dNTP used in their synthesis. Thus, when a fixed 
radiochemical concentration of (^P) dATP was used to label the 
cDNAs, increasing the chemical concentration of dATP in the 
reaction mixture resulted in the synthesis of cDNAs of greater 
length (Figure 3«1), but, of course, also decreased their specific 
radioactivity. As the cDNAs were to be used as probes, it was 
necessary to make the best compromise between length and specific 
radioactivity. A concentration of 50^ aM dATP was adopted on the 
basis of the results in Figure 3 .1.
The mouse skeletal muscle cDNA library was a gift from Dr D.P.
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Figure 3*1 The variation in length and specific
readioactivity of single-stranded cDNA 
as a function of the chemical concentration 
of the radioactively-labelled dNTP.
Single-stranded cDNA was prepared from 1
poly(A)+ from skeletal/nuscle using various chemical
concentrations of dATP, but using a fixed concentration
of*^-(^P) dATP. Aliquots from each reaction mixture,
containing approximately 20 x 10^cpm, were taken and
electrophoresed in a denaturing 1% agarose gel. The gel
was dried and autoradiographed for approximately four
hours. Each track of the dried gel was then sliced into
1cm portions (from top to bottom) and the radioactivity
present in each portion was measured as Cherenkhov
radiation in a scintillation spectrometer, (a) shows the
autoradiograph of the initial gel. The concentrations of
dATP were (4) 20nM, (X) 15/*M, (_3 .) 50/tX. and ('t ) 150
juM. (b) The graph shows for different concentrations of
dATP the yield of cDNA in terms of the percentage of the 
32P-label present in each gel slice in relation to the 
length of DNA in that slice, (c) The table summarises the 
yield, length and specific radioactivity of the cDNA 
obtained using the different chemical concentrations of 
dATP.
(a )
1 2  3 4
(c)
dATP peak length specific radioactivity yield of cDNA 
of cDNA
20nM 300 bases 2 .6x1 O^cpm/^ig of cDNA 5.7x10”^pg
15pM 1600 bases 3.6x10 cpm/^ig of cDNA 1.1x10_^ g
50piM 2-3000 bases 1 .1 x1 Qpcym/jxg of cDNA 1.8x10_^pg
6 _o
1 50jiM 3000 bases 3.6x10 cpj^ /jig of cDNA 3.9x10~ y.g
20nM ••----- •
15uM ■  
50uM 
150)iM o-
30_
H*
20
c+
15
H-
c +
30 4020
length of single-stranded cDNA 
(bpxl0-2)
Leader, University of Glasgow, who had constructed it in the plasmid 
vector pBR322, using cDNA reverse transcribed from poly (A)+ RNA 
isolated from eleven day old mice (Leader et al, 1986). The 
library was plated as described (section 2.8.1) with two 
nitrocellulose filter replicas being taken of each master plate. 
These were then hybridised to ^^P-labelled cDNA probes derived from 
skeletal and cardiac muscle, washed at medium stringency and then 
subjected to autoradiography.
Figure 3.2 presents the results of hybridisation to two such 
replica filters, from which several points can be made. First, 
only approximately 20$ of the bacterial colonies actually gave a 
hybridisation signal on the autoradiograph of the filter probed 
with the skeletal muscle cDNA (Figure 3»2(a)). Those colonies not 
giving rise to a hybridisation signal presumably contain cloned 
cDNAs corresponding to low abundance mRNAs.
A second point to note is that there were clones in the 
skeletal muscle cDNA library which gave a hybridisation signal with 
the cardiac muscle probe, but not with the skeletal muscle probe 
(Figure 3.2(b)). Examples of these are clones C1 and C2. Such 
colonies presumably contain cloned cDNAs derived from mRNAs which 
are more abundant in cardiac muscle than in skeletal muscle.
Figure 3.2 shows that there were also colonies of the type 
sought; those which gave a hybridisation signal with the skeletal 
muscle probe, but not with the cardiac muscle probe. Examples of 
these are clones S1, S2 and S3 . 247 colonies were selected for
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Figure 3*2 Examples of the results of the initial
screening of the mouse skeletal muscle 
cDNA library.
The mouse skeletal muscle cDNA library was screened 
with ^ P  single-stranded cDNA reverse-transcribed from 
(a) skeletal muscle poly (A)+ RNA and (b) cardiac 
muscle poly (A)+ RNA. The filters were hydridised 
overnight, washed five times for ten mintues in 2 x SSC at 
room temperature and then twice for 30 minutes in 0.1 x 
SSC and 42°C. S1, S2 and S3 are examples of colonies 
giving hybridisation signals only with the skeletal 
muscle probe. C1 and C2 are colonies which give 
hybridisation signals only with the cardiac muscle probe.
^P-labelled skeletal 
muscle cDNA probe
(b)
32 P-labelled cardiac 
muscle cDNA probe
further investigation, out of the approximately 1 .5 x 10^ colonies 
screened.
The initial screening of the cDNA library by the replica 
plating and colony hybridisation procedure had several inherent 
technical difficulties associated with it. There was a considerable 
chance of unequal transfer of colonies to each of the replica 
filters, and also of contamination of the filters with cell debris, 
both of which could have distorted the hybridisation signal. This 
in turn may have resulted in the selection of colonies regarded as 
being specific to skeletal muscle, but which were not in fact so.
As the first screening had reduced the number of clones to more 
manageable proportions, it was possible to circumvent these problems 
by small scale preparation of plasmid DNA from each clone and 
application of approximately equal amounts of the DNA directly onto 
duplicate nitrocellulose filters (dot-blotting) for subsequent 
hybridisation to the two -^P-labelled single-stranded cDNA probes.
Figure 3.3 presents the autoradiographs of two such duplicate 
filters of dot blotted DNA. It is apparent, from Figure 3*3> that 
the majority of the clones selected from the initial screening as 
being specific to skeletal muscle, were not in fact so, since in the 
rescreen they gave a hybridisation signal with the cardiac muscle 
probe. Indeed there were even a number (clones C156 and C152 in 
Figure 3*3) which appeared to specify proteins more abundant in 
cardiac muscle than in skeletal muscle. Nevertheless, there were 
several clones which did appear to represent mRNAs more abundant in 
skeletal muscle than in cardiac muscle, eight of which gave a
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Figure 3»3 Examples of the results of the secondary- 
screening of the 247 clones selected from 
the initial screening of the mouse skeletal 
muscle cDNA library.
Plasmid DNA was prepared from the 247 clones selected 
from the initial screening of the mouse cDNA library (cf.
IVV duxpWale.
Fig 3*2). 2yUl of each preparation was spotted directly
onto separate duplicate nitrocellulose filters and 
hybridised to (a) (^P) single-stranded skeletal muscle 
cDNA and (b) (^P) single-stranded cardiac muscle cDNA.
The filters were bydridised overnight, washed five times 
for ten minutes in 2 x SSC, 0.1$ SDS at room temperature, 
twice for 30 minutes in 0.1 x SSC, 0.1$ SDS at 45°C 
and then autoradiographed. S202 is a clone which gave a 
hybridisation signal only with the skeletal muscle 
probe. C152 and C156 are clones which are apparently 
more abundant in cardiac muscle than in skeletal muscle.
(a)
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hybridisation signal only with the skeletal muscle cDNA probe (e.g. 
clone S202).
To characterise these eight clones further, a different 
approach was adopted. Instead of screening the cloned cDNAs with 
single-stranded cDNA probes derived from reverse-transcribed mRNA, 
the mRNAs themselves were screened with the nick-translated plasmid 
DNA isolated from each of the clones. This approach was adopted to 
overcome problems in the previous screenings caused by the 
underrepresentation of a particular cDNA within the total cDNA 
probe, as it allowed hybridisation of a high specific activity probe 
to a full length mRNA. In addition, poly (A)+ RNAs isolated from 
liver and brain were included as further controls for expression of 
the proteins, represented by the clones, in non-muscle tissue.
Figure 3.4 presents the autoradiographs of the RNA blots 
obtained for each of the eight clones. A variety of hybridisation 
patterns were obtained from this third screening. All but one of 
the clones hybridised with skeletal muscle poly (A) + RNA and at 
least one of the other poly (A)+ RNAs. Four clones, numbers 21, 33» 
215 and 239 gave a hybridisation signal with all four of the poly (A)+ 
RNAs, suggesting that the mRNA represented by each of these clones 
was expressed ubiquitously. Clones 40 and 44 hybridised to the 
skeletal muscle poly (A)+ RNA, and to a more or lesser extent, to poly 
A+ RNA from two of the other sources, whereas clone 9 appeared to be 
specific to muscle tissue. Clone 202 was the only one which gave a 
hybridisation signal solely with skeletal muscle poly (A)+ RNA, and so 
it was selected for further characterisation. Clone 202 will
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Figure 3*4 Results of hybridising the eight clones
from the second screening of the skeletal 
muscle cDNA library to RNA from various 
sources.
Serial dilutions of poly (A)+ RNA were prepared 
from skeletal muscle, cardiac muscle, liver and brain and 
spotted directly onto nitrocellulose filters. Eight such 
filters were probed with nick-translated plasmid DNA 
prepared from clones 9, 21, 33» 40, 44» 202, 215 and 
239* The filters were hybridised overnight, washed five 
times for ten minutes in 2 x SSC, 0.1$ SDS at room 
temperature and twice for 30 minutes in 0.1 x SSC, 0.1$ 
SDS and 50°C and then autoradiographed.
Amounts of RNA indicated are in jjg .
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subsequently be referred to as pCM202*
3-2 Characterisation and Identification of pCM202
Construction of a cDNA library by G/C tailing and cloning into 
the unique Pst I restriction site of pBR322 should result in the 
regeneration of a Pst I restriction site at both ends of the 
inserted foreign DNA (Figure 3 .5a). Therefore pCM202 was digested with 
Pst I and the resulting fragments separated by agarose gel 
electrophoresis. Two bands resulted, with apparent lengths of 4.4 
kbp and 45O bp (Figure 3*6). The 4.4 kbp fragment comigrated with 
the linearised vector DNA and therefore it was concluded that pCM202 
contained an insert of approximately 450 bp in length.
In view of the relatively small size of the cDNA insert in 
pCM202, it was decided to transfer the entire 450 bp Pst I 
fragment into the plasmid vector pUC 18 (Figure 2.2) and to 
determine its nucleotide sequence using the chemical method of Maxam 
and Gilbert (1980) . By labelling the insert DNA at either the 
flanking Hind III or Eco RI site, in the multiple cloning 
region, using the Klenow reaction (section 2«6.1), and sequencing in 
opposite directions, the entire nucleotide sequence of the 450bp 
cDNA fragment of pCM202 was obtained. This revealed a G/C tail (16- 
20 G or C residues in series) at only one end of the fragment, 
indicating that one of the Pst I sites lay within the cDNA 
insert. As digestion of pCM202 with Pst I had resulted in only two 
detectable fragments (Figure 3 .6) it was assumed that one of the 
Pst I sites had not been regenerated by the G/C tailing.
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Figure 3*5 Regeneration of PstI restriction sites by the
G/C-tailing cloning procedure.
(a) Construction of a cDNA library by the G/C tailing 
procedure and cloning into the unique Pst I restriction 
site of pBR322 should result in the regeneration of a 
Pst I restriction site at both ends of the inserted 
foreign DNA (Villakomeroff et al 1978). (b) All the
tropomyosin clones found in this study lacked at least 
one regenerated Pst I site. In most cases it was found 
that a C- T mutation in the first base of the recognition 
site had resulted in the Pst I site not being 
regenerated. In pCM202 and pCM212, however, misalignment 
of the G/C tails resulted in only 3 out of the 6 bases of 
the Pst I recognition site being regenerated.
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Figure 3*6 Analysis of pCM202 with restriction 
endonuclease Pst I.
pCM202 was digested with Pst I at 37°C for two 
hours and the resulting fragments separated by 
electrophoresis in a 1$ agarose gel (a) Lanes 1-3 contain 
(from left to right) pBR322 digested with Pst I, pCM202 
digested with Pst I and \}x 174 digested with Hpa II 
(DNA size markers). The size of the small Pst I 
fragment of pCM202 was estimated at approximately 450 bp 
from the graph (b).
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Therefore pCM202 was digested with Pst I/Hind III and Pst 
I/Bgl I to determine in which orientation the cDNA insert lay 
(Figure 3 .7) and its sequence determined from the internal Pst I 
site to the G/C cloning tail (which lacked a regenerated Pst I 
site - see Figure 3 .5b). This completed the nucleotide sequence of 
the cDNA insert of pCM202, which is presented in Figure 3.8 along 
with the translation of the six possible reading frames.
Although the nucleotide sequence of pCM202 had not been 
determined on both strands (Figure 3*7) > the presence of an open 
reading frame (i.e. one which was not interrupted by stop codons), 
extending over the entire 489bp of sequence (Figure 3*8), suggested 
that it would be worthwhile, at this stage, to subject the sequence 
to analysis on the VAX cluster at EMBL, Heidelberg, to see if it was 
similar to any of the sequences contained in the Genbank and EMBL 
nucleotide sequence databases. This was done using the program 
WORDSEARCH, of the UWGCG software package (Devereux et al, 1984)»
The result of the computer search indicated that pCM202 represented 
the mRNA for an isoform of tropomyosin. It was found to share the 
greatest sequence homology with the major chicken oc-tropomyosin 
(McLeod 1982; Figure 3 .9), but because there were no mouse 
tropomyosin sequences in the databases the exact identity of the 
pCM202 insert could not be determined.
When the amino-acid sequence, predicted from the open reading 
frame in Figure 3 .8 , was compared with the protein sequences in the 
NBRF amino-acid databases on the VAX cluster at EMBL, Heidelberg, an 
almost perfect match was revealed with rabbit jj-tropomyosin (Mak et
- 99 -
Figure 3*7 Partial restriction map of pCM202 
showing sequencing strategy
(a) The orientation of the cDNA insert of pCM202, 
with respect to the vector DNA, was determined by 
performing "double digests" of the DNA and separating the 
resulting fragments on a 1^ agarose gel. Lanes 1-3 
contain (from left to right) pCM202 digested with Pst 1/
Bgl I, H)x 174 digested with Hpa II (DNA size markers) 
and pCM202 digested with Pst I/Hind III. This allows 
one to deduce the orientation indicated in (b)(ii).
(b)(i) scale indicating the size of the cDNA insert of 
pCM202. (ii) The partial restriction map of pCM202 is 
presented, indicating the vector DNA (dotted line), and 
the orientation of thepCM202 cDNA insert. 51b' refers to 
nucleotide 516 in the £-tropomyosin sequence (the A of the 
initiator methionine codon AUG being numbered 1), as 
predicted from Figure 3»10, the rabbit ^ -tropomyosin amino- 
acid sequence. Plasmids pCM1 and pCM2 were constructed 
in pUC18 as indicated, and the nucleotide sequence of the 
cDNA determined using the sequencing strategy outlined in 
(iii). Arrows (->) denote the direction and approximate 
length of the sequence determined from individual 
subclones. Arrows above the central line indicate 
sequence determined on the coding strand of the DNA.
Those below the central line indicate sequence determined 
on the non-coding strand of DNA.
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Figure 3-8 Conceptual translation of reading frames in
pCM202.
The nucleotide sequence of pCM202 is presented 
opposite together with a translation of all six possible 
reading frames (A1- A3, B1-B3). The one letter amino-acid 
code is used. Stop codons are indicated by an asterix 
(*). A3 was the only reading frame found to be open, 
i.e. not interrupted by stop codons.
L V R N V G T  * R M P  S T A R S R P K P  . . . .A1
* E * M W G P R E C H R P R G A G R S R  A2
E S K C G D L E N A I D R A E Q A E A   A3
CTGAGAGTAAATGTGGGGACCTAGAGAATGCCATCGACCGCGCGGAGCAGGCCGAAGCCG
T K S K L K T D A S S W R K S  S R P S R  ....Al
Q K A S  * R P M Q A A G G R A A G P  P E  A2
D K K Q A E D R C K Q L E E E Q Q A L Q  ....A3
ACAAAAAGCAAGCTGAAGACCGATGCAAGCAGCTGGAGGAAGAGCAGCAGGCCCTCCAGA
R S  * R G Q R T R W K S  I P S P * R M P   Al
E A E G D R G R G G K V F R V R E G C P....A2
K K L K G T E D E V E K Y S E S V K D A  ....A3 
AGAAGCTGAAGGGGACAGAGGACGAGGTGGAAAAGTATTCCGAGTCCGTGAAGGATGCCC
R R N W S  R L R R R P P  T L K Q M W P  L ....Al 
G E T G A G * E E G H R R  * S R C G L S  . ...A2
Q E K L E Q A E K K A T D A E A D V A S   A3
AGGAGAAACTGGAGCAGGCTGAGAAGAAGGCCACCGACGCTGAAGCAGATGTGGCCTCTC
* T A A F S S * R R  S W I G H  R S A W  L  Al
E P P H S A R R G G V G  S G T G A P  G Y  A2
L N R R I Q L V E E E L D R A Q  E R L A   A3
TGAACCGCCGCATTCAGCTCGTAGAGGAGGAGTTGGATCGGGCACAGGAGCGCCTGGCTA
Q P C K S W R R L R K P R M R A R E E  *  Al
S L A K A G G G  * E S R G  * E R E  R N E . . . . A 2
T A L Q K L E E A E K A A D E  S E  R G M  ....A3 
CAGCCTTGCAAAAGCTGGAGGAGGCTGAGAAAGCCGCGGATGAGAGCGAGAGAGGAATGA
R S L K T G P  * R M R K R W S C R R C  S ....Al
G H * K P G H E G * G K D G A A G D A A  A2
K V I E N R A M K D E E K M E L Q E M Q  ... .A3 
AGGTCATTGAAAACCGGGCCATGAAGGATGAGGAAAAGATGGAGCTGCAGGAGATGCAGC
* R K P S T S L R T Q T A N M R R W P G  ....Al
E G S Q A H R  * G L R P  Q I * G G G Q E  A2
L K E A K H I A E D S D R K Y E E V A R  ....A3 
TGAAGGAAGCCAAGCACATCGCTGAGGACTCAGACCGCAAATATGAGGAGGTGGCCAGGA
■ S W *  Al
A G D  A2
K L V T  A3
AGCTGGTGAC
V T S F L A T S S Y L R S E S S A M C L   Bl
S P A S  W P  P P H I C G L  S P Q R C A W  B2
H Q L P G H L L I F A V *  V L S D V L   B3
GTCACCAGCTTCCTGGCCACCTCCTCATATTTGCGGTCTGAGTCCTCAGCGATGTGCTTG
A S F S C I S C S S I F S S S F M A R F  ....Bl 
L P S A A S P A A P S F P H P S W P G F....B2
G F L Q L H L L Q L H L F L I L H G P V  ....B3 
GCTTCCTTCAGCTGCATCTCCTGCAGCTCCATCTTTTCCTCATCCTTCATGGCCCGGTTT
S M T F I P L S L S S A A F S A S S S F   Bl
Q * P S F L S R S H P R L S Q P P P A F   B2
F N D L H S S L A L I G R F L S L L Q L   B3
TCAATGACCTTCATTCCTCTCTCGCTCTCATCCGCGGCTTTCTCAGCCTCCTCCAGCTTT
C K A V A R R S C A R S N S S S T S * M  ....Bl 
A R L  * P G A P  V P  D P T P P L R A E  C....B2
L Q G C S Q A L L C P  I Q L L L Y E L N   B3
TGCAAGGCTGTAGCCAGGCGCTCCTGTGCCCGATCCAACTCCTCCTCTACGAGCTGAATG
R R F R E A T S  A S A S V A F F S A  C S  ....Bl
G G S E R P H L L Q R R W P S S Q P A P  B2
A A V Q R G H I C F S V G G L L L S L L   B3
CGGCGGTTCAGAGAGGCCACATCTGCTTCAGCGTCGGTGGCCTTCTTCTCAGCCTGCTCC
S F S W A S F T D S E Y F S T S S S V P   Bl
V S P G H P  S R T  R N  T F P P R P  L S P....B2
Q F L L G I L H G L G I L F H L V L C P  ... .B3 
AGTTTCTCCTGGGCATCCTTCACGGACTCGGAATACTTTTCCACCTCGTCCTCTGTCCCC
F S F F W R A C C S  S S S C L H R S  S A   Bl
S A S S G G P  A A L  P P A A C  I G L Q L  B2
L Q L L L E G L L L F L Q L L A S V F S  ....B3 
TTCAGCTTCTTCTGGAGGGCCTGCTGCTCTTCCTCCAGCTGCTTGCATCGGTCTTCAGCT
C F L S A S A C S A R S M A F S R S P H   Bl
A F C R L R P A P R G R W H S L G P H I   B2
L L F V G F G L L R A V D G I L * V P T  ....B3 
TGCTTTTTGTCGGCTTCGGCCTGCTCCGCGCGGTCGATGGCATTCTCTAGGTCCCCACAT
L L S  Bl
Y S Q  B2
F T L R ....B3 
TTACTCTCAG
Figure 3*9 Result of the search of the nucleotide
databases, Genbank and EMBL.
The nucleotide sequence of pCM202 was used to search 
the nucleotide sequences stored in the Genbank and EMBL 
databases. The "Quality" of the match indicates the 
extent of homology between the nucleotide sequence of 
pCM202 with a given sequence in the nucleotide database. 
The highest quality of match (156.2) was found to be with 
the major chicken ©£-tropomyosin (McLeod 1982).
cmi202.rft check: 60S'/ Jrom: 37 to: 40(7 /reverse
ger.banK.sst entry: 1818 check: 768l from: 1 to: S89 
ENTRi': ISIS SEARCHSET of: chktrooal. check: 76S1 from: 1 to: 989 
diskSusers: [puoda t a. genbank _40. awe eg. jiothervert'. chk trooa 1.
Gaos: 3 Quail tv: 156.2 Ratio: 0.442 Words: 51 Width: 3 Limits: * / - •
3-59 ouoCAvCAoGCCGAAGCCGACAAAAAGoAAGCTOAACACCGATGCAAG. . 312
10 gcogacaagaaggcagcgqa gaagaggaqcaagcagctggaqgac 54
311 CAGCTGGAGGAAGAGCAGCAGGCCCTCCAGAAGAAGCTGAAGGGGACAGA 262 
55 aaactagtggctctqcaaaagaacctgaag..gqcactqaqqatgagctg 102 
Press RETURN' to cortinue
261 GoACoAouTuGAAACTATTCCuG fCGTGAGG foCuACGAuTCGAGCAuGu 2l2 
103 gacaaatattccaagtcccttaaagatgcacaggaaaagttogaactggc 152 
211 TCAGAAGAAGGCCACCGACGCTGAAGCAGATGTGACCTCTCTGAACCGCC 162 
153 tgacaaaaaggccacagatgctgagagtgaagtaGcttccctgoacagac 202 
161 uCATT-AGCTCu 1 AGAuuAGGAGTToGA .l Go U u ACAGGAu Lu o u TG o u T 1 . .i 
20 3 ccatccaactggttgaggaagagttggatcggcctcagcagcgr.ttcgct 252 
ill Aw Au:. - . i uu AA A Aw‘w To ^ h u G AuGu T G AoriHr-G w w l a T-wf Au h  w.*'. U w
o C ‘ C C I I k w C o 3 d 3 C C « 0 0 3 Q Q H G C Z t Q d C 3 a C C C t u C a C d * G r j d Q t 0 o  - 'J *1
S i  . G A A G o T w  A i T G A A A A u u G C u ' w ’- A  * ; j A i j G a A A A C A  1*2
30 3 aacacqaatqaacg^cattgasaataqaQccoagaagqatgaagagaaga 352
al, 1980) as illustrated in Figure 3*10. There were only eight 
mismatched amino acids, all of which occurred at the N-terminus of 
the amino acid sequence, predicted for pCM202* However, these 
corresponded exactly to eight amino acids nearer the C-terminus of 
the rabbit tropomyosin in a region not covered by pCM202* Thus it 
was possible that this region of mismatched amino-acids represented 
a cloning artefact rather than a real difference between the amino- 
acid sequences of mouse and rabbit £ -tropomyosin.
The skeletal muscle cDNA library was rescreened using the nick- 
translated Pst I fragment of pCM202 as probe, in order to try to 
obtain clones containing more of the mouse -tropomyosin cDNA. 
Approximately 10,000 colonies were screened, from which twenty-two 
putative positives were selected. Plasmid DNA was prepared from 
each, subjected to electrophoresis on an agarose gel, transferred to 
nitrocellulose and then hybridised to the pCM202 probe. The 
resulting autoradiograph is presented in Figure 3.11, from which it 
can be seen that only three clones, pCM212, pCM222 and pCM232 gave 
positive hybridisation signals.
The DNA from each clone was digested with Pst I in order to 
determine the size of their inserts. However, as with pCM202, it 
was possible that one or both Pst I sites may not have been 
regenerated by the G/C tailing procedure and, therefore, each of the 
clones was also linearised with the restriction enzyme Hind III 
and their sizes determined. It can be seen from Figure 3*12 that 
pCM232 is similar in size to pCM202, containing two Pst I 
fragments of 4*4 kbp and 450 bp with an overall size of
- 100 -
Figure 3*10 Comparison of the predicted amino-acid 
sequence of pCM202 with that of rabbit 
tropomyosin
The amino-acid sequence of pCM202, predicted from A3 
the only open reading frame in Figure 3»8 was compared 
with tropomyosin sequences in the NBRF amino-acid 
database. An almost perfect match was found with that of 
rabbit ^-tropomyosin (Mak et al 1980). The figure 
opposite shows a comparison of the sequence with 
identities being indicated by vertical lines. Notice the 
identity between the boxed regions, which is discussed in 
the text.
MDAIKKKMQMLKLDKENAIDRAEQAEADKKQAEDRCKQLEEEQQALQKKLKGTEDEVEKY rabbit
lESKCGDL|ENAIDRAEQAEADKKQAEDRCKQLEEEQQALQKKLKGTEDEVEKY mouse
SESVKDAQEKLEQAEKKATDAEADVASLNRRIQLVEEELDRAQERLATALQKLEEAEKAA rabbit
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
SESVKDAQEKLEQAEKKATDAEADVASLNRRIQLVEEELDRAQERLATALQKLEEAEKAA mouse
DESERGMKVIENRAMKDEEKMELQEMQLKEAKHIAEDSDRKYEEVARKLVILEGELERSE rabbit
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
DESERGMKVIENRAMKDEEKMELQEMQLKEAKHIAEDSDRKYEEVARKLV mouse
ERAEVAESKCGDLEEELKIVTNNLKSLEAQADKYSTKEDKYEEEIKLLEEKLKEAETRAE rabbit
FAERSVAKLEKTIDDLEDEVYAQKMKYKAISEE LDNALNDIT S L rabbit
Figure 3*11 Rescreen of the mouse skeletal muscle cDNA 
library using pCM202 as probe
The Pst I fragment of pCM202 was nick-translated 
and used to rescreen the mouse skeletal muscle cDNA 
library. Twenty-two puta .tive positives were selected 
and used for small-scale preparations of plasmid DNA. 2 
jil of each plasmid was then electro- phoresed through a 1$ 
agarose gel, blotted onto nitrocellulose and probed with 
pCM202. Hybridisation was overnight at 42°C followed 
by washing five times for ten minutes in 2xSSC, 0.1$ SDS, 
twice for 30 minutes in O.IxSSC at 45°C and then 
autoradiographfi. (a) shows the gel stained with ethidium 
bromide, (b) shows an autoradiograph of the 
nitrocellulose filter after hybridisation. Three clones, 
numbers 9, 27 and 28 gave a positive hybridisation signal 
and were designated pCM212, pCM232 and pCM222 
respectively.
M U  ■
1
1 5f1 6|1 7|1 8|2C|21|24|25j26j27|2£|29
27 28
Figure 3»12 Estimation of the sizes of the inserts in the 
tropomyosin clones pCM212, pCM222 and pCM232.
Each of the tropomyosin clones were digested with 
Pst I and Hind III in order to determine the size of 
its insert, (a) shows a \% agarose gel. Lanes 1-6 
contained (from left to right) 174 digested with Hpa
II, ^DNA digested with Hind III, pCM202 digested with 
Pst I, pCM232 digested with Pst I, pCM212 digested 
with Pst I (NB In lane 6 the relative intensites of the 
two upper hands indicate partial digestion.) (b) shows a 
0.7$ agarose gel. Lanes 1-6 contain (from left to right) 
XDNA digested with Hind III, pCM202 digested with Hind
III, pCM232 digested with Hind III, pCM222 digested 
with Hind III, pCM212 digested with Hind III and Jl DNA 
digested with Hind III.
2 7 0
1697
375 
349
approximately 4.8 kbp. Digestion of pCM222 produced two Pst I 
fragments of approximately 4.6 kbp and 700 bp whereas pCM212 
produced two Pst I fragments of approximately 4.9 kbp and 3.0 kbp.
It was decided to determine the sequence of each of cDNA 
inserts of pCM212, pCM222 and pCM232 by subcloning fragments of each 
into the bacteriophage vectors M13mp18 and Ml3mp19 and using the 
chain termination sequencing reactions of Sanger (1977). Figure 
3-13 outlines the sequencing strategy adopted for pCM232. It also 
presents a portion of the sequence to demonstrate that pCM232 is, in 
fact, identical to pCM202. Thus it contains the region at the 5 ’ end 
containing the misplaced amino acids (cf Figure 3 .10) and the G/C 
tails which are of identical length to those found in pCM202.
pCM222 was found to contain the coding region of ^ -tropomyosin 
from the initiator methionine to amino acid 172 (516 nucleotides), 
and thus was able to confirm that the first eight amino acids at the 
5' end of pCM202 were indeed misplaced (Figure 3 .14) although the 
region of tropomyosin from which they were considered to be derived 
was also not covered by pCM222. In addition to the coding region of 
f>-tropomyosin pCM222 also contained at least 88 nucleotides 
(probably 95 - see Discussion) of the 5’ non-coding region of the 
mRNA. However preceding these was a region of DNA corresponding to 
nucleotides 287-505 of the coding region of ^ -tropomyosin (numbering 
from the A of the initiator methionine codon AUG), but in an 
inverted orientation, as illustrated in Figure 3 .15 . The nucleotide 
sequence at the junction between this inverted DNA and the 5 1 non­
coding region of ^ -tropomyosin is shown in Figure 3 .16. It should
- 101 -
Figure 3*13 Strategy adopted for sequencing pCM232
(i) Scale indicating the size of the cDNA insert of 
pCM232. (ii) The partial restriction map of pCM232 is 
shown indicating the restriction enzyme sites used for 
determining the nucleotide sequence. The vector DNA is 
indicated by the dotted line. The nucleotide sequence 
was determined by subcloning fragments of the plasmid 
into M13pm18 and M13mp19 and using the dideoxy chain 
termination method, (iii) The sequencing strategy is 
indicated by the arrows ( — >). Arrows above the central 
line indicate sequence determined on the coding strand of 
DNA, those below the line indicate sequence on the non­
coding strand of DNA. The arrows also denote the 
direction and approximate length of the sequence 
determined for each individual subclone, (iv) A 
comparison between the extreme 5' and 3' boundaries of 
pCM202 and pCM232 is shown. Identities are indicated by 
a vertical line.
I I I I I I
1 too 200 300 400 489
Box BBox A
( i i ) —  -
Bgl I Bam HIPstl TAIL
I---------------- a »  —  »
BOX A
(G),,CTGAGAGTAAATGTGGGGAC pCM202loi| | | | | | | | | | II | | | ■ | | |
(G)16CTGAGAGTAAATGTGCGGAC PCM232
BOX B
pCM202 AGGTGGCCAGGAAGCTGGTGA(C) 1 ,
t I I I I l I l I I I I I I I I I I II I , J  2
pCM232- AGGTGGCCAGGAAGCTGGTGA(C) 1 5
Figure 3*14 Partial restriction map and strategy-
adopted for sequencing pCM222
(i) Scale indicating the size of the cDNA insert of 
pCM222. (ii) The partial restriction map of pCM222 is 
shown indicating the restriction enzyme sites used in 
determining the nucleotide sequence. The nucleotide 
sequence was determined by the chain termination method. 
Numbering is with respect to the ^ -tropomyosin sequence 
with the A of the initiator methionine codon AUG counted 
as 1. The vector DNA is indicated by the dotted line.
The open box (95 nucleotides) indicates the 5' non-coding 
region of the mRNA, and the shaded box (b) the main 
tropomyosin coding sequence. The second shaded box, (a), 
also contains tropomyosin sequence, but opposite in 
orientation to the main sequence (b), as indicated by the 
open arrows (i=0)- ( iii) The sequenciang strategy adopted
for pCM222 is presented. Arrows (— indicate the 
direction and approximate length of sequence determined 
for each individual subclone. Arrows above the central 
line indicate sequence determined on the coding strand of 
DNA, while those below the line indicate sequence 
determined on the non-coding strand of DNA.
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Figure 3«15 Partial nucleotide sequence of pCM222
Part of the nucleotide sequence of pCM222 is 
presented opposite including the region of inverted DNA, 
the 5' non coding sequence of the mRNA and the first 150 
nucleotides of the coding sequence. The amino-acid 
sequence is also presented, the three letter amino-acid 
code being used. Numbering above each line is according 
to the amino-acid sequence of j&-tropomyosin starting with 
the initiator methionine. (NB The first 218 nucleotides 
contain the inverted repeat DNA and therefore the amino- 
acids are in reverse orientation. The nucleotide sequence 
presented in this region is from the non-coding strand of 
^-tropomyosin, but the same strand of DNA as the rest of 
the sequence presented, and so the codons and amino-acids 
presented do not correspond to each other.) Numbering 
below each line is according to nucleotide position. A 
comparison between the nucleotide sequences of pCM222 and 
pCM202 is also presented. Identities are indicated by 
vertical lines. Note the bozed region containing the 
first seven codons of pCM202 which is discussed in the 
text.
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Figure 3*16 The nucleotide sequence at the junction 
between the inverted DNA and the 5' 
non-coding DNA of pCM222
(i) A schematic representation of pCM222 is 
presented. The vector DNA is indicated by the dotted 
line. The tropomyosin coding sequence is indicated by 
the shaded boxes, the 5' non-coding region of the mRNA by 
the open box. The open arrows ( cz^) indicate the regions 
of inverted DNA. (ii) A comparison is made between the 
nucleotide sequence on the coding strand of DNA of Boxes 
A and B. Numbering is with respect to the tropomyosin 
sequence (the A of the initiator methionine codon AUG 
being counted as 1). Identities are indicated by a 
vertical line. Note that the nucleotide sequence in Box 
B is in reverse orientation. Note also that the unique 
nucleotides of the 5' non-coding region extend only as 
far as nucleotide -87*
BOX A -107 -97 -87 -77
5 i TGOCCGATCCAACTCCTCCTGACCTGTCCCCT 3 1
j 1 1 ILLI I  I I t l H + h H H  — I----------1-------------------------
3 1 -AOGACACGGitUiiWiAiAAiiAGATicTci 5
313 303 293 283 BOX B
be mentioned here that this artefact is thought to have arisen 
during the construction of the double stranded cDNA and not after 
transformation of the cells. However the possible origins of this 
(and other) artefact(s) will be considered in the Discussion.
Clone pCM212 had been shown by restriction endonuclease 
digestion (Figure 3*12) to be approximately 3*5kb larger than 
pBR322. On analysis of this clone it was found that the primary 
tropomyosin insert accounted for approximately 1.1kb of this 
difference, the remainder being due to a duplication. The sequence 
of the tropomyosin will be presented first, followed by a 
description of how the overall structure of pCM212 was determined.
pCM212 contained the entire coding region of mouse |$- 
tropomyosin (852 nucleotides) together with 72 nucleotides of the 5' 
non-coding (cf. the 5* non-coding sequence of pCM222), and 151 
nucleotides of the 3' non-coding, regions of the mRNA (Figure 3-17) • 
It was from this clone that the majority of the sequence data were 
obtained, with more than 95$ of the ^ -tropomyosin sequence being 
determined on both strands of the DNA. The 72 nucleotides of the 5' 
non-coding region were identical to those found in pCM222 and, 
furthermore, the extensive sequencing was able to confirm that there 
was only one Sst I restriction site in this region of the DNA and 
therefore that the additional 5’ non-coding sequence predicted from 
pCM222 was valid. The presence of the entire coding region also 
confirmed that the misplaced amino-acids in pCM202 had arisen as a 
result of a duplication of nucleotides 561-582 of the coding region 
of £-tropomyosin. However the mechanism by which this could have
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Figure 3*17 Partial restriction map and strategy for
sequencing the tropomyosin region of pCM212
(i) Scale indicating the extent of the tropomyosin 
sequence of pCM212. Numbering is according to the scale 
in Figure 3-18. (ii) The partial restriction map of 
pCM212 is presented indicating restriction enzyme sites 
which were used in determining the nucleotide sequences.
The vector DNA is indicated by the dotted line, the 
tropomyosin coding sequence by the shaded box, the 3' non­
coding sequence by the hatched box and the 5' non-coding 
sequence by the open box. (iii) The sequencing strategy 
adopted for pCM212 is presented. The arrows (— ^) 
indicate the direction and approximate length of the 
sequence determined for each individual subclone. Arrows 
above the central line indicate sequence determined on the 
coding strand of the DNA, while those below the line 
indicate sequence on the non-coding strand of DNA.
2550 
2650 
2750 
28-50 
2950 
3050 
3
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occurred will be considered in the Discussion.
The extra DNA in clone pCM212, other than the primary 
tropomyosin insert, lay 5' of the latter. Much of this lacked 
restriction enzyme sites convenient for cloning into the M13 
sequencing vectors and so a different strategy had to be adopted for 
determining its sequence. The entire 3 .oH>Pst I fragment of 
pCM212 , containing the region for which no sequence had been 
determined, was subcloned into M13mp18. A recombinant phage was 
selected, replicative form DNA prepared from this, and a library of 
deletion subclones made using the method outlined in section 2 •11• 
Clones carrying deletions of varying lengths were selected, as 
described, and sequenced (see Box A of Figure 3*18). The overall 
structure of the DNA bounded by the G/C cloning tails in pCM212 was 
as follows. Following nucleotide 3615 of the vector there was a 
Pst I site and a G/C cloning tail. Then there was a region 
corresponding to nucleotides 778-1008 of the tropomyosin sequence 
in the orientation 5' - 3'. Following this was an "internal" G/C 
tail, lacking a Pst I site (because of a misalignment of the G/C 
tails during the ligation of insert to vector) and nucleotides 3608- 
1671 of the plasmid vector. Following this was a second "internal" 
G/C tail. Interestingly, nucleotides 1675-1671 contain part (5 out 
of 6) of a Pst I recognition site which may be significant in 
explaining the origin of the direct repeat - see Discussion.
However, following the second internal G/C tail was a region of DNA 
corresponding to nucleotides 744-468 (amino-acids 248-156) of the £- 
tropomyosin sequence in inverted orientation (3 ' - 5 '). Then the £- 
tropomyosin sequence, described in Figure 3-17» was found
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Figure 3*18 Partial restriction map, and strategy-
adopted for sequencing pCM212
(i) Approximate scale indicating the length of the 
cDNA insert of pCM212. Bases 2450-3550 are represented 
in more detail in Figure 3*17* (ii) Partial restriction 
map of pCM212 indicating the restriction enzyme sites 
which were used to determine the nucleotide sequence.
The sites of the four G/C cloning tails are indicated.
The vector DNA is indicated by the dotted line, while the 
solid shaded box indicates the total insert DNA. pCM212 
also contained regions of repeated DNA. Directly 
repeated DNA is indicated by the open arrows (i— ). 
Invertedly repeated DNA is indicated by the shaded arrows 
(■■♦). (iii) The sequencing strategy adopted for pCM212 
is shown. Arrows (— indicate the direction and 
approximate length of sequence determined from each 
individual subclone. Arrows above the central line 
indicate sequence determined on the coding strand of the 
DNA, while those below the line indicate sequence on the 
non-coding strand of DNA. Over 95$ of the mouse 
^-tropomyosin cDNA sequence was determined on both strands 
of the DNA. Arrows enclosed within Box A indicate 
sequence determined using the deletion subclone library 
prepared by the method outlined in Section 2.11 .
Figure 
3.17
immediately following this inverted repeat. At the extreme 3' eQd 
of the insert there was a G/C cloning tail, lacking a regenerated 
Pst I site (because of a misalignment of the G/C tails during the 
ligation of insert to vector) then the sequence of the plasmid 
vector resuming at nucleotide 3608 and continuing in the direction 
3608 - 1 (Figure 3*18). A large part of the DNA sequence determined 
for pCM212 is presented in Figure 3*19•
The presence of an "internal" G/C tail immediately preceding 
the inverted repeat suggests that the original cDNA clone contained 
only the tropomyosin sequence with an associated inverted repeat, 
which was presumed to have arisen in a manner similar to that for 
the inverted repeat in pCM222 and before the double stranded cDNA 
was cloned into pBR322 (see Discussion). However, the direct repeat, 
including both the ^ -tropomyosin 3' non-coding sequence and the 
fragment of pBR322, must have arisen in vivo after the ligation of 
the cDNA with the vector and subsequent to the transformation of E. 
Coli. This will be considered further in the Discussion. Figure 
3*20 shows the junction between the 5' non-coding sequence of the £- 
tropomyosin cDNA and the region of inverted DNA, as well as 
comparing the internal G/C tails with those at the extreme ends of 
the cDNA insert.
Approximately 1.1kb of mouse ^ -tropomyosin sequence is 
presented in Figure 3.21 together with the predicted amino acid 
sequence.
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Figure 3*19 The nucleotide sequence of clone pCM202
The partial nucleotide sequence of pCM212 is 
presented. Numbers above each line refer to nucleotide 
position within the total insert DNA, whereas numbers 
below each line refer to nucleotide position with respect 
to the £ -tropomyosin sequence. Note the boxed regions 
indicating the repeated DNA. The open box indicates the 
directly repeated DNA whereas the shaded box indicates 
the invertedly repeated DNA. (NB Only part of the 
internal pBR322 sequence is presented.) Restriction 
enzyme sites which were used for sequencing are 
indicated. G/C cloning tails are indicated by lower case 
letters.
pBR322 4 3 6 3 -3 6 0 9
GACACCACGATGCCTGCAG/ggggggggggggggg 
Pst I
1 86
TCTATGCACAGAAGATGAAGTACAAGGCCATCAGCGAGGAGCTGGACAACGCACTCAATGACATCACTTCCCTCTGAGTCCCCA 
778 864
20687 ______
CTGTGGCCATCGCAGGCCCCTTTCTCTCCTCTCTTTACATTCTCTCTGAGGGGAGGGGGCAGCCAGGAGGAGCACCAGCTAGCCACGTTGCACAGCCAGCCTGAGGGCAGCCTGAGGAAC 
8 65 Nhe I 984
207 326
ACGTCTGCCACCCCTGCCACCCAC/cccccccccccccc/CAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGG 
985 1006
327 2155
ATGGAGGCGGAT....... pBR322 nucleotides 3611-1671.........ACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACA
2156
GGGTAGCCAGCAGCATCCTGCGATGCAG CTTTGCCACAGATCTTTCAGCiyCACTCTGCffCGGGTClvAGCCTCT^TCAGCTTprrCCTCCAGAAGTT 
744 /  Bgl/II /  /  /  /  /  /  677
2274
TGA7CTCTTCTZCGTATTTGTCCTCTT 
67
CTTGTCCeCTTGGGCTTCCAGGGATTTCAAGM'GTTGGTAACAATTT'DCAGCTCCXCCTCTAGOTCCCCACA^TTACTCTOAG
2394
CCACCICGGCTCTOTCTTCCG 
556
CTCCCCTTCCAGGATCACCAGCTTECTGGCCATCTCCTCATATTTGCGQTCTGAGT flGAGC TCGCGCC TAGCC CAGTC TAC CTACTC 
Sst I -40
2514   2633
TTCACCGCTCTCCCGCCAGCCCACTCCCCACCGCAGCCATGGACGCCATCAAGAAGAAGATGCAGATGCTGAAACTGGACAAGGAGAATGCCATCGACCGCGCGGAGCAGGCCGAAGCCG 
-39 1 Aha II 83
ACAAAAAGCAAGCTGAAGACCGATGCAAGCAGCTGGAGGAAGAGCAGCAGGCCCTCCAGAAGAAGCTGAAGGGGACAGAGGACGAGGTGGAAAAGTATTCCGAGTCCGTGAAGGATGCCC 
84 Pvu II 203
2754   2873
AGGAGAAACTGGAGCAGGCTGAGAAGAAGGCCACCGACGCTGAAGCAGATGTGGCCTCTCTGAACCGCCGCATTCAGCTCGTAGAGGAGGAGTTGGATCGGGCACAGGAGCGCCTGGCTA 
204 Sau 3AI 323
2874 2993
CAGCCTTGCAAAAGCTGGAGGAGGCTGAGAAAGCCGCGGATGAGAGCGAGAGAGGAATGAAGGTCATTGAAAACCGGGCCATGAAGGATGAGGAAAAGATGGAGCTGCAGGAGATGCAGC 
324 Pst I 443
2994
TGAAGGAAGCCAAGCACATCGCTG2 
444
GGAGrTCAGACCGCAAATATGAGGAGGTGGCCAGGAAGZTGGTGAT
3114
GTAAATJSTGGGGACGTAGAGGAGGAGCTGAAKATTGTTACCAAGCAATGGCAACAAQGTTAAGC 
564
AGATCAAGTATT
GCTGAAAkAGGCTGAQACCCGAGCAGAGTTTGOTGAAAGATCTGTGGCAAAC ITGGAGAAAACCATTGATGATCTGGAAGATGAAG rCTATGCACAGAAGATGAAGTACA
Sau 3AIBg/ II
3354 3473
AGGCCATCAGCGAGGAGCTGGACAACGCACTCAATGACATCACTTCCCTCTGAGTCCCCACTGTGGCCATCGCAGGCCCCTTTCTCTCCTCTCTTTACATTCTCTCTGAGGGGAGGGGGC 
804 923
3474 3558 pBR322 3611-1
AGCCAGGAGGAGCACCAGCTAGCCACGTTGCACAGCCAGCCTGAGGGCAGCCTGAGGAACACGTCTGCCACCCCTGCCACCCAC/cccccccccccccc/CAGCAATGGCAACAACGTT 
924 Nhe I 1006
Figure 3-20 Detailed examination of the direct and inverted
repeats of pCM212
(i) A schematic representation of clone pCM212 is 
presented. The vector DNA is indicated by the dotted 
line and the solid box indicates the insert DNA. The 
four G/C cloning tails are also indicated. Directly 
repeated DNA is indicated by the open arrows ( «=»• 
Invertedly repeated DNA is indicated by the shaded arrows 
(■■^). (ii) A comparison between the nucleotide sequences 
found on the same strand of DNA in Box A and Box B is 
shown. Numbering is with respect to the £ -tropomyosin 
cDNA sequence (the A of the initiator methionine codon,
AUG, is counted as 1). Note that the sequence in Box B 
is in reverse orientation. Note also that the unique 
nucleotides in Box A only extend up to nucleotide -70.
(iii) A comparison between the nucleotide sequences 
surrounding the G/C tails in Box 2 and Box 4 is shown.
The nucleotide sequences presented are from the same 
strand of DNA. Note the complete identity betwen the two 
sequences as indicated by the vertical lines, (iv) A 
comparison between the nucleotide sequences surrounding 
the G/C tails in Box 1 and Box 3 is shown. The 
nucleotide sequences presented are from the same strand of 
DNA. Note the partial homology immediately preceding the 
G tails, as indicated by the vertical lines.
Box BB ox3 BoxABox1 Box 2
(ii)
BOX A
5 .----
3 «— -— GGAGGAGTATAAAC 
493 483
-84 -74 -64 -54
CATaTTTGCGGTCJGAGTCCAGAGCTCGCGCCTAGCCCA 31
gtataaacgccagactcaAgagtcgctacacgaa 3'
473 463 BOX B
(iii)
(iv)
30X 2
BOX 4
5 1 gccacccCtgccacccac(C)15AGCAATG
ggcaacaacgtt 3
111 ti n H n---
GCAACAACGTT 3
BOX 1
5' —
BOX 3
5' —
— GACACCACGATGCCT^CAG(G).,GTCTATGCACAGAAGAT H- ■ > ——--- 1--►
 3
— GCAGCATCCTGCGATGCAG(G)22CTTTGCCACAGAGATCT 3
Figure 3*21 The nucleotide sequence of mouse 
tropomyosin cDNA
The nucleotide sequence and deduced amino-acid 
sequence of mouse ^ -tropomyosin cDNA is presented. Over 
95$ of the sequence was determined on both strands of the 
DNA, with the majority of the sequence derived from clone 
pCM212. Nucleotides -95 ->-75 were obtained from clone 
pCM222. Numbers above each line refer to amino acid 
position and numbers below each line to nucleotide 
position.
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3»3 Expression of ^-tropomyosin in vivo
Total RNA was isolated from liver, brain, skeletal muscle and 
cardiac muscle, subjected to electrophoresis through denaturing 
formaldehyde agarose gels and then transferred to nitrocellulose 
or nylon membranes (section 2»7»2). In order to determine the size 
of the p-tropomyosin mRNA the 450bp Pst I fragment of clone pCM202 
was nick-translated and hybridised to the immobilised RNA. The 
resulting autoradiograph is presented in Figure 3.22. Several 
different species of RNA hybridised to this probe. Two of them 
occur in RNA isolated from skeletal muscle tissue and have lengths 
of approximately 1.3kb and 2.$kb, whereas one, possibly two, species 
are detected in the RNA isolated from cardiac muscle and have 
lengths of approximately 1.2kb. No tropomyosin mRNA was detected in 
the RNA isolated from either liver or brain, even when the amount 
loaded onto the gel was increased to ten times that which was loaded 
in the skeletal and cardiac tracks. In order to determine which of 
the mRNA species detected by the Pst I fragment of pCM202 
corresponded to the ^-tropomyosin isoform a probe which was 
considered to be specific for £ -tropomyosin was prepared. This was 
done by digesting clone pCM212 with the restriction endonucleases 
Bgl II and Bgl I. This resulted in a fragment of DNA containing 
nucleotides 732-1008 of the ^-tropomyosin sequence together with the 
G/C cloning tail and approximately 150 nucleotides of the plasmid 
vector pBR322. This fragment of DNA was nick-translated and 
hybridised to RNA from the four different tissues. The resulting 
autoradiogra' ?h is presented in Figure 3*23* Only the 1 *3kb 
tropomyosin mRNA species in skeletal muscle RNA was detected by this
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Figure 3*22 Hybridisation of the Pst I fragment of
clone pCM202 with total RNA
Total RNA was isolated from skeletal muscle, cardiac
muscle, liver and brain. 1 jig (I0yt4g for liver and brain)
was electrophoresed through a 0.7$ agarose gel containing
formaldehyde and the RNA blotted onto nitrocellulose.
The Pst I fragment of clone pCM202 was labelled with 
32P. Hybridisation was overnight in 50$ Formamide, 5 
x SSC, 5x Denhardt's, 0.1$ SDS at 42°C. The filter 
was washed 5 times for 10 minutes in 2 x SSC, 0.1$ SDS and 
then autoradiographed. Tracks 1-4 contain, from left to 
right, skeletal muscle RNA, liver RNA, cardiac muscle 
RNA, brain RNA. Molecular weight size markers are 
indicated.

probe, although hybridisation signals were also detected in liver 
and brain RNA. However these bands correspond to the 18S and 28S 
ribosomal RNA fraction, and probably arise as a result of the high 
G/C content of these RNAs and the presence of the G/C cloning tail 
contained within the probe. The fact that similar bands were not 
found in the skeletal and cardiac RNA can be explained in terms of 
the lower concentration of RNA applied to these tracks. The 
conclusion that |£-tropomyosin has an mRNA of length 1 «3kb is 
consistent with the results reported by McLeod et al 1985 for the 
human ^-tropomyosin mRNA.
To determine the pattern of tropomyosin expression throughout 
the development of skeletal muscle, a skeletal muscle cell line 
(C2C12) was examined. This cell line can be cultured as individual 
myoblasts at a high concentration of serum but can be induced to 
fuse into post-mitotic myotubes if the concentration of serum is 
decreased. RNA was isolated from these cells at five different 
stages of their development (section 2.4*3«2). Figure 3*24 presents 
photographs of the cells at the individual myoblast stage, the final 
fused myotube stage and an intermediate stage taken 16 hours after 
reduction of the serum concentration where the cells can be seen to 
be aligning themselves in preparation for fusion. The RNA isolated 
from each developmental stage was separated on a denaturing 
formaldehyde agarose gel and transferred to a nitrocellulose 
membrane. The 400bp Pst I fragment of clone pCM202 was then 
hybridised to the immobilised RNA. Figure 3-25 presents the 
resulting autoradiograph. No tropomyosin mRNA species were detected 
in either of the samples of RNA isolated from the cells grown in
- 106 -
Figure 3*23 Hybridisation of the jj-tropomyosin-specific
probe with total RNA
Total RNA was isolated from skeletal muscle, cardiac
muscle, liver and brain. 1 jxg (lO^ig for liver and brain)
was electrophoresed in a 0.7$ agarose gel containing
formaldehyde and the RNA blotted onto nitrocellulose.
The filter was hybridised overnight at 42°C in 50$
formamide, 5 x SSC, 5 x Denhardt's and 0.1$ SDS. After
hybridisation the filter was washed in 2 x SSC, 0.1$ SDS
at room temperature 5 times for 10 minutes and
autoradiographed. Tracks 1-5 contain, from left to right 
35S-labelled DNA digested with Hind III, skeletal muscle 
RNA, liver RNA, cardiac muscle RNA and brain RNA. Note
the bands corresponding to 18S and 28S rRNA discussed in
the text. One single tropomyosin species is seen in 
skeletal muscle, corresponding to a mRNA of 1 *3kb in 
length.
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Figure 3*24 Differentiating myoblasts in culture
(a) Individual myoblasts cultured in 20$ foetal calf serum.
(b) The morphology of the cells 16 hours after the reduction 
of the serum concentration to 2$. Note that the cells can 
be seen to be aligning themselves in preparation for 
fusion.
(c) The morphology of the cells 64 hours after reduction of the 
serum concentration. Note the multinucleate nature of the 
cells and in particular the long muscle fibre in the
middle part of the photograph.
2U hours
« •
+16 hours
+ 64- hours
high concentrations of serum (tracks 1 and 2). However in the 
first sample taken after reduction of the serum concentration a 
1.2kb species of mENA is clearly detectable. The 1 «3kb species is 
not present whereas the 2.'4kb species is just apparent. RNA 
samples taken 24 hours later clearly show all three species of mRNA 
and a further high molecular weight species (approximately 2 .6kb in 
length), as do the samples taken after a further 24 hours. No 
further samples were taken as the cells at this stage were fully 
fused and thereafter began to die, as is typical of fused myoblasts 
in culture (Blau et al 1983)*
A control experiment performed with a (^P) -labelled cDNA probe 
for actin, from D-P» Leader, (Figure 3*26) clearly shows actin mRNA 
species in the RNA samples taken at all five timepoints and 
therefore it is evident that induction of the tropomyosin mRNAs 
occurs only after fusion of the myoblasts.
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Figure 3-25 Hybridisation of the |&-tropomyosin coding 
probe with RNA isolated at various stages 
of muscle cell development
Total RNA was isolated from C2C12 cells, at five 
stages in their development, separated on a 0.7$ agarose 
gel containing formaldehyde and blotted onto 
nitrocellulose. Hybridisation with the (^P)-labelled 
Pst I fragment of clone pCM202 was overnight in 50$ 
formamide. 5 x SSC, 5 x Denhardt's and 0.1$ SDS. The 
filter was washed in 2 x SSC and 0.1$ SDS for 5 times 10 
minutes at room temperature and then autoradiographed. 
Tracks 1-7 contain, from left to right, skeletal muscle 
RNA, cardiac muscle RNA, RNA isolated from C2C12 cells 24 
hours before reduction of serum, 1 hour before reduction 
of serum, 16 hours after reduction of serum, 40 hours 
after reduction of serum and 64 hours after reduction of 
serum.
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Figure 3-26 Hybridisation of an actin cDNA probe with 
RNA isolated at various stages of muscle 
cell development
Total RNA was isolated from C2C12 cells at different 
stages of their development, separated on a 0.7$ agarose 
gel containing formaldehyde and transferred onto a 
nitrocellulose filter. Hybridisation with the (32p)_ 
labelled actin cDNA probe (from D.P* Leader, University 
of Glasgow) was overnight in 50$ formamide, 5 x SSC, 5 x 
Denhardt's and 0.1$ SDS. After hybridisation the filter 
was washed in 2 x SSC and 0.1$ SDS for 5 times 10 minutes 
at room temperature and then for 2 times 30 minutes at 
42°C in 0.1 x SSC, 0.1$ SDS. The filter was allowed 
to dry and then autoradiographed. Lanes 1-10 contain, 
from left to right, skeletal muscle RNA, cardiac muscle 
RNA, liver RNA, brain RNA,A/Hind III DNA size markers, 
and C2C12 RNA isolated 24 hours before reduction of 
serum, 1 hour before reduction of serum, 16 hours after 
reduction of serum, 40 hours after reduction of serum and 
64 hours after reduction of serum.
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CHAPTER 4
Discussion
4*1 Isolation of cDNAs specific for skeletal muscle
The initial objective of this work was to isolate a cDNA clone 
corresponding to a mRNA expressed in skeletal muscle but not in 
cardiac muscle. One set of cDNA clones isolated which satisfy this 
description are those corresponding to the mRNA encoding £- 
tropomyosin.
4-1 • 1 £ -tropomyosin
Two lines of evidence support the specificity of £-tropomyosin 
for skeletal muscle. Firstly, although tropomyosin is a protein 
which is expressed ubiquitously, protein analysis has detected the 
f-isoform only in skeletal muscle (Cummins and Perry, 1973; Fine and 
Blitz, 1975; Mak et al 1980). Secondly, numerous studies 
involving the isolation of tropomyosin cDNAs from various tissues 
have resulted in the isolation of the £-tropomyosin cDNA only from 
skeletal muscle (McLeod et al 1985)• This is consistent with the 
results obtained in this thesis, when a (^p)-labelled cDNA probe, 
representing tropomyosin coding sequence, was hybridised to "dot- 
blotted" mRNA isolated from skeletal muscle, cardiac muscle, liver 
and brain (Figure 3*4)» The stringency under which the above 
hybridisation was performed did not allow cross-hybridisation with
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the isoform of tropomyosin found in cardiac muscle which is clearly 
visible in track 3 of Figure 3*22, a "Northern" blot of RNA which 
was hydridised to the same probe, but at a much lower stringency. 
Furthermore a (^p)-labelled cDNA probe containing the 3' non-coding 
region of £ -tropomyosin (containing sequence which was considered to 
be unique to the £-isoform) selected a complementary species only in 
skeletal muscle (Figure 3«23)» However at this stage it may be 
worth noting that band selected by this probe was of a lower 
intensity than that selected by the coding region probe. One 
interpretation of this may be that more than one 1 «3kb species of 
tropomyosin mRNA is present in skeletal muscle. This would be 
consistent with the findings of McLeod and Gooding (1988) who 
reported that twooL-isoforms (o^  andc*-2) both with an mRNA 
of 1 «3kb in length are found in adult human skeletal muscle.
The Northern blot of RNA isolated from skeletal muscle, cardiac 
muscle, liver and brain (Figure 3*22) which was hybridised to the 
tropomyosin coding region probe at low stringency also revealed at 
least two other species of RNA. These presumably correspond to 
other isoforms of tropomyosin present in cardiac muscle and skeletal 
muscle but which do not correspond to the 1.3kb mRNA of 0 -  
tropomyosin.
In particular, in skeletal muscle there is a second, minor but 
quite clear, species of approximately 2.4kb in length. This does 
not correspond to any species of tropomyosin previously reported to 
be present in adult skeletal muscle. In fact the only tropomyosin 
mRNA species of approximately this size so far reported is the 2.5kb
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fibroblast mRNA formed by the alternative splicing of the transcript 
which also gives rise to©*JTM2, one of the *Sr-isoforms previously 
reported to be present in skeletal muscle (McLeod et al, 1986;
McLeod and Gooding 1988). Interestingly, however, McLeod and 
Gooding (1988) do report that this 2.5kb species is present in mRNA 
isolated from foetal skeletal muscle, even although it is absent 
from the mature tissue.
There is also at least one mRNA species in cardiac muscle which 
cross-hybridises with the tropomyosin coding region probe. This 
diffuse band corresponding to a mRNA of approximately 1 .2kb in 
length is presumed to contain the two oc-tropomyosin isoforms reported 
by McLeod and Gooding (1988). Only isoform specific probes, 
however, would help to resolve this.
The expression of tropomyosin mRNAs was next examined during 
the differentiation of the mouse myoblast cell line C2C12. In 
prefusion myoblasts no tropomyosin mRNA species were detectable, but 
upon fusion both the 1 .3kb species and the 2.4kb species were 
induced (Figure 3*25)• The 2.4kb mRNA appeared to be expressed 
slightly before the 1 «3kb mRNA and its abundance relative to the 
latter was greater than that found in the mRNA isolated from 
skeletal muscle of 11 day old mice (Figure 3*22). Thus its presence 
in the later may be due to its persistence from an earlier 
developmental stage. Furthermore if its identity is that of the 
fibroblast mRNA reported by McLeod et al (1986) this poses the 
question of its function in skeletal muscle. Since it appears only 
after fusion of the myoblasts and is clearly present in the mature
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tissue, the possibility exists that it may also be involved with the 
sacromere along with the ^-isoform. Studies, in vivo, with an 
isoform-specific antibody, for example, would help to elucidate 
this.
It would also appear that other tropomyosin mRNA species, not 
present in 11 day old leg muscle, are also expressed in the fused 
myoblasts. As equally abundant as, and appearing before the 1 .3kb 
species is one of approximately 1 .2kb in length. Comparison of this 
with the 1 .2kb species of cardiac muscle resolved on the same gel 
indicates clearly that these two species are different. The only 
other species of this size previously reported is another non-muscle 
isoform with a mRNA of 1.1kb, the alternative splicing product of 
the primary transcript which also gives rise to the rat £- 
tropomyosin mRNA (Helfman et al 1986). In addition a second high 
molecular weight species (approximately 2.6kb in length) is detected 
after fusion of the myoblasts. This, however, does not correspond 
to anything previously described and may perhaps represent a 
separate isoform or else be a variant of one of the other spec ies 
poly-adenylated at a different site.
If the identities of the 1 .2kb and 2«4kb myoblast species are 
as suggested it would appear that the initial induction of the mRNAs 
for the major tropomyosins of skeletal muscle (the £- andoc^- 
isoforms) is accompanied by expression of the alternatively spliced 
mRNAs, although this expression is subsequently suppressed. Table 
4*1 briefly summarises the origin of each of the tropomyosin species 
discussed above.
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Positive identification of each of the tropomyosin species 
present in differentiating myoblasts requires the use of isoform- 
specific probes. Nevertheless it is evident that the programme 
leading to the expression of tissue-specific isoforms of tropomyosin 
during muscle differentiation involves the transient expression of 
several other species. This is consistent with the expression of 
multiple isoforms of other muscle proteins such as actin and myosin, 
during differentiation of skeletal muscle (Bains et al, 1984;
Meydert et al, 1987). However in the case of actin, at least, 
differential splicing is not involved.
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Table 4*1 The genetic origins of different tropomyosin mRNAs
(McLeod and Gooding, 1988)
Muscle mRNA product Gene Fibroblast mRNA product
(kb)
TM 1 .1
1 -3 cxJTM.1 TM <x- 1 *3
2.0
1 -3 ocTM.2 TMnm 2.5
The mRNA and protein products of three alternatively spliced 
tropomyosin genes are shown. This thesis proposes that each of 
these mRNA species, apart from the 1 .3 and 2.0kb species derived 
from TM«=*-, are expressed in skeletal muscle at some stage of its 
development.
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4»1 *2 Other cDNA clones specific for skeletal muscle.
None of the other cDNA clones isolated by diferential screening 
proved, in the end, to be specific for skeletal muscle. Little was 
known beforehand about what differences one might expect to find 
between two such closely related tissues as skeletal and cardiac 
muscle, other than the existence of isotypic variants of the major 
structural and functional proteins.
The mammalian genome has been estimated to have the potential 
of coding for up to 300,000 separate genes (Lewin, 1984), but each 
individual tissue is considered to express only a fraction of this 
number. Studies on the mRNA expressed in several terminally 
differentiated tissues have shown that each tissue expresses 
approximately 15-20000 genes (Young et al, 1985; Getz et al, 1976; 
Hastie and Bishop, 1976). Of these only about 20$ are thought to be 
specific to the individual tissue. In addition, the mRNA expressed 
within a tissue falls into one of three categories, high abundance 
mRNA, medium abundance mRNA and low abundance mRNA. The high 
abundance mRNAs of which there are several thousand copies per cell 
constitute less than 1$ of the mRNA species, the medium abundance 
mRNAs, present at several hundred copies per cell, a further 5-10$, 
but the great majority of mRNA species are low abundance mRNAs, 
which are present at only 1-2 copies per cell. It is thought that 
the majority of mRNA species specific to a particular tissue fall 
within the category of low abundance mRNAs.
It is quite clear from the initial screening of the cDNA
- 114 -
library by the method of Grunstein and Hogness (section 2.8.1) that 
the technique was not sensitive enough to detect any but the most 
abundant mRNA species. Thus any differences detected between 
skeletal and cardiac muscle cDNA clones would necessarily involve 
these more abundant mRNAs. Furthermore the similarity between 
cardiac and skeletal muscle isoforms in many cases would be expected 
to lead to cross hybridisation. This then probably explains why 
only one skeletal muscle-specific cDNA was selected. Table 4-2 
lists the possible classes of proteins corresponding to the other 
cDNAs in the clones selected during the screening process which 
turned out not to be specific for skeletal muscle.
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Table 4»2 Possible classes of cDNAs isolated during the 
screening of the mouse skeletal muscle library
Seven of the eight cDNA clones subjected to the final screening 
procedure involving hybridisation to poly(A)+ RNA turned out not 
to be specific for skeletal muscle. The table below indicates the 
possible classes of proteins which these seven clones may represent, 
based on the hybridisation pattern produced when each was hybridised 
to skeletal muscle, cardiac muscle, liver and brain poly(A) RNA.
Clone Skeletal muscle Cardiac muscle Liver Brain Possible protein
classification
9 ++ ++ Muscle eg troponin
21 ++ ++ ++ ++ Metabolic
33 +++ +++ +++ +++ Metabolic
40 + + +++ Neuromuscular
eg acetylcholine 
receptor
44 +++ ++ + Metabolic
215 + + ++ ++ Metabolic
239 +++ +++ + + Muscle eg actin
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4*2 Significance of the mouse ^ -tropomyosin cDNA sequence.
The mouse ft-tropomyosin cDNA sequence isolated during the 
course of this work is almost full length. 1.1 kb of sequence was 
determined from a total of 1«3kb as estimated from Northern blot 
analysis (Figure 3*22). The sequence, obtained from overlapping 
cDNA clones, contained all 852 nucleotides of the coding region 
together with 87 (probably 95) nucleotides of the 5' non-coding 
region and 151 nucleotides of the 3' non-coding region. The only 
^-tropomyosin cDNA described before this work was that of human, 
which, although complete at the 3' end lacked the 5' non-coding 
sequence together with the sequence encoding the first 152 amino- 
acids (McLeod et al, 1985)* Comparison of the 3' non-coding 
region of the mouse £-tropomyosin cDNA with that of the human 
(Figure 4*1), suggests that the mouse cDNA is approximately 80 
nucleotides short at the 3' end.
When McLeod et al (1985) compared the partial human 
^-tropomyosin cDNA sequence with that of T M a  284 amino-acid 
human fibroblast tropomyosin they found that the regions encoding 
amino-acids 153 to 187 and 214 to 257 shared complete (100$) 
nucleotide identity and thus proposed that the£- and TM^g- 
isoforms arose via the differential splicing of the same primary 
transcript. Thus two regions encoding amino-acids 188 to 213 and 
258 to 284 must be contained within alternatively spliced exons. 
This is analogous to the differential splicing found for the
and the TM30yiTn.. isoforms of tropomyosin, but in that particular 
case a further region involving the 5' and of the tropomyosin was
- 117 -
Figure 4»1 Comparison of mouse ^-tropomyosin cDNA with
i *
human and TM^^_tropomyosin cDNAs
A comparison of the mouse f-tropomyosin cDNA sequence 
with that of human £ -tropomyosin and the human
TM^g-tropomyosin cDNA sequences is shown. The 
initiator methionine and termination codons are indicated. 
Identities with the mouse sequence are indicated by 
dashes. Where the sequences differ, the replacement 
nucleotide is given. Note the gaps introduced into the 5' 
and 3' non-coding regions to give the best match. Note 
also that the 3' non-coding region of the isoform
bears little relation to those of both ^-isoforms and 
therefore little matching has been performed. Two regions 
corresponding to amino-acids 188 to 213 and 258 to 284 
show the greatest sequence divergence between the 
£-isoforms and the TM^^-isoform. These regions are 
referred to in the text.
CTCCTGACCTGTCCCCTGTGCATCCAGA GCTCGCG..-Mouse Beta
 CG---- C-A— G-----C TC A-C.. - Human Cytoplasmic
Met
CCTAGCCCAGTCTACCTACTCTTCACCGCTCTCCCGCCAGCCCACTCCCCACCGCAGCC ATG..-Mouse Beta
- ---------- CGTCCGG— C-----
GAC GCC ATC AAG AAG AAG ATG
GCC ATC GAC CGC GCG GAG CAG
GAC CGA TGC AAG CAG CTG GAG
CTG AAG GGG ACA GAG GAC GAG
GAT GCC CAG GAG AAA CTG GAG
GAA GCA GAT GTG GCC TCT CTG
GAG TTG GAT CGG GCA CAG GAG
GAG GAG GCT GAG AAA GCC GCG
ATT GAA AAC CGG GCC ATG AAG
ATG CAG CTG AAG GAA GCC AAG
TAT GAG GAG GTG GCC AGG AAG
CGC TCG GAA GAG AGA GCC GAG
GAG GAG GAG CTG AAA ATT GTT
 A — T CG--- CC A-G
CAA GCG GAC AAG TAT TCC ACC 
TCA -A G G---------------
AAA CTT CTG GAG GAG AAG CTG
-CTG— G---G-------C----------
CAG ATG CTG AAA CTG GAC AAG
GCC GAA GCC GAC AAA AAG CAA
GAA GAG CAG CAG GCC CTC CAG
GTG GAA AAG TAT TCC GAG TCC
CAG GCT GAG AAG AAG GCC ACC
AAC CGC CGC ATT CAG CTC GTA
CGC CTG GCT ACA GCC TTG CAA
GAT GAG AGC GAG AGA GGA ATG
GAT GAG GAA AAG ATG GAG CTG
CAC ATC GCT GAG GAC TCA GAC
----------------- T --------
CTG GTG ATC CTG GAA GGG GAG
GTG GCT GAG AGT AAA TGT GGG
----- C  C CG- GCC A-A
ACC AAC AAC TTG AAA TCC CTG
GA- C-G GC- C-C — G T------
AAA GAG GAC AAA TAC GAA GAA
------ A — T ----- T -------G
------ A — T ----- T -------G
AAA GAG GCT GAG ACC CGA GCA
-GCC ...Human Cytoplasmic
GAG AAT...Mouse Beta 
  — C...Human Cytoplasmic
GCT GAA...Mouse Beta 
  — G...Human Cytoplasmic
AAG AAG...Mouse Beta 
   ...Human Cytoplasmic
GTG AAG...Mouse Beta 
   ...Human Cytoplasmic
GAC GCT...Mouse Beta 
— T  ...Human Cytoplasmic
GAG GAG...Mouse Beta 
   ...Human Cytoplasmic
AAG CTG...Mouse Beta 
   ...Human Cytoplasmic
AAG GTC...Mouse Beta 
   ...Human Cytoplasmic
CAG GAG...Mouse Beta 
   ...Human Cytoplasmic
CGC AAA...Mouse Beta
   ...Human Cytoplasmic
   ...Human Beta
CTG GAG...Mouse Beta
   ...Human Cytoplasmic
   ...Human Beta
GAC CTA...Mouse Beta
C-G — G...Human Cytoplasmic
   ...Human Beta
GAA GCC...Mouse Beta
ATG  ...Human Cytoplasmic
— G  ...Human Beta
GAG ATC...Mouse Beta
   ...Human Cytoplasmic
   ...Human Beta
GAG TTT...Mouse Beta
   ...Human Cytoplasmic
   ...Human Beta
GCT GAA AGA TCT GTG GCA AAG TTG GAG AAA ACC ATT GAT GAT CTG GAA...Mouse Beta
— C — G — G --- --- --- --- --- --- --- — C --- — C — A ---. .. .Human Cytoplasmic
— C — G — G --- --- --- --- --- --- --- --- — C --- — C — A ---. ., .Human Beta
GAT GAA GTC TAT GCA CAG AAG ATG AAG TAC AAG GCC ATC AGC GAG GAG...Mouse Beta
— G ACC T-G GCC AGT GCC --- GA- G— A— GTC -AG — T CA- C—  ACC....Human Cytoplasmic
— C
End
— T -----------A. ..Human Beta
CTG GAC AAC GCA CTC AAT GAC ATC ACT TCC CTC TGA GTCCCCAC TG.,..Mouse Beta
T— --- C-G A-C — G CTG — A C— -AC AA- — G TGA -GG ---GCCCCACC.,..Human Cytoplasmic
--- --- --- --- --- --- --- --- — C --- --- --- -  — -----GCCAGC— .,. .Human Beta
TGGCCATCGCAGGCCCCTTTCTCTCCTCTC TTTACATTCTCTCTGAGGGGAGGGG GCAGCC...Mouse Beta 
CCCAGCCA—GCTATGGT—GC—A—C— AAC-CCCA-T-AAACTGA— TTACT— CCTCTCpolyA..Human Cytoplasmic 
—  C-T -T-TC-------------C---C---------- AT----------A----G-. . .Human Beta
AGGAGGAGCACCAGCTAGCCACGTTGCACAGCCAGCCTGAGGGCAGCCTGAGGAACACGTCTG...Mouse Beta 
---------- GA-AT-GC-A— A------------- G---G-A------- AG---GAG-CC-CA. . .Human-Beta
CCACCCCTGCCACCCAC ...Mouse Beta
T— TG--CA TCTGGCACTGGCTTCATCCTTTACCTATCCCCTTCCACCCTCCTTT. . .Human Beta
GGTTGCTTAATAAATTCTGAACTTGGpolyA .Human Beta
also found to be subject to alternative splicing (McLeod et al, 
1986).
The mouse tropomyosin cDNA sequence thus made it possible to 
compare the 5' regions of the and TM^-isoforms to see if the 
identity between them extends over the remaining sequence (encoding 
amino-acids 1-152) not covered by McLeod et al (1985)*
The result of the comparison (Figure 4-1) indicated that the 
nucleotide sequence corresponding to the first 1 52 amino-acids 
showed no less homology between the mouse tropomyosin and human
TM^-isoform (93*5% identity) than did the mouse and human fi- 
tropomyosin isoforms over the region corresponding to amino-acids 
153-284 (93$ identity). Furthermore those differences which did 
exist in the 5' region (encoding amino-acids 1-152) between the 
mouse and human TM^^-isoforms were scattered randomly and not 
clustered like those in the regions encoding amino-acids 188 to 213 
and 258 to 284. Thus it would appear that the £- and TM^g- 
isoforms do share common exons in the 5* region of the gene and that 
the only exons subject to alternative splicing are those previously 
reported by McLeod et al (1 985)-
While the final part of the mouse ^-tropomyosin clone was being 
determined Helfman et al (1986) published the approximately full 
length cDNA sequences of the rat ^-tropomyosin and TM^-tropomyosin 
isoforms. Comparison of these two isoforms also accords with the 
view that both isoforms arise via the alternative splicing of the 
same primary transcript, with only the two exons, encoding amino-
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acids 188 to 213 and 258 to 284 being subject to alternative 
splicing.
Although Helfman et al (1986) did not have the complete 5' 
non-coding region of the ^-tropomyosin cDNA, primer extension and S1 
nuclease experiments allowed its deduction. Comparison of this 
deduced sequence with the 5' non-coding sequence of the mouse £- 
tropomyosin cDNA indicated that 95 nucleotides of the mouse 5' non­
coding region had been cloned (Figure 4*3) and that it lacked only 
the terminal 16 bases of the 5 * end.
It is clear from the comparison of £ -tropomyosin amino-acid 
sequences, presented in Figure 4»2, that ^ -tropomyosin is very 
highly conserved between species. The only differences to be found 
between the amino-acid sequences of mouse, rat, human and rabbit £- 
tropomyosin is that the human sequence (as predicted from the human
sequence) has a Glu residue at position 66 whereas the 
other species have an Asp residue at this position. This 
difference, however, is a conservative substitution and as such 
should not dramatically affect the properties of tropomyosin.
The availability of the human and rat ^-tropomyosin cDNA 
sequences made it possible to compare them with the mouse sequence 
(Figure 4»3) to see to what extent the 5' and 3' non-coding 
sequences of £ -tropomyosin have been conserved between species. In 
order to do this, the most useful frames of reference are the 
neutral positions in the coding regions of the cDNAs. To obtain a 
value for the number of neutral mutations which have occurred since
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Figure 4*2 Comparison of the deduced amino-acid sequences 
of mouse, human, rat and rabbit £ -tropomyosin
A comparison of the deduced mouse -tropomyosin amino- 
acid sequence with that of human, rat and rabbit is 
shown. Identities with the mouse sequence are indicated 
by dashes. Note the only difference between the four 
species is that human £-tropomyosin has a glutamic acid 
residue at position 66.
10 20 30 40 50
MDAIKKKMQM LKLDKENAID RAEQAEADKK QAEDRCKQLE EEQQALQKKL....Mouse
---------- ------------------------------------------------ .... Human
--------- ----------------------------------------------- Rat
---------- ------------------------------------------------ .... Rabbit
60 70 80 90 100
KGTEDEVEKY SESVKDAQEK LEQAEKKATD AEADVASLNR RIQLVEEELD....Mouse
--------------  E------------------------------------- .... Human
--------- --------------------- ------------------------- Rat
---------- ------------------------------------------------ .... Rabbit
110 120 130 140 150
RAQERLATAL QKLEEAEKAA DESERGMKVI ENRAMKDEEK MELQEMQLKE....Mouse
---------- -------- - - ------------------------------------ ....Human
------  — ----------------- ------ ----------------------------Rat
--------------  ;-- ------------------------------------ .... Rabbit
160 170 180 190 200
AKHIAEDSDR KYEEVARKLV ILEGELERSE ERAEVAESKC GDLEEELKIV....Mouse
---------- ------------------------------------------------ .... Human
---------- ----------------------------------------------------Rat
---------- ------------------------------------------------ .... Rabbit
210 220 230 240 250
TNNLKSLEAQ ADKYSTKEDK YEEEIKLLEE KLKEAETRAE FAERSVAKLE....Mouse
---------- ------------------------------------------------ .... Human
--------- ---------- ---------------------------------Rat
---------- ------------------------------------------------ .... Rabbit
260 270 280 284
KTIDDLEDEV YAQKMKYKAI SEELDNALND ITSL Mouse
------------   .... Human
---------------  ;-   Rat
------------   .... Rabbit
Figure 4*3 Comparison of the mouse, human and rat 
jj-tropomyosin cDNA sequences
A comparison between the mouse, human and rat 
tropomyosin cDNA sequences is shown. The human 
sequence was partially predicted from the human T
tropomyosin cDNA sequence as is referred to in the text. 
The initiator methionine and termination codons are 
indicated. Identities with the mouse sequence are 
indicated by dashes. Where the human and rat sequences 
differ from the mouse the replacement nucleotide is 
indicated. Note the gaps introduced into the 5' and 3' 
non-coding regions to produce the best match.
CTCCTGACCTGTCCCCTGTGCATCCAGA GCTCGCG...Mouse Beta
 CG----C-A— G--- C TC A-C. . .Human Beta
 A--------- G-GTGCAT-- T --- T— ...Rat Beta
Met
CCTAGCCCAGTCTACCTACTCTTCACCGCTCTCCCGCCAGCCCACTCCCCACCGCAGCC ATG...Mouse Beta
- ------- -CGTCCGG— C-------CTG— G--G----- C---------- GCC ...Human Beta
G------ G---------------------G----- G---------------------  ...Rat Beta
GAC GCC ATC AAG AAG AAG ATG CAG ATG CTG AAA CTG GAC AAG GAG AAT...Mouse Beta
 -- --- --- --- --- --- --- --- --- --- --- --- --- --- --- .. .Rat Beta
GCC ATC GAC CGC GCG GAG CAG GCC GAA GCC GAC AAA AAG CAA GCT GAA...Mouse Beta
 -- --- --- — A  --- --- --- --- --- — G  --- --- --- . . .Rat Beta
GAC CGA TGC AAG CAG CTG GAG GAA GAG CAG CAG GCC CTC CAG AAG AAG...Mouse Beta
 -- --- --- --- --- --- --- --- --- --- --- --- --- --- — A.. .Rat Beta
CTG AAG GGG ACA GAG GAC GAG GTG GAA AAG TAT TCC GAG TCC GTG AAG...Mouse Beta
 -- --- --- --- — X  --- --- --- --- --- --- — t  -.. .Rat Beta
GAT GCC CAG GAG AAA CTG GAG CAG GCT GAG AAG AAG GCC ACC GAC GCT...Mouse Beta
— G  -- --- --- --- --- --- — C  --- --- --- — T — T  . . .Human Beta
 -- --- --- --- --- --- --- — C  --- --- --- --- — T  .. .Rat Beta
GAA GCA GAT GTG GCC TCT CTG AAC CGC CGC ATT CAG CTC GTA GAG GAG...Mouse Beta
— G  -- --- --- — C  --- --- --- --- --- — G — T  --- . . .Human Beta
GAG TTG GAT CGG GCA CAG GAG CGC CTG GCT ACA GCC TTG CAA AAG CTG...Mouse Beta
 C—  — C  — C  ----- --- --- --- --- C—  — G   . . .Human Beta
 -- --- --- --- --- --- --- --- --- --- --- --- --- --- --- .. .Rat Beta
GAG GAG GCT GAG AAA GCC GCG GAT GAG AGC GAG AGA GGA ATG AAG GTC...Mouse Beta
    ----- — X  -------------       .. .Rat Beta
ATT GAA AAC CGG GCC ATG AAG GAT GAG GAA AAG ATG GAG CTG CAG GAG...Mouse Beta
 — G  --     — --- — G  -------    .. .Rat Beta
ATG CAG CTG AAG GAA GCC AAG CAC ATC GCT GAG GAC TCA GAC CGC AAA...Mouse Beta
 -- --- — A  ------------------           .. .Rat Beta
TAT GAG GAG GTG GCC AGG AAG CTG GTG ATC CTG GAA GGG GAG CTG GAG...Mouse Beta
— C  ----- --- --- --- --- --- --- --- --- — A  - . . .Rat Beta
CGC TCG GAA GAG AGA GCC GAG GTG GCT GAG AGT AAA TGT GGG GAC CTA...Mouse Beta
 -- — G  — G — T   — C  --------     . . .Human Beta
 — X  -- --- --- --- --- --- --- --- --- --- --- --- --- . . .Rat Beta
GAG GAG GAG CTG AAA ATT GTT ACC AAC AAC TTG AAA TCC CTG GAA GCC...Mouse Beta
-----------------------------------------------X  . . .Rat Beta
CAA GCG GAC AAG TAT TCC ACC AAA GAG GAC AAA TAC GAA GAA GAG ATC...Mouse Beta
— G  ----- --- --- --- --- — A — T  — T  — G  -.. .Human Beta
 -- --- --- --- --- --- --- --- --- --- --- --- --- --- --- .. .Rat Beta
AAA CTT CTG GAG GAG AAG CTG AAA GAG GCT GAG ACC CGA GCA GAG TTT...Mouse Beta
 -- --- --- --- --- --- — G    --- --- --- --- --- .. .Rat Beta
GCT GAA AGA TCT GTG GCA AAG TTG GAG AAA ACC ATT GAT GAT CTG GAA...Mouse Beta
— C — G — G  --- --- --- --- --- --- --- — C  — C — A  . . .Human Beta
 -- --- --- --- --- --- --- --- --- --- — C  — C  --- .. .Rat Beta
GAT GAA GTC TAT GCA CAG AAG ATG AAG TAC AAG GCC ATC AGC GAG GAG...Mouse Beta
 -- --- --- --- --- --- --- --- --- --- --- --- --- --- --- . . .Rat Beta
END
CTG GAC AAC GCA CTC AAT GAC ATC ACT TCC CTC TGA GTCCCCAC T...Mouse Beta
 -- --- --- --- --- --- --- — C  --- --- ------- GCCCAGC. . .Human Beta
 -- --- — G  --- --- --- --- --- --- --- — T  -. . .Rat Beta
GTGGCCATCGCAGGCCCCTTTCTCTCCTCTC TTTACATTCTCTCTGAGGGGAGGGG GCAGC...Mouse Beta
------ C-T T-TC----------- C C--------- AT-------- A G. . .Human Beta
-----------------  X  C-------------------------------...Rat Beta
CAGGAGGAGCACCAGCTAGCCACGTTGCACAGCCAGCCTGAGGGCAGCCTGAGG AACACGTC...Mouse Beta
---------- GA-AT-GC-A— A----------- G-- G-A---------- G-GAG-CC-. . .Human Beta
----------- ft-A— g--- T------------ T---------------- G--------...Rat Beta
TGCCACCCCTGCCACCCAC 
CAT— TG--CA-------
.Mouse Beta 
.Human Beta 
.Rat Beta
the divergence of mice, rats and men, the following procedure was 
adopted. Within the constraints of the genetic code for a conserved 
amino acid sequence some nucleotides are more free to mutate than 
others. Thus, unlike the non-coding regions, where there is 
theoretically no constraint on mutation, each codon must he 
multiplied by a factor reflecting the effective number of positions 
at which neutral mutation can occur. This factor is equal to 1 .0 
for each codon of the four codon families, such as that for Ala,
0.67 for the three codon family of lie, 0.33 for the two codon 
families, such as that of Asp, and 0 for the unique codons of Met 
and Trp. Each codon in the six codon families of Ser, Leu and Arg 
was assessed separately. Using these values it was calculated that 
of the 852 nucleotides encoding mouse -tropomyosin, the effective 
number of positions at which neutral mutations can occur is 160.
When the divergence of the effective neutral nucleotides in the 
coding regions of mouse and rat ^-tropomyosin were calculated it was 
found to be 14$- This compared to a 9$ divergence in the 3' non­
coding region and a 10.5$ divergence in the 5' non-coding region. 
This suggests that there has been some pressure to conserve the non­
coding regions of the mRNA since if there had been no pressure then 
one would expect them to show a divergence at least as great as that 
shown by the coding regions. Similarly a comparison between the 
mouse and human cDNA sequences showed a 35 *5$ divergence in the 
coding region compared to a 30$ divergence in the 3' non-coding 
region and a 27*5$ divergence in the 5' non-coding region.
The extent of conservation of the 3' non-coding region of £-
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tropomyosin between species is not as great as that found in the ot- 
cardiac isoform of actin (Leader et al,1986) and in the mRNAs of 
some other proteins (Yaffe et al, 1985)* However Gunning et al 
(1984) have proposed that despite divergence of the primary 
sequence, secondary structure motifs may be conserved.
Nevertheless, analysis of the 3' non-coding region of ^-tropomyosin 
using the computer program CINTHOM (an unpublished adaptation by P. 
Taylor, Institute of Virology, University of Glasgow of the diagonal 
matrix program of Pustell and Kafatos, 1982) has failed to find any 
conserved potential secondary structure. However, as will be 
explained in more detail later, the 5' non-coding region of
-tropomyosin contains at least two regions of sequence capable of 
forming some form of secondary structure with sequence elements 
within the coding region.
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4*3 The origins of the direct and inverted repeats in the 
P -tropomyosin cDNAs
All the ^-tropomyosin cDNA clones isolated during the course of 
this work contained what appear to be cloning artefacts. Two of 
them, pCM222 and pCM212, contained regions of invertedly repeated 
DNA (Figures 3*14 and 3*17, respectively) and two, pCM202/pCM232 and 
pCM212, contained directly repeated DNA (Figure 3*17)• These two 
different types of artefact are thought to have arisen in different 
ways and therefore will be dealt with separately. The case of the 
inverted repeats will be discussed first.
It has been proposed that regions of inverted DNA found in cDNA 
clones arise during the synthesis of the second strand of cDNA, and 
before the subsequent ligation of the cDNA to a vector (Fields and 
Winter, 1981; Volekaert et al, 1981). Synthesis of the second 
strand of cDNA using the method of Villakomeroff (1978), relies on 
the principle that when the RNA is removed from the reaction 
(usually be boiling or alkaline hydrolysis), following first strand 
synthesis, the 3' end of the single-stranded cDNA which is left will 
fold back on itself (forming a hairpin loop) to prime the synthesis 
of the second strand of cDNA. The second strand of cDNA is then 
synthesised by E.Coli DNA polymerase I. At the end of the second 
strand reaction the single-stranded hairpin loop is removed by S1 
nuclease digestion before the double stranded cDNA is cloned into 
the vector. Thus the formation of almost full length cDNAs, (or 
those containing the 5' end of the mRNA, at least), relies on the 
formation of a stable hairpin loop at the extreme 3' end of the
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single-stranded first strand of cDNA (presuming, of course, that a 
full length first strand had been synthesised). However, in many 
cases the extreme 3' end of the first strand of cDNA cannot form a 
stable hairpin loop with an adjacent region of sequence, but does so 
with an appropriate sequence distal to it. Inverted repeats, like 
those found in pCM212 and pCM222, are thought to arise when the 
extreme 3' end of the first strand of cDNA forms the hairpin loop 
structure with an appropriate sequence distal to it. However before 
the single-stranded loop is lost through S1 nuclease digestion one 
of two possible events is thought to happen (Figure 4*4)* One is 
that the region of double-stranded cDNA denatures or "slips" so that 
one long single-stranded cDNA is formed once again with the extreme 
3' end of this now being able to form the hairpin loop with a 
proximal sequence. This then primes second-strand synthesis and 
results in a double-stranded cDNA containing an inverted repeat 
immediately preceding the original sequence (Figure 4«4a)* The 
second possibility is that the 5' —  3'o<oK\A.Gk<xs£ activity of DNA 
Polymerase I is invoWed in the generation of the inverted repeat.
It is proposed that during second strand synthesis the original 
first strand of cDNA becomes nicked and denatures from the second 
strand, thus leaving both a region of single-stranded DNA and of 
double-stranded DNA. The point at which the occurs then
serves as a primer for complementary strand synthesis (Figure 4«4b). 
The reason why denaturation or "slippage" of the hairpin structure 
should occur is unclear, but may be as a result of the instability 
of the hairpin structure because of the formation of a large 
single-stranded loop. For example in pCM212 this would contain 
approximately 600 bases and in pCM222 approximately 380 bases.
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Figure 4»4 Schematic representations of the process 
leading to inverted repeat sequences in 
cDNA clones
Two theoretical schemes for the generation of 
inverted DNA repeats in cDNA clones are shown, (a) The 
inherent instability of a large hairpin loop structure 
may cause slippage or denaturation during second strand 
synthesis, (b) The exonuclease activity of the E.Coli 
DNA polymerase I has been implicated in the generation of 
inverted repeat sequences. Again the inherent instability 
of a large hairpin loop would cause unfolding of the 
molecule during second-strand synthesis revealing a new 
3' end which is used to prime the synthesis of a new 
second strand.
( a )  c b a
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I reverse transcriptase
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 e' ssDNA
c' b '  '
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Figures 3*20 and 3-16(ii) indicate the sequences which are presumed 
to have been the original 3' ends of the first strands of both 
pCM212 and pCM222 respectively and shows that they are complementary 
to nucleotides 463 to 470 and 289 to 297, of the jS-tropomyosin 
coding region. Analysis of the extreme 5' non-coding sequences of 
both pCM212 and pCM222 in relation to the remaining sequence in the 
clone, using the computer program CINTHOM indicated that hairpin 
structures were unlikely to form between any regions other than 
those indicated in Figures 3*20 and 3-16.
The two direct repeats, found in clones pCM202 and pCM212 are 
thought to have distinct origins and therefore will be dealt with 
separately. It is difficult to present a theoretical model for the 
origin of the direct repeat in pCM202. The only precedent for such 
a repeat is a tandem repeat found in the 3* non-coding region of a 
mouse skeletal muscle actin cDNA clone (Leader et al, 1986).
However there are certain differences worth noting. The direct 
repeat of 70 nucleotides found in the skeletal muscle actin cDNA 
occurs tandemly, that is the 70 nucleotides are repeated immediately 
without any intervening DNA sequence. Furthermore the tandem repeat 
is found internally within a larger sequence with over 1kb of 
sequence 5' to the repeat and 140 bases 3' to the repeat. The 
direct repeat in pCM202, however, involves the duplicative 
transposition of 21 nucleotides of DNA to a position 500 nucleotides 
upstream of where they are found in native £-tropomyosin. In 
addition there is only one copy of this sequence in the cDNA clone 
(Figure 4*5)« Nevertheless, I can offer no better explanation than 
that of Leader et al (1986), that during first strand synthesis,
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Figure 4*5 The direct repeat DNA found in clone pCN202
A diagrammatic representation of clone pCM202 is 
presented. The first 21 nucleotides are a direct repeat 
of the sequence from nucleotide 546 to 567 of
tropomyosin. Note that pCM202 is truncated before it 
reaches this region.
H
-o
>
the cDNA became dislodged from the mRNA template and that 
reattachment occurred approximately 500 nucleotides 3' to the point 
at which detachment had occurred. However no potential secondary 
structure interactions can be found to support this model.
The second direct repeat, found in pCM212, is thought to have 
arisen after the transformation of E. coli with the original cDNA 
clone. The original cDNA clone is thought to have consisted of the £- 
tropomyosin sequence together with the associated inverted repeat 
and bound by two G/C cloning tails (nucleotides 2184 to 3572 of the 
pCM212 sequence presented in Figure 3-19)* Thus although the strain 
of E.Coli used was a rec A”strain of bacteria it is proposed that 
the direct repeat arose as a result of an initial recombination 
event which duplicated the £-tropomyosin sequence together with part 
of the pBR322 sequence, and then the subsequent deletion of part of 
one of the £-tropomyosin copies. Figure 4 *6 represents a theoretical 
model of the secondary structure formation which may have been 
involved in the deletion of one of the copies of the £ -tropomyosin 
sequence.
4*4 The CpG dinucleotide distribution in ^-tropomyosin cDNA
One feature of the mouse ^-tropomyosin cDNA sequence that was 
of interest was the distribution of CpG dinucleotides. The 
relevance of this is to DNA methylation which has been implicated in 
the control of expression of mammalian genes. Mammalian DNA can be 
methylated most commonly resulting in a 5-methylcytosine (mC) 
residue occurring predominantly in the dinucleotide CpG. The
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Figure 4*6 Theoretical secondary structure interactions 
proposed for clone pCM212
Clone pCM212 is considered to have originally 
comprised of the ^ -tropomyosin sequence together with a 
region of invertedly repeated DNA (the inverted repeated 
DNA is indicated by arrows). The region of directly 
repeated DNA together with the two extra G/C cloning 
tails actually found in clone pCM212 are considered to 
have arisen as a result of a recombination event in 
vivo which led to the duplication of the ^ -tropomyosin 
sequence together with the inverted repeat and part of 
the pBR322 vector and then the subsequent deletion of 
part of one of the tropomyosin sequences. The figure 
opposite illustrates that the invertedly repeated DNA is 
able to form a stem and loop structure, with its 
corresponding sequence in 0-tropomyosin. The subsequent 
deletion of this structure would give rise to a cDNA clone 
with the characteristics of that found in the clone 
pCM212.
recombination 
leading to 
duplication
v
secondary structure forms
deletion
▼
j<—
>
incidence of CpGs in the genome is less than expected from its base 
composition, but this has been ascribed to the mCs being 
deaminated to produce T residues. This would thus result in the 
replacement of CpG by TpG, with CpA appearing in the complementary 
strand (Salser, 1977; Bird, 1980). Consequently the occurrence of 
the dinucleotide CpG has been used as a ga&ge of the methylation 
state of the DM. Although it is considered that vertebrate 
genomes, in general, contain a deficit of CpG dinucleotides, it has 
emerged that the 5' flanking regions of several mammalian house­
keeping genes have "GC-rich islands". Therefore to explain the high 
incidence of CpG residues in these regions it has been suggested 
that the DNA must be unmethylated. However Peter et al (1988) 
have recently suggested that there may be hemimethylation of the DNA 
in the 5' exons of actin genes. Their proposal was based on a 
deficit of CpG dinucleotides occurring in the codon position [2,3]> 
but not the in [3>l] position, the reasoning involved being 
explained in more detail below. This pattern was not found in 
several other cDNAs examined, and so it was of interest to analyse 
the coding region of the mouse £ -tropomyosin cDNA for the occurrence 
of CpG dinucleotides with reference to the codon position 
([2,3], [3,1]) in which they occur.
There are four occurrences of CpG in the [2,3] codon position. 
When this is compared to the thirteen theoretically possible 
occurrences (assuming the amino-acid sequence is a constraining 
factor) an obvious deficit is found. The number of theoretically 
possible occurrences was calculated by counting the number of codons 
containing a C in position two and then dividing this number by four
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to find the number which would theoretically have a G in position 
three. This assumes that there is a random distribution of all four 
bases in position three, but in fact, since the mouse |3-tropomyosin 
sequence contains a higher occurrence of G residues in the third 
position (41 *8$) than any of the other bases, the observed deficit, 
calculated for a random 25% distribution of G residues in position 
three, is an underestimation.
The theoretical maximum occurrence of CpG dinucleotides in the 
[3*1] position was calculated using a factor which reflects the 
constraint of the genetic code on a conserved amino-acid sequence. 
Each codon which has a G residue in position one was examined 
together with the codon immediately preceding it. The preceding 
codon was then given a value which reflected the chance of it having 
a C residue in position three. Thus for four codon families such as 
Ala this value was 0.25* for the three codon family of lie the 
value was 0.33* Bor the two codon families such as Asp the value 
was 0.5, but for the two codon families such as Glu the value was 0. 
The six codon families of Arg and Leu were given a value of 0.17 
and the six codon families of Ser a value of 0.33* Finally the 
unique codons of Met and Trp were given a value of 0. The summation 
of all these values calculated for the £-tropomyosin sequence (24) 
was then compared to the actual occurrence of CpG dinucleotides in 
the [3,1 ] position (19) and once again a deficit was apparent. The 
true deficit may in fact be greater since ^-tropomyosin contains 21% 
C residues in position three. However, when the regional 
distribution of CpG dinucleotides in the [3»l] position was mapped 
(Figure 4*7) it was found that they were clustered in the 5' half of
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Figure 4*7 The regional distribution of CpG dinucleotides 
in the nucleotide sequence of mouse 
£-tropomyosin cDNA
The occurrence of CpG dinucleotides in the codon 
positions [1»2], [2,3] and [3 *1] of the mouse 
^-tropomyosin cDNA sequence were mapped. These are shown 
together with a composite showing total occurrences. Each 
CpG dinucleotide is indicated by a vertical line. The 
initiator methionine and termination codons are 
indicated. The table below indicates the occurrences of 
CpG in each codon position in relation to the expected 
occurrence as discussed in the text.
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the cDNA. In these exons no deficit is apparent (for amino-acids 1- 
150, 14 occurrences out of an expected 12 occurrences), whereas in 
the 3' half of the cDNA the deficit tends to that found for the 
[2 ,3] position. This is similar to the findings of Peter et al 
(1988) for actin cDNAs. In the absence of any physical or 
biological rationale for the selection either against NCG codons, 
or in favour of NNC codons followed by a G, Peter et al (1988)
interpreted the deficit in terms of strand-specific hemimethylation
as follows.
As explained diagrammatically in Figure 4*8, in order to 
conserve the amino-acid sequence one must select against 
deaminations of mCpGs which result in an amino-acid change.
Therefore if the coding strand is methylated, deaminations of 
mCpGs in the [1,2] and [2 ,3] positions will be selected against, 
thus no deficit of CpG dinucleotides in these codon positions 
will be evident. However if the non-coding strand is methylated 
then deaminations of mCpG in the [1,2] and [3»l] positions will 
result in amino-acid changes and thus would be selected against, 
whereas deamination of mCpG in the [2 ,3] will result only in a 
silent nucleotide mutation. Therefore one might expect to find no 
CpG deficits in the [1 ,2] and [3»l] positions but a theoretical CpG
deficit in the [2 ,3] position would be possible.
This idea of hemimethylation is, of course, difficult to prove 
since only a fraction of methylated CpGs are detectable by 
restriction enzyme analysis which in any case could not distinguish 
between hemimethylated and fully methylated DNA. At present the
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Figure 4»8 The theoretical effect of hemimethylation 
of DNA on amino-acid sequences
A diagrammatic scheme indicating the possible 
consequences, for an amino acid sequence, of the 
hemimethylation of germ line DNA. Note that if the 
coding strand of DNA is methylated deamination of a 5- 
methylcytosine in the dinucleotide CpG in codon positions 
[l ,2j and [2 ,3] would lead to an amino-acid change 
(indicated by parentheses). Similarly if the non-coding 
strand of DNA is methylated, deamination of the 5- 
methylcytosine of CpG dinucleotides in the codon 
positions L3,l] and [l,2] would result in amino-acid 
changes. The consequence this has for the distribution of 
CpG dinucleotides in a sequence of DNA is discussed in 
the text
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only method of test this hypothesis would appear to he the direct 
sequencing of genomic DNA using the chemical scission reactions of 
Maxam and Gilbert (1980).
It is difficult to say what implications the hemimethylation of 
the 5' regions, of DNA would have on the expression of tropomyosin. 
Clearly if ^ -tropomyosin and are subject to alternative
splicing, the hemimethylation of the DNA cannot be used to 
distinguish muscle genes from non-muscle genes for example, since 
both isoforms share common 5' exons. However since the mRNAs of 
both isoforms appear to have identical 5' termini it is more likely 
that the control mechanisms for alternative splicing of the pre-mRNA 
lie within the 3' half of the mRNA. Thus one imagines that 
hemimethylation, if it occurs, would only be involved in the 
(de)activation of the gene as a whole and not differential 
expression of ^ -tropomyosin the
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